Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| CV OUTCOMES 2 | |||
| 2013-002795-41 | EudraCT Number |
Not provided
Not provided
See Detailed Description
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study evaluates the PCSK9 inhibitor, Bococizumab (PF-04950615;RN316), compared to placebo, in reducing the occurrrence of major cardiovascular events, including cardiovascular death, myocardial infarction, stroke, and unstable angina requiring urgent revascularization in high risk subjects who are receiving background lipid lowering therapy and have cholesterol laboratory values of LDL-C >/= 100 mg/dL (2.6 mmol/L) or non-HDL-C >/=130 mg/dL (3.4 mmol/L).
The trial was terminated prematurely on November 1, 2016, due to the emerging clinical profile and the evolving treatment and market landscape for lipid-lowering agents. These indicated that bococizumab was not likely to provide value to patients, physicians, or shareholders. The decision was not based on a recommendation by the independent Data Monitoring Committee to stop the program.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| bococizumab (PF-04950615) | Experimental | 150 mg, every 2 weeks, subcutaneous. |
|
| Placebo | Placebo Comparator | Placebo comparator, every 2 weeks, subcutaneous. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| bococizumab (PF-04950615) | Drug | 150 mg, every 2 weeks, subcutaneous. The duration of the treatment period will depend upon reaching the targeted number of adjudicated and confirmed CV outcome events, approximately 3 to 4 years after the entry of first subject into the study. |
| Measure | Description | Time Frame |
|---|---|---|
| Event Rate Per 100 Participant-years for First Occurrence of Major Cardiovascular (CV) Event | Event rate per 100 participant-years for first occurrence of major CV event (adjudicated by Adjudication Committee) was reported. Major CV event was defined as any of the following: CV death [defined as sudden cardiac death, fatal myocardial infarction (MI), death due to heart failure, death due to stroke (fatal ischemic stroke or fatal stroke of undetermined etiology), or death due to other CV causes] non-fatal MI, non-fatal stroke, and hospitalization for unstable angina needing urgent revascularization. Event rate was calculated as the number of events per 100 participant-years at risk. | From baseline until the date of first adjudicated and confirmed occurrence of major CV event (maximum duration: up to 3.4 years) |
| Measure | Description | Time Frame |
|---|---|---|
| Event Rate Per 100 Participant-years for First Occurrence of Composite Endpoint of Cardiovascular (CV) Death, Non-fatal Myocardial Infraction (MI) or Non-fatal Stroke | Event rate per 100 participant-years for first occurrence of composite endpoint of CV Death, non-fatal MI or non-fatal stroke (adjudicated by Adjudication Committee) was reported. CV death was defined as sudden cardiac death, fatal MI, death due to heart failure, death due to stroke (fatal ischemic stroke or fatal stroke of undetermined etiology), or death due to other CV causes. Event rate was calculated as the number of events per 100 participant-years at risk. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Pfizer CT.gov Call Center | Pfizer | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Ernest Hendrix, MD, PC | Athens | Alabama | 35611 | United States | ||
| North Alabama Research Center, LLC |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 35277540 | Derived | Chasman DI, Hyde CL, Giulianini F, Danning RD, Wang EQ, Hickling T, Ridker PM, Loomis AK. Genome-wide pharmacogenetics of anti-drug antibody response to bococizumab highlights key residues in HLA DRB1 and DQB1. Sci Rep. 2022 Mar 11;12(1):4266. doi: 10.1038/s41598-022-07997-5. | |
| 29716940 | Derived | Pradhan AD, Aday AW, Rose LM, Ridker PM. Residual Inflammatory Risk on Treatment With PCSK9 Inhibition and Statin Therapy. Circulation. 2018 Jul 10;138(2):141-149. doi: 10.1161/CIRCULATIONAHA.118.034645. Epub 2018 May 1. |
| Label | URL |
|---|---|
| To obtain contact information for a study center near you, click here. | View source |
Not provided
The trial was terminated prematurely on November 1, 2016, due to the emerging clinical profile and the evolving treatment and market landscape for lipid-lowering agents.
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Placebo | Participants received single dose of placebo matched to PF-04950615 subcutaneous injection once in every 2 weeks over a period of 3 years. Participants were followed up to 40 days after the last dose. |
| FG001 | Bococizumab (PF-04950615) |
| Title | Milestones | Reasons Not Completed | |||||
|---|---|---|---|---|---|---|---|
| Overall Study |
|
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot | Yes | No | No | Study Protocol | Feb 12, 2016 | Mar 21, 2018 |
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Placebo | Drug | Placebo comparator, every 2 weeks, subcutaneous. The duration of the treatment period will depend upon reaching the targeted number of adjudicated and confirmed CV outcome events, approximately 3 to 4 years after the entry of first subject into the study. |
|
| From baseline until the date of first adjudicated and confirmed occurrence of CV death, non-fatal MI or non-fatal stroke (maximum duration: up to 3.4 years) |
| Event Rate Per 100 Participant-years for First Occurrence of Composite Endpoint of All-cause Death, Non-fatal Myocardial Infraction (MI), Non-fatal Stroke or Hospitalization for Unstable Angina Needing Urgent Revascularization | Event rate per 100 participant-years for first occurrence of composite endpoint of all-cause death, non-fatal MI, non-fatal stroke or hospitalization for unstable angina needing urgent revascularization (adjudicated by Adjudication Committee) was reported. All-cause death was defined as the death due to any cause during the course of study. Event rate was calculated as the number of events per 100 participant-years at risk. | From baseline until the date of first adjudicated and confirmed occurrence of all-cause death, non-fatal MI, non-fatal stroke or hospitalization for unstable angina needing urgent revascularization (maximum duration: up to 3.4 years) |
| Event Rate Per 100 Participant-years for First Occurrence of Composite Endpoint of All-cause Death, Non-fatal Myocardial Infarction (MI) or Non-fatal Stroke | Event rate per 100 participant-years for first occurrence of composite endpoint of all-cause death, non-fatal MI or non-fatal stroke (adjudicated by Adjudication Committee) was reported. All-cause death was defined as the death due to any cause during the course of study. Event rate was calculated as the number of events per 100 participant-years at risk. | From baseline until the date of first adjudicated and confirmed occurrence of all-cause death, non-fatal MI or non-fatal stroke (maximum duration: up to 3.4 years) |
| Event Rate Per 100 Participant-years for First Occurrence of Hospitalization for Unstable Angina Needing Urgent Revascularization | Event rate per 100 participant-years for first occurrence of hospitalization for unstable angina needing urgent revascularization (adjudicated by Adjudication Committee) was reported. Event rate was calculated as the number of events per 100 participant-years at risk. | From baseline until the date of first adjudicated and confirmed occurrence of hospitalization for unstable angina needing urgent revascularization (maximum duration: up to 3.4 years) |
| Event Rate Per 100 Participant-years for First Occurrence of Composite Endpoint of Cardiovascular (CV) Death, Non-fatal Myocardial Infarction (MI), Non-fatal Stroke or Hospitalization for Unstable Angina | Event rate per 100 participant-years for first occurrence of composite endpoint of CV death, non-fatal MI, non-fatal stroke or hospitalization for unstable angina (adjudicated by Adjudication Committee) was reported. CV death was defined as sudden cardiac death, fatal MI, death due to heart failure, death due to stroke (fatal ischemic stroke or fatal stroke of undetermined etiology), or death due to other CV causes. Event rate was calculated as the number of events per 100 participant-years at risk. | From baseline until the date of first adjudicated and confirmed occurrence of CV death, non-fatal MI, non-fatal stroke or hospitalization for unstable angina (maximum duration: up to 3.4 years) |
| Event Rate Per 100 Participant-years for Cardiovascular (CV) Death | Event rate per 100 participant-years for occurrence of CV death (adjudicated by Adjudication Committee) was reported. CV death was defined as sudden cardiac death, fatal MI, death due to heart failure, death due to stroke (fatal ischemic stroke or fatal stroke of undetermined etiology), or death due to other CV causes. Event rate was calculated as the number of events per 100 participant-years at risk. | From baseline until the date of adjudicated and confirmed occurrence of CV death (maximum duration: up to 3.4 years) |
| Event Rate Per 100 Participant-years for First Occurrence of Any Myocardial Infarction (Fatal or Non-fatal) | Event rate per 100 participant-years for first occurrence of any myocardial infarction (fatal or non-fatal) (adjudicated by Adjudication Committee) was reported. Event rate was calculated as the number of events per 100 participant-years at risk. | From baseline until the date of first adjudicated and confirmed occurrence of any myocardial infarction (fatal or non-fatal) (maximum duration: up to 3.4 years) |
| Event Rate Per 100 Participant-years for Fatal Myocardial Infarction (MI) | Event rate per 100 participant-years for occurrence of fatal MI (adjudicated by Adjudication Committee) was reported. Event rate was calculated as the number of events per 100 participant-years at risk. | From baseline until the date of adjudicated and confirmed occurrence of fatal MI (maximum duration: up to 3.4 years) |
| Event Rate Per 100 Participant-years for First Occurrence of Non-fatal Myocardial Infarction (MI) | Event rate per 100 participant-years for first occurrence of non-fatal MI (adjudicated by Adjudication Committee) was reported. Event rate was calculated as the number of events per 100 participant-years at risk. | From baseline until the date of first adjudicated and confirmed occurrence of non-fatal MI (maximum duration: up to 3.4 years) |
| Event Rate Per 100 Participant-years for First Occurrence of Any Stroke (Fatal or Non-fatal) | Event rate per 100 participant-years for first occurrence of any stroke (fatal or non-fatal) (adjudicated by Adjudication Committee) was reported. Event rate was calculated as the number of events per 100 participant-years at risk. | From baseline until the date of first adjudicated and confirmed occurrence of any stroke (fatal or non-fatal) (maximum duration: up to 3.4 years) |
| Event Rate Per 100 Participant-years for First Occurrence of Any Stroke (Fatal or Non-fatal), of Any Etiology | Event rate per 100 participant-years for first occurrence of any stroke (fatal or non-fatal) of any etiology (adjudicated by Adjudication Committee) was reported. Event rate was calculated as the number of events per 100 participant-years at risk. | From baseline until the date of first adjudicated and confirmed occurrence of any stroke (fatal or non-fatal) of any etiology (maximum duration: up to 3.4 years) |
| Event Rate Per 100 Participant-years for Fatal Stroke | Event rate per 100 participant-years for occurrence of fatal stroke (adjudicated by Adjudication Committee) was reported. Event rate was calculated as the number of events per 100 participant-years at risk. | From baseline until the date of adjudicated and confirmed occurrence of fatal stroke (maximum duration: up to 3.4 years) |
| Event Rate Per 100 Participant-years for First Occurrence of Non-fatal Stroke | Event rate per 100 participant-years for first occurrence of non-fatal stroke (adjudicated by Adjudication Committee) was reported. Event rate was calculated as the number of events per 100 participant-years at risk. | From baseline until the date of first adjudicated and confirmed occurrence of non-fatal stroke (maximum duration: up to 3.4 years) |
| Event Rate Per 100 Participant-years for First Occurrence of Hospitalization for Unstable Angina | Event rate per 100 participant-years for first occurrence of hospitalization for unstable angina (adjudicated by Adjudication Committee) was reported. Event rate was calculated as the number of events per 100 participant-years at risk. | From baseline until the date of first adjudicated and confirmed occurrence of hospitalization for unstable angina (maximum duration: up to 3.4 years) |
| Event Rate Per 100 Participant-years for First Occurrence of Hospitalization for Congestive Heart Failure (CHF) | Event rate per 100 participant-years for first occurrence of hospitalization for CHF (adjudicated by Adjudication Committee) was reported. Event rate was calculated as the number of events per 100 participant-years at risk. | From baseline until the date of first adjudicated and confirmed occurrence of hospitalization for CHF (maximum duration: up to 3.4 years) |
| Event Rate Per 100 Participant-years for First Occurrence of Coronary Revascularization | Event rate per 100 participant-years for first occurrence of coronary revascularization (adjudicated by Adjudication Committee) was reported. Event rate was calculated as the number of events per 100 participant-years at risk. | From baseline until the date of first adjudicated and confirmed occurrence of coronary revascularization (maximum duration: up to 3.4 years) |
| Event Rate Per 100 Participant-years for First Occurrence of Coronary Artery Bypass Graft Surgery (CABG) | Event rate per 100 participant-years for first occurrence of CABG (adjudicated by Adjudication Committee) was reported. Event rate was calculated as the number of events per 100 participant-years at risk. | From baseline until the date of first adjudicated and confirmed occurrence of CABG (maximum duration: up to 3.4 years) |
| Event Rate Per 100 Participant-years for First Occurrence of Percutaneous Coronary Intervention (PCI) | Event rate per 100 participant-years for first occurrence of PCI (adjudicated by Adjudication Committee) was reported. Event rate was calculated as the number of events per 100 participant-years at risk. | From baseline until the date of first adjudicated and confirmed occurrence of PCI (maximum duration: up to 3.4 years) |
| Event Rate Per 100 Participant-years for First Occurrence of Any Arterial Revascularizations | Event rate per 100 participant-years for first occurrence of any arterial revascularizations (adjudicated by Adjudication Committee) was reported. Event rate was calculated as the number of events per 100 participant-years at risk. | From baseline until the date of first adjudicated and confirmed occurrence of any arterial revascularizations (maximum duration: up to 3.4 years) |
| Event Rate Per 100 Participant-years for All-cause Death | Event rate per 100 participant-years for occurrence of all-cause death (adjudicated by Adjudication Committee) was reported. All-cause death was defined as the death due to any cause during the course of study. Event rate was calculated as the number of events per 100 participant-years at risk. | From baseline until the date of adjudicated and confirmed occurrence of all-cause death (maximum duration: up to 3.4 years) |
| Percent Change From Baseline in Low Density Lipoprotein Cholesterol (LDL-C) at Week 14 | Baseline, Week 14 |
| Nominal Change From Baseline in Low Density Lipoprotein Cholesterol (LDL-C) at Week 14 | Baseline, Week 14 |
| Percent Change From Baseline in Low Density Lipoprotein Cholesterol (LDL-C) at Last Post-baseline Measurement | Baseline, last post-baseline measurement (any time up to Week 140) |
| Percent Change From Baseline in Lipid Levels at Week 14 | Lipids included non-high density lipoprotein cholesterol (non-HDL-C), very low density lipoprotein cholesterol (VLDL-C), remnant lipoprotein cholesterol (RLP-C), apolipoprotein B (Apo B), HDL-C, apolipoprotein A-I (Apo A-I) and total cholesterol. | Baseline, Week 14 |
| Percent Change From Baseline in Log-transformed Triglycerides and Lipoprotein (a) (Lp[a]) at Week 14 | Baseline, Week 14 |
| Percent Change From Baseline in Log-transformed High Sensitivity C-Reactive Protein (Hs-CRP) at Week 14 | Baseline, Week 14 |
| Athens |
| Alabama |
| 35611 |
| United States |
| Central Alabama Research | Birmingham | Alabama | 35209 | United States |
| Clinical Research Advantage, Inc./Simon Williamson Clinic | Birmingham | Alabama | 35211 | United States |
| The Kirklin Clinic | Birmingham | Alabama | 35233 | United States |
| Birmingham Heart Clinic, P.C. | Birmingham | Alabama | 35235 | United States |
| University of Alabama at Birmingham (Drug Shipment) | Birmingham | Alabama | 35294 | United States |
| Appalachian Cardiovascular Associates | Fort Payne | Alabama | 35967 | United States |
| Fundamental Research, LLC | Gulf Shores | Alabama | 36542 | United States |
| Avant Research Associates, LLC | Guntersville | Alabama | 35976 | United States |
| Boyett Health Services | Hamilton | Alabama | 35570 | United States |
| The Office of Saadat Ansari MD LLC | Huntsville | Alabama | 35801 | United States |
| CB Flock Research Corporation | Mobile | Alabama | 36608 | United States |
| Alaska Heart Institute | Anchorage | Alaska | 99508 | United States |
| Phoenix Heart, PLLC | Glendale | Arizona | 85306 | United States |
| Arrowhead Internal Medicine | Glendale | Arizona | 85308 | United States |
| Clinical Research Advantage, Inc./Family Practice Specialists, Ltd. | Phoenix | Arizona | 85018 | United States |
| Cochise Clinical Research | Sierra Vista | Arizona | 85635 | United States |
| Clinical Research Advantage, Inc. (Administrative Mailing Only) | Tempe | Arizona | 85282 | United States |
| Southwest Heart Group | Tucson | Arizona | 85710 | United States |
| Arizona Endocrine and Rheumatology Associates | Tucson | Arizona | 85715 | United States |
| Arkansas Heart Hospital Clinic | Little Rock | Arkansas | 72211 | United States |
| Arkansas Site Management Services, LLC | Little Rock | Arkansas | 72211 | United States |
| Cardiology Consultants of Orange County Medical Group, Inc. | Anaheim | California | 92801 | United States |
| Premier Valley Medical Group | Bakersfield | California | 93309 | United States |
| Cardiovascular Research Foundation of Southern California | Beverly Hills | California | 90210 | United States |
| Westside Medical Associates of Los Angeles | Beverly Hills | California | 90211 | United States |
| Southbay Pharma Research | Buena Park | California | 90620 | United States |
| Pioneer Medical Group | Cerritos | California | 90703 | United States |
| John Muir Physician Network Clinical Research Center | Concord | California | 94520 | United States |
| Atlantic Ave Medical Clinic Inc. | Cudahy | California | 90201 | United States |
| Multani Medical Group | Downey | California | 90241 | United States |
| Triwest Research Associates, LLC | El Cajon | California | 92020 | United States |
| Diagnamics Inc. | Encinitas | California | 92024 | United States |
| T. Joseph Raoof, Md, Inc/Encino Research Center | Encino | California | 91436 | United States |
| Aviva Research | Escondido | California | 92025 | United States |
| Valley Research | Fresno | California | 93720 | United States |
| St. Jude Hospital Yorba Linda DBA St. Joseph Heritage Healthcare | Fullerton | California | 92835 | United States |
| Omnibus Clinical Research | La Palma | California | 90623 | United States |
| Alliance Research Centers | Laguna Hills | California | 92653 | United States |
| Prime Care Clinical Research Center | Laguna Hills | California | 92653 | United States |
| Clinical Trials Research | Lincoln | California | 95648 | United States |
| Long Beach Memorial Medical Center | Long Beach | California | 90806 | United States |
| American Institute of Research | Los Angeles | California | 90017 | United States |
| Intermed Group | Los Angeles | California | 90017 | United States |
| Academic Medical Research Institute | Los Angeles | California | 90022 | United States |
| Eastside Clinical Research Associates | Los Angeles | California | 90022 | United States |
| Richard S. Cherlin, MD | Los Gatos | California | 95032 | United States |
| Facey Medical Foundation | Mission Hills | California | 91345 | United States |
| California Medical Research Associates Inc. | Northridge | California | 91324 | United States |
| Valley Clinical Trials, Inc. | Northridge | California | 91325 | United States |
| Diabetes Associates Medical Group | Orange | California | 92868 | United States |
| Saviers Medical Group | Port Hueneme | California | 93041 | United States |
| California Research Foundation | San Diego | California | 92103-6204 | United States |
| San Diego Family Care dba Linda Vista Health Center | San Diego | California | 92111 | United States |
| San Diego Family Care | San Diego | California | 92111 | United States |
| Ritchken & First Md's | San Diego | California | 92117 | United States |
| Wetlin Research Associates, Inc. | San Diego | California | 92120 | United States |
| West Coast Research LLC | San Ramon | California | 94582 | United States |
| Syrentis Clinical Research | Santa Ana | California | 92705 | United States |
| Coastal Biomedical Research, Inc. | Santa Monica | California | 90404 | United States |
| Encompass Clinical Research | Spring Valley | California | 91978 | United States |
| St. Joseph's Medical Associates | Stockton | California | 95204 | United States |
| Westlake Medical Research | Thousand Oaks | California | 91360 | United States |
| Harbor-UCLA Medical Center - Torrance | Torrance | California | 90502-2004 | United States |
| Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center | Torrance | California | 90502 | United States |
| Bayview Research Group | Valley Village | California | 91607 | United States |
| Coastal Metabolic Research Centre | Ventura | California | 93003 | United States |
| Ventura Clinical Trials | Ventura | California | 93003 | United States |
| Clinical Research Advantage, Inc. / Cassidy Medical Group - Vista | Vista | California | 92083 | United States |
| Allianz Research Institute | Westminster | California | 92683 | United States |
| American Institute of Research Studies | Whittier | California | 90603 | United States |
| American Institute of Research | Whittier | California | 90603 | United States |
| Elite Clinical Trials, Inc. | Wildomar | California | 92595 | United States |
| Elite Clinical Trials, Incorporated | Wildomar | California | 92595 | United States |
| Colorado Springs Health Partners | Colorado Springs | Colorado | 80906 | United States |
| Lynn Institute of the Rockies | Colorado Springs | Colorado | 80909 | United States |
| Memorial Hospital: University of Colorado Health | Colorado Springs | Colorado | 80909 | United States |
| Lynn Institute of Denver | Denver | Colorado | 80246 | United States |
| Western Colorado Research, LLC | Glenwood Springs | Colorado | 81601 | United States |
| South Denver Cardiology Associates, PC | Littleton | Colorado | 80120 | United States |
| Connecticut Clinical Research, LLC | Bridgeport | Connecticut | 06606 | United States |
| Bridgeport Hospital | Bridgeport | Connecticut | 06610 | United States |
| Cardiology Associates of Fairfield County, PC | Stamford | Connecticut | 06905 | United States |
| Stamford Therapeutics Consortium | Stamford | Connecticut | 06905 | United States |
| Christiana Care Health Services, Inc. | Newark | Delaware | 19713 | United States |
| Alfieri Cardiology | Wilmington | Delaware | 19803 | United States |
| ACRC - Cardiology | Atlantis | Florida | 33462 | United States |
| GulfCoast Endocrine and Diabetes Center | Clearwater | Florida | 33756 | United States |
| Morton Plant Mease Health Care, Inc. Cardiovascular Research | Clearwater | Florida | 33756 | United States |
| Team Medical Research | Coral Gables | Florida | 33134 | United States |
| The Heart Group, PA | Daytona Beach | Florida | 32114 | United States |
| Cardiology Associates Research Company | Daytona Beach | Florida | 32117 | United States |
| The Cardiology Center | Delray Beach | Florida | 33484 | United States |
| Continental Research Corp | Doral | Florida | 33126 | United States |
| Care Research Center Inc | Doral | Florida | 33166 | United States |
| Integrity Clinical Research, LLC | Doral | Florida | 33166 | United States |
| Moonshine Research Center, Inc. | Doral | Florida | 33166 | United States |
| Invesclinic, LLC | Fort Lauderdale | Florida | 33308 | United States |
| The Office of Dr. Alan Graff, MD, PA | Fort Lauderdale | Florida | 33308 | United States |
| Broward Health Medical Center | Fort Lauderdale | Florida | 33316 | United States |
| The Office of Maxine E. Hamilton, MD, PA | Fort Lauderdale | Florida | 33316 | United States |
| State Of The Art Research, LLC | Hialeah | Florida | 33010 | United States |
| Direct Helpers Medical Center Inc | Hialeah | Florida | 33012 | United States |
| Research Physicians Network Alliance | Hollywood | Florida | 33021 | United States |
| Pines Clinical Research, Inc. | Hollywood | Florida | 33024 | United States |
| East Coast Institute for Research, LLC | Jacksonville | Florida | 32204 | United States |
| Westside Center for Clinical Research | Jacksonville | Florida | 32205 | United States |
| River City Clinical Research | Jacksonville | Florida | 32207 | United States |
| East Coast Institute for Research, LLC | Jacksonville | Florida | 32216 | United States |
| East Coast Institute for Reserach, LLC | Jacksonville | Florida | 32216 | United States |
| Jacksonville Center for Clinical Research | Jacksonville | Florida | 32216 | United States |
| The Office of Rachel Day | Jacksonville | Florida | 32216 | United States |
| Baker-Gilmore Cardiovascular Institute | Jacksonville | Florida | 32223 | United States |
| Solutions Through Advanced Research, Inc. | Jacksonville | Florida | 32256 | United States |
| Meridien Research | Lakeland | Florida | 33805 | United States |
| The Heart Institute at Largo | Largo | Florida | 33770 | United States |
| South Florida Clinical Research Institute | Margate | Florida | 33063 | United States |
| Future Clinical Research, Inc. | Miami | Florida | 33122 | United States |
| Advanced Clinical Research of Miami (ACROM) International | Miami | Florida | 33125 | United States |
| Project4Research, Inc | Miami | Florida | 33125 | United States |
| A & L Clinical Research | Miami | Florida | 33126 | United States |
| Finlay Medical Research | Miami | Florida | 33126 | United States |
| Pharmax Research Clinic, Inc. | Miami | Florida | 33126 | United States |
| Team Medical Research, Inc. | Miami | Florida | 33134 | United States |
| Team Medical Research | Miami | Florida | 33134 | United States |
| South Florida Research Center, Inc. | Miami | Florida | 33135 | United States |
| Florida Medical Center & Research, Inc. | Miami | Florida | 33142 | United States |
| Medical Research Center | Miami | Florida | 33144 | United States |
| Nuren Medical & Research Center | Miami | Florida | 33144 | United States |
| Doctors Research Institute | Miami | Florida | 33145 | United States |
| Advanced Pharma CR, LLC | Miami | Florida | 33147 | United States |
| Coast Research Institute | Miami | Florida | 33155 | United States |
| My Community Research Center, Inc. | Miami | Florida | 33155 | United States |
| Columbus Clinical Services LLC | Miami | Florida | 33165 | United States |
| Cardiovascular Research Center of South Florida | Miami | Florida | 33173 | United States |
| Research Institute of South Florida, Inc. | Miami | Florida | 33173 | United States |
| A & O Research Center, Inc. | Miami | Florida | 33174 | United States |
| BWell Research Center | Miami | Florida | 33175 | United States |
| Pharmacology International Research, Inc. | Miami | Florida | 33175 | United States |
| Advanced Clinical Research | Miami | Florida | 33176 | United States |
| South Florida Research Group, LLC | Miami | Florida | 33176 | United States |
| International Research Associates, LLC | Miami | Florida | 33183 | United States |
| Kendall South Medical Center, Inc. | Miami | Florida | 33185 | United States |
| Kendall South Medical Center, Inc | Miami | Florida | 33185 | United States |
| M & M Medical Center, Inc | Miami | Florida | 33185 | United States |
| Med Research Of Florida, LLC | Miami | Florida | 33186 | United States |
| Research Physicians Network Alliance | Miami Beach | Florida | 33140 | United States |
| G & I Medical Research LLC | Miami Lakes | Florida | 33014 | United States |
| Ocean Blue Medical Research Center, Inc. | Miami Springs | Florida | 33166 | United States |
| Southwest Florida Research, LLC | Naples | Florida | 34102 | United States |
| BayCare Medical Group | New Port Richey | Florida | 34653 | United States |
| The Heart & Vascular Institute of Florida | New Port Richey | Florida | 34653 | United States |
| Bravo Health Care Center | North Bay Village | Florida | 33141 | United States |
| Harmony Clinical Research, Inc. | North Miami Beach | Florida | 33162 | United States |
| Florida Hospital | Orlando | Florida | 32803 | United States |
| Omega Research Consultants, LLC | Orlando | Florida | 32806 | United States |
| Aba Family Medicine, LLC | Ormond Beach | Florida | 32174 | United States |
| Millennium Research | Ormond Beach | Florida | 32174 | United States |
| Ribo Research, LLC dba Peninsula Research | Ormond Beach | Florida | 32174 | United States |
| A and R Research Group LLC | Pembroke Pines | Florida | 33024 | United States |
| Research Physicians Network Alliance | Pembroke Pines | Florida | 33025 | United States |
| South Broward Research | Pembroke Pines | Florida | 33027 | United States |
| DBC Research USA | Pembroke Pines | Florida | 33029 | United States |
| DBC Research | Pembroke Pines | Florida | 33029 | United States |
| Cardiology Consultants | Pensacola | Florida | 32501 | United States |
| DMI Research, Inc. | Pinellas Park | Florida | 33782 | United States |
| Clinical Research of Central Florida | Plant City | Florida | 33563 | United States |
| Clinical Research of Florida | Plant City | Florida | 33563 | United States |
| Jeffrey D Greff,MD | Plantation | Florida | 33313-6066 | United States |
| St. Johns Center for Clinical Research | Ponte Vedra | Florida | 32081 | United States |
| Charlotte Heart Group Research Center | Port Charlotte | Florida | 33952 | United States |
| Intercoastal Medical Group | Sarasota | Florida | 34232 | United States |
| Intercoastal Medical Group | Sarasota | Florida | 34233 | United States |
| Cardiovascular Center Of Sarasota | Sarasota | Florida | 34239 | United States |
| Heart & Vascular Center Research | Sarasota | Florida | 34239 | United States |
| Intercoastal Medical Group (Drug Shipment Address and Administrative) | Sarasota | Florida | 34239 | United States |
| The Office of Bridget Bellingar, DO | Seminole | Florida | 33777 | United States |
| Meridien Research | St. Petersburg | Florida | 33709 | United States |
| Advance Medical Research | St. Petersburg | Florida | 33713 | United States |
| Vita Health & Medical Center, Inc./Concept Clinical Trials, LLC | Tamarac | Florida | 33319 | United States |
| Interventional Cardiac Consultants | Trinity | Florida | 34655 | United States |
| Cardiology Partners Clinical Research Institute | Wellington | Florida | 33449 | United States |
| Cleveland Clinic Cardiology Associates | West Palm Beach | Florida | 33401 | United States |
| Metabolic Research Institute, Inc. | West Palm Beach | Florida | 33401 | United States |
| Clinical Research of Central Florida | Winter Haven | Florida | 33880 | United States |
| Atlanta Diabetes Associates | Atlanta | Georgia | 30318 | United States |
| Emory University Hospital | Atlanta | Georgia | 30322 | United States |
| Atlanta Center For Medical Research | Atlanta | Georgia | 30331 | United States |
| Columbus Regional Research Institute | Columbus | Georgia | 31904 | United States |
| Rockdale Medical Research Associates | Conyers | Georgia | 30094 | United States |
| Georgia Heart Specialists, LLC | Covington | Georgia | 30014 | United States |
| Neurostudies.net, LLC | Decatur | Georgia | 30033 | United States |
| Alta Pharmaceutical Research Center | Dunwoody | Georgia | 30338 | United States |
| In-Quest Medical Research, LLC | Norcross | Georgia | 30071 | United States |
| Atlanta Center for Clinical Research / Internal Medicine | Roswell | Georgia | 30075 | United States |
| Dr. B. Abraham, P.C. | Snellville | Georgia | 30039 | United States |
| Georgia Clinical Research, LLC | Snellville | Georgia | 30078 | United States |
| Clinical Research Atlanta | Stockbridge | Georgia | 30281 | United States |
| East-West Medical Research Institute | Honolulu | Hawaii | 96814 | United States |
| Elite Clinial Trials, LLLP | Blackfoot | Idaho | 83221 | United States |
| Elite Clinical Trials (Additional Administrative Room / Exam Rooms) | Blackfoot | Idaho | 83221 | United States |
| St. Luke's Idaho Cardiology Associates | Caldwell | Idaho | 83605 | United States |
| Solaris Clinical Research | Meridian | Idaho | 83646 | United States |
| Saltzer Medical Group, PA | Nampa | Idaho | 83686-6011 | United States |
| Northwest Heart Clinical Research, LLC | Arlington Heights | Illinois | 60005 | United States |
| Clinical Research Advantage, Inc./Michigan Avenue Internists | Chicago | Illinois | 60604 | United States |
| Apex Medical Research, AMR, Inc. | Chicago | Illinois | 60616 | United States |
| Clinical Research Advantage,Inc./Medical and Procedural Specilaists of Illinois | Chicago | Illinois | 60631 | United States |
| Evanston Premier Healthcare Research, LLC | Evanston | Illinois | 60201 | United States |
| Clinical Investigation Specialists, Inc | Gurnee | Illinois | 60031 | United States |
| Heart Care Centers of Illinois | Mokena | Illinois | 60448 | United States |
| Advanced CardioVascular Consultants | Rock Island | Illinois | 61201 | United States |
| Investigators Research Group, LLC | Brownsburg | Indiana | 46112 | United States |
| Investigative Clinical Research of Indiana, LLC | Elwood | Indiana | 46036 | United States |
| Deaconess Clinic Downtown | Evansville | Indiana | 47713 | United States |
| Clinical Research Advantage, Inc. | Evansville | Indiana | 47714 | United States |
| MediSphere Medical Research Center, LLC | Evansville | Indiana | 47714 | United States |
| Clinical Research Advantage, Inc. / Family Medicine Associates | Evansville | Indiana | 47725 | United States |
| Deaconess Clinic Mt. Pleasant | Evansville | Indiana | 47725 | United States |
| American Health Network of Indiana LLC | Franklin | Indiana | 46131 | United States |
| American Health Network of Indiana LLC | Greenfield | Indiana | 46140 | United States |
| American Health Network of Indiana, LLC | Muncie | Indiana | 47304 | United States |
| Cardiovascular Research of Northwest Indiana, LLC | Munster | Indiana | 46321 | United States |
| Buynak Clinical Research, P.C. | Valparaiso | Indiana | 46383 | United States |
| West Broadway Clinic | Council Bluffs | Iowa | 51501 | United States |
| Clinical Research Advantage, Inc. | Council Bluffs | Iowa | 51503 | United States |
| Midwest Cardiovascular Research Foundation | Davenport | Iowa | 52803 | United States |
| University of Iowa-College of Public Health-Preventive Intervention Center | Iowa City | Iowa | 52242 | United States |
| Northeast Iowa Medical Education Foundation | Waterloo | Iowa | 50702 | United States |
| The Iowa Clinic, PC | West Des Moines | Iowa | 50266 | United States |
| Hutchinson Clinic, P.A | Hutchinson | Kansas | 67502 | United States |
| University Of Kansas Medical Center | Kansas City | Kansas | 66160 | United States |
| Midwest Heart & Vascular Specialists, LLC | Overland Park | Kansas | 66209 | United States |
| Women's & Family Care D.B.A. GTC Research | Shawnee Mission | Kansas | 66218 | United States |
| Women's & Family Care, LLC D.B.A GTC Research | Shawnee Mission | Kansas | 66218 | United States |
| Women's & Family Care, LLC D.B.A. GTC Research | Shawnee Mission | Kansas | 66218 | United States |
| Central Cardiology Associates Research | Elizabethtown | Kentucky | 42701 | United States |
| The Research Group of Lexington, LLC | Lexington | Kentucky | 40503 | United States |
| L-MARC | Louisville | Kentucky | 40213 | United States |
| Research Integrity, LLC. | Owensboro | Kentucky | 42303 | United States |
| Grace Research, LLC | Bossier City | Louisiana | 71111 | United States |
| Avant Research Associates, LLC | Crowley | Louisiana | 70526 | United States |
| Centex Studies | Lake Charles | Louisiana | 70601 | United States |
| Imperial Health, LLP | Lake Charles | Louisiana | 70601 | United States |
| American Clinical Research, LLC | Marrero | Louisiana | 70072 | United States |
| West Jefferson Heart Clinic of Louisiana New Orleans Physician Services, Inc. | Marrero | Louisiana | 70072 | United States |
| Clinical Trials of America LA | Monroe | Louisiana | 71201 | United States |
| KAMP Medical Research Inc. | Natchitoches | Louisiana | 71457 | United States |
| Clinical and Translation Research Center (CTRC) University Medical Center of New Orleans, Diagnostic | New Orleans | Louisiana | 70112 | United States |
| Section of Nephrology and Hypertension, LSU Health Sciences Center-New Orleans | New Orleans | Louisiana | 70112 | United States |
| Maine Research Associates | Auburn | Maine | 04210 | United States |
| Acadia Clinical Research, LLC | Bangor | Maine | 04401 | United States |
| Acadia Clinical Research | Bangor | Maine | 04401 | United States |
| Cranbrook Cardiology Research Associates | Cape Elizabeth | Maine | 04107 | United States |
| Anne Arundel Medical Center | Annapolis | Maryland | 21401 | United States |
| MedStar Cardiology Associates | Annapolis | Maryland | 21401 | United States |
| MedStar Chesapeake CardioVascular Associates | Baltimore | Maryland | 21204 | United States |
| MedStar Union Memorial Heart Specialists | Baltimore | Maryland | 21218 | United States |
| Maryland Cardiovascular Specialists | Baltimore | Maryland | 21229 | United States |
| Overlea Personal Physicians | Baltimore | Maryland | 21236 | United States |
| Shahid Saeed, MD, PC | Baltimore | Maryland | 21237 | United States |
| Maryland Heart Associates, LLC | Glen Burnie | Maryland | 21061 | United States |
| Lutherville Personal Physicians | Lutherville | Maryland | 21093 | United States |
| MD Medical Research | Oxon Hill | Maryland | 20745 | United States |
| MetroWest Medical Center - Pharmacy Department | Framingham | Massachusetts | 01702 | United States |
| MetroWest Medical Center Research Clinic | Framingham | Massachusetts | 01702 | United States |
| MetroWest Medical Center | Framingham | Massachusetts | 01702 | United States |
| ActivMed Practices and Research, Inc. | Methuen | Massachusetts | 01844 | United States |
| Charles River Medical Associates | Natick | Massachusetts | 01760 | United States |
| Endeavor Medical Research | Alpena | Michigan | 49707 | United States |
| St. Joseph Mercy Health System (Drug shipment Only) | Ann Arbor | Michigan | 48106 | United States |
| University of Michigan - Domino Farms | Ann Arbor | Michigan | 48106 | United States |
| Quest Research Institute | Bingham Farms | Michigan | 48025 | United States |
| IHA Chelsea Family & Internal Medicine | Chelsea | Michigan | 48118 | United States |
| Healthy Heart Cardiology | Grandville | Michigan | 49418 | United States |
| Westside Family Medical Center, Pc | Kalamazoo | Michigan | 49009 | United States |
| Sparrow Clinical Research Institute | Lansing | Michigan | 48912 | United States |
| Sparrow Thoracic & Cardiovascular Institute | Lansing | Michigan | 48912 | United States |
| Detroit Clinical Research Center, PC | Livonia | Michigan | 48154 | United States |
| MidMichigan Medical Center Midland | Midland | Michigan | 48670 | United States |
| Michigan Cardio Vascular Institute | Saginaw | Michigan | 48601 | United States |
| Tri-County Research, Inc. | Sterling Heights | Michigan | 48310 | United States |
| Medical Research Associates, Inc. | Traverse City | Michigan | 49684 | United States |
| Oakland Medical Research Center | Troy | Michigan | 48085 | United States |
| Arcturus Healthcare, PLC, Troy Internal Medicine Research Division | Troy | Michigan | 48098 | United States |
| Michigan Heart & Vascular Institute | Ypsilanti | Michigan | 48197 | United States |
| Duluth Clinic, dba Essentia Health Duluth Clinic Investigational Drug Room | Duluth | Minnesota | 55805 | United States |
| St. Mary's Medical Center dba Essentia Health St. Mary's Medical Center | Duluth | Minnesota | 55805 | United States |
| St. Mary's Medical Center | Duluth | Minnesota | 55805 | United States |
| The Duluth Clinic, Ltd. | Duluth | Minnesota | 55805 | United States |
| Radiant Research, Inc. | Edina | Minnesota | 55435 | United States |
| Minneapolis Clinic of Neurology | Golden Valley | Minnesota | 55422 | United States |
| Allina Health System, dba Abbott Northwestern Hospital | Minneapolis | Minnesota | 55407 | United States |
| Lillehei Clinical Research Unit, University of Minnesota | Minneapolis | Minnesota | 55455 | United States |
| CentraCare Heart and Vascular Center | Saint Cloud | Minnesota | 56303 | United States |
| HealthEast St. Joseph's Hospital inpatient Pharmacy | Saint Paul | Minnesota | 55102 | United States |
| Olive Branch Family Medical Center | Olive Branch | Mississippi | 38654 | United States |
| Cardiology Associates Research, LLC | Tupelo | Mississippi | 38801 | United States |
| Missouri Cardiovascular Specialists, LLP | Columbia | Missouri | 65201 | United States |
| Saint Luke's Lipid and Diabetes Research Center | Kansas City | Missouri | 64111 | United States |
| Kansas City VA Medical Center | Kansas City | Missouri | 64128-2226 | United States |
| Mercy Research | St Louis | Missouri | 63141 | United States |
| Glacier View Research Institute, Cardiology | Kalispell | Montana | 59901 | United States |
| Montana Medical Research Inc. | Missoula | Montana | 59808 | United States |
| Bryan Heart | Lincoln | Nebraska | 68506 | United States |
| Creighton Diabetes Research Center | Omaha | Nebraska | 68131 | United States |
| University of Nebraska Medical Center | Omaha | Nebraska | 68198 | United States |
| AB Clinical Trials | Las Vegas | Nevada | 89119 | United States |
| Clinical Research of South Nevada | Las Vegas | Nevada | 89121 | United States |
| Clinical Research Advantage, Inc. | Las Vegas | Nevada | 89128 | United States |
| John V. Bernard, MD dba Wellness and Research Center | Belvidere | New Jersey | 07823 | United States |
| Advanced Heart Care LLC | Bridgewater | New Jersey | 08807 | United States |
| Lourdes Cardiology Services | Cherry Hill | New Jersey | 08034 | United States |
| USMA Clinical Research | Elizabeth | New Jersey | 07201 | United States |
| Lourdes Cardiology Services | Hammonton | New Jersey | 08037 | United States |
| NJ Heart | Linden | New Jersey | 07036 | United States |
| Arysmed LLC | Lodi | New Jersey | 07644 | United States |
| Amici Clinical Research, LLC | Martinsville | New Jersey | 08836 | United States |
| Rutgers Biomedical and Health Sciences-Robert Wood Johnson Medical School | New Brunswick | New Jersey | 08901 | United States |
| Cardiac & Endovascular Associates | Ridgewood | New Jersey | 07450 | United States |
| The Valley Hospital | Ridgewood | New Jersey | 07450 | United States |
| Cardio Metabolic Institute | Somerset | New Jersey | 08873 | United States |
| TLB Research LLC | Trenton | New Jersey | 08611 | United States |
| Lourdes Cardiology Services | Voorhees Township | New Jersey | 08043 | United States |
| Westwood Cardiology Associates, P.A. | Westwood | New Jersey | 07675 | United States |
| Albuquerque Clinical Trials, Inc. | Albuquerque | New Mexico | 87102 | United States |
| Albany Medical College, Division of Community Endocrinology | Albany | New York | 12206 | United States |
| Sorin Medical, P.C. | Brooklyn | New York | 11214 | United States |
| NY Total Medical Care, PC | Brooklyn | New York | 11215 | United States |
| NY Scientific | Brooklyn | New York | 11235 | United States |
| Buffalo Heart Group, Llp | Buffalo | New York | 14215 | United States |
| NYU Hudson Valley Cardiology | Cortlandt Manor | New York | 10567 | United States |
| Scott Research,Inc | Laurelton | New York | 11413 | United States |
| SJH Cardiology Associates | Liverpool | New York | 13088 | United States |
| Long Island Heart Associates | Mineola | New York | 11501 | United States |
| Mid Hudson Medical Research, PLLC | New Windsor | New York | 12553 | United States |
| Manhattan Medical Research Practice | New York | New York | 10016 | United States |
| Peters Medical Research NY, LLC | New York | New York | 10016 | United States |
| Weill Cornell Medical College | New York | New York | 10065 | United States |
| DiGiovanna Institute for Medical Education And Research | North Massapequa | New York | 11758-1802 | United States |
| Hudson Valley Cardiovascular Practice, PC | Poughkeepsie | New York | 12601 | United States |
| Rochester Clinical Research, Inc. | Rochester | New York | 14609 | United States |
| Institute for Clinical Studies | Rosedale | New York | 11422 | United States |
| Saratoga Clinical Research, LLC | Saratoga Springs | New York | 12866 | United States |
| Central New York Cardiology | Utica | New York | 13501 | United States |
| Great Lakes Medical Research | Westfield | New York | 14787 | United States |
| Buffalo Medical Group | Williamsville | New York | 14221 | United States |
| Novant Health Clinical Research | Charlotte | North Carolina | 28204 | United States |
| Novant Health Heart and Vascular Institute | Charlotte | North Carolina | 28204 | United States |
| Sensenbrenner Primary Care | Charlotte | North Carolina | 28277 | United States |
| NC Heart and Vascular | Clayton | North Carolina | 27520 | United States |
| LeBauer Cardiovascular Research Foundation | Greensboro | North Carolina | 27401 | United States |
| Clinical Trials of America, Inc. | Hickory | North Carolina | 28601 | United States |
| Carolina Cardiology Cornerstone | High Point | North Carolina | 27262 | United States |
| Clinical Trials of America- NC, LLC | Lenoir | North Carolina | 28645 | United States |
| Research Institute of the Carolinas of Piedmont Healthcare, PA | Mooresville | North Carolina | 28117 | United States |
| Burke Primary Care | Morganton | North Carolina | 28655 | United States |
| Eastern Nephrology Associates | New Bern | North Carolina | 28562 | United States |
| Boice Willis Clinic | Rocky Mount | North Carolina | 27804 | United States |
| PMG Research of Rocky Mount, LLC | Rocky Mount | North Carolina | 27804 | United States |
| NC Heart and Vascular Research | Smithfield | North Carolina | 27577 | United States |
| Piedmont Healthcare/Research | Statesville | North Carolina | 28625 | United States |
| Wake Forest University Health Sciences Institutional Review Board | Winston-Salem | North Carolina | 27157 | United States |
| Lillestol Research LLC | Fargo | North Dakota | 58103 | United States |
| Radiant Research, Inc | Akron | Ohio | 44311 | United States |
| The Lindner Center for Research and Education at The Christ Hospital | Cincinnati | Ohio | 45219 | United States |
| Metabolic and Atherosclerosis Research Center | Cincinnati | Ohio | 45227 | United States |
| Sterling Research Group, Ltd. | Cincinnati | Ohio | 45246 | United States |
| Rapid Medical Research, Inc. | Cleveland | Ohio | 44122 | United States |
| Cleveland Clinic - Taussig Cancer Institute | Cleveland | Ohio | 44195 | United States |
| Radiant Research, Inc. | Columbus | Ohio | 43212 | United States |
| Optimed Research, LTD | Columbus | Ohio | 43235 | United States |
| Dayton Heart Center | Dayton | Ohio | 45414 | United States |
| Premier Health Specialists, Inc. (dba Dayton Heart Center) | Dayton | Ohio | 45414 | United States |
| PriMed Clinical Research | Dayton | Ohio | 45419 | United States |
| Delaware Research Group, LLC | Delaware | Ohio | 43015 | United States |
| North Ohio Heart Center (Administrative Only) | Elyria | Ohio | 44035 | United States |
| North Ohio Heart Center | Elyria | Ohio | 44035 | United States |
| North Ohio Heart Center | Lorain | Ohio | 44053 | United States |
| SV Research LLC | Marion | Ohio | 43302 | United States |
| Office of Daniel G. Williams, MD | Perrysburg | Ohio | 43551 | United States |
| North Ohio Heart Center, Inc. | Sandusky | Ohio | 44870 | United States |
| ProMedica Northwest Ohio Cardiology Consultants | Toledo | Ohio | 43615 | United States |
| Mercy Health Youngstown, LLC d/b/a St. Elizabeth Youngstown Hospital | Youngstown | Ohio | 44501 | United States |
| LION Research | Norman | Oklahoma | 73069 | United States |
| LION Research | Norman | Oklahoma | 73072 | United States |
| COR Clinical Research LLC | Oklahoma City | Oklahoma | 73103 | United States |
| Oklahoma Heart Hospital Physicians | Oklahoma City | Oklahoma | 73120 | United States |
| Oklahoma Heart Hospital Research Foundation | Oklahoma City | Oklahoma | 73120 | United States |
| South Oklahoma Heart Research, LLC | Oklahoma City | Oklahoma | 73135 | United States |
| Integrated Medical Research PC | Ashland | Oregon | 97520 | United States |
| Hillsboro Cardiology, PC | Hillsboro | Oregon | 97123 | United States |
| Portland Preventive Cardiology LLC | Portland | Oregon | 97225 | United States |
| Abington Hosptial | Abington | Pennsylvania | 19001 | United States |
| Clinical Research Associates of Central PA | Altoona | Pennsylvania | 16602 | United States |
| Brandywine Clinical Research | Downingtown | Pennsylvania | 19335-2620 | United States |
| Doylestown Cardiology Associates - VIAA | Doylestown | Pennsylvania | 18901 | United States |
| Doylestown Health Cardiology, a division of Doylestown Health Physicians | Doylestown | Pennsylvania | 18901 | United States |
| Amh/Feasterville Family Health Care Center | Feasterville-Trevose | Pennsylvania | 19053 | United States |
| Greater Pittsburgh Vascular | Jefferson Hills | Pennsylvania | 15025 | United States |
| Detweiler Family Medicine and Associates, PC | Lansdale | Pennsylvania | 19446 | United States |
| Green and Seidner Family Practice Associates | Lansdale | Pennsylvania | 19446 | United States |
| Family Medical Associates | Levittown | Pennsylvania | 19056 | United States |
| Mercer Bucks Cardiology | Newtown | Pennsylvania | 18940 | United States |
| Philadelphia Health Associates-Adult Medicine | Philadelphia | Pennsylvania | 19146 | United States |
| Allegheny Endocrinology Associates | Pittsburgh | Pennsylvania | 15212 | United States |
| Preferred Primary Care Physicians | Pittsburgh | Pennsylvania | 15236 | United States |
| Guthrie Medical Group, PC | Sayre | Pennsylvania | 18840 | United States |
| SFM Clinical Trials, Inc. | Scotland | Pennsylvania | 17254 | United States |
| Fay-West Family Practice | Scottdale | Pennsylvania | 15683 | United States |
| Grand View - Lehigh Valley Health Services, Buxmont Cardiology Division | Sellersville | Pennsylvania | 18960 | United States |
| Montgomery Medical, Inc. | Smithfield | Pennsylvania | 15478 | United States |
| Preferred Primary Care Physicians | Uniontown | Pennsylvania | 15401 | United States |
| Berks Cardiologists, Ltd. | Wyomissing | Pennsylvania | 19610 | United States |
| Coastal Cardiology | Charleston | South Carolina | 29407 | United States |
| Upstate Pharmaceutical Research | Greenville | South Carolina | 29615 | United States |
| Mountain View Clinical Research, Inc. | Greer | South Carolina | 29651 | United States |
| The Diabetes Center, LLC | Murrells Inlet | South Carolina | 29576 | United States |
| Black Hills Cardiovascular-Regional Health Research | Rapid City | South Dakota | 57701 | United States |
| Mid-Cumberland Infectious Disease Consultants, PLC | Clarksville | Tennessee | 37043 | United States |
| Collierville Medical Specialists | Collierville | Tennessee | 38017 | United States |
| Stern Cardiovascular Foundation, Inc. | Germantown | Tennessee | 38138 | United States |
| Holston Medical Group | Kingsport | Tennessee | 37660 | United States |
| New Phase Research & Development | Knoxville | Tennessee | 37909 | United States |
| PMG Research,Inc d/b/a PMG Research of Knoxville | Knoxville | Tennessee | 37912 | United States |
| Cardiovascular Research of Knoxville | Knoxville | Tennessee | 37917 | United States |
| New Orleans Center for Clinical Research | Knoxville | Tennessee | 37920 | United States |
| Volunteer Research Group | Knoxville | Tennessee | 37920 | United States |
| Baptist Memorial Medical Group, Inc. | Memphis | Tennessee | 38119 | United States |
| The Green Clinic, PC | Memphis | Tennessee | 38119 | United States |
| Southwind Medical Specialists | Memphis | Tennessee | 38125 | United States |
| Tennessee Center for Clinical Trials | Tullahoma | Tennessee | 37388 | United States |
| Trinity Clinical Research, LLC | Tullahoma | Tennessee | 37388 | United States |
| PharmaTex Research | Amarillo | Texas | 79106 | United States |
| Arlington Family Research Center, Inc. | Arlington | Texas | 76012 | United States |
| Texas Diabetes & Endocrinology | Austin | Texas | 78731 | United States |
| Austin Heart, PLLC | Austin | Texas | 78756 | United States |
| Aztec Medical Research, LLC | Channelview | Texas | 77530 | United States |
| Corsicana Medical Research, PLLC | Corsicana | Texas | 75110 | United States |
| Protenium Clinical Research, LLC | Dallas | Texas | 75208 | United States |
| VA North Texas Health Care System - Dallas VAMC | Dallas | Texas | 75216 | United States |
| Baylor Heart and Vascular Institute | Dallas | Texas | 75226 | United States |
| Dallas Diabetes and Endocrine Center | Dallas | Texas | 75230 | United States |
| Cardiovascular Research Institute of Dallas | Dallas | Texas | 75231 | United States |
| Radiant Research, Inc. | Dallas | Texas | 75231 | United States |
| Research Institute of Dallas | Dallas | Texas | 75231 | United States |
| Doctors Hospital At Renaissance | Edinburg | Texas | 78539 | United States |
| Amir Malik Research | Fort Worth | Texas | 76104 | United States |
| The Medical Group Of Texas | Fort Worth | Texas | 76104 | United States |
| Rockwood Medical Clinic | Fort Worth | Texas | 76164 | United States |
| San Gabriel Clinical Research, LLC | Georgetown | Texas | 78626 | United States |
| East Texas Cardiology PA | Houston | Texas | 77002 | United States |
| Spring Clinical Research | Houston | Texas | 77002 | United States |
| Med Tech Research, LP | Houston | Texas | 77024 | United States |
| Prime Care Medical Group | Houston | Texas | 77024 | United States |
| Associates in Medicine, PA | Houston | Texas | 77027 | United States |
| Alan S. Hoffman, M.D. | Houston | Texas | 77030 | United States |
| Baylor College of Medicine | Houston | Texas | 77030 | United States |
| Investigational Product Shipment Address TO: Investigational Drug Services (IDS), | Houston | Texas | 77030 | United States |
| Centex Studies, Inc. | Houston | Texas | 77058 | United States |
| Northwest Houston Cardiology | Houston | Texas | 77070 | United States |
| Texas Center For Drug Development, Inc. | Houston | Texas | 77081 | United States |
| Private Practice Leadership, LLC | Houston | Texas | 77094 | United States |
| Protenium Clinical Research | Hurst | Texas | 76054 | United States |
| South Texas Cardiovascular Consultants, PLLC | Kerrville | Texas | 78028 | United States |
| Caprock Cardiac Center Research Institute Inc. | Lubbock | Texas | 79410 | United States |
| Midland Clinical Research Center | Midland | Texas | 79707 | United States |
| Hill Country Medical Associates | New Braunfels | Texas | 78130 | United States |
| North Hills Medical Research, Inc. | North Richland Hills | Texas | 76180 | United States |
| Grace Research, LLC | Palestine | Texas | 75801 | United States |
| Med-Olam Clinical Research | Pasadena | Texas | 77504 | United States |
| Austin Institute for Clinical Research, Inc. | Pflugerville | Texas | 78660 | United States |
| Austin Institute for Clinical Research,Inc. | Pflugerville | Texas | 78660 | United States |
| Centex Studies, Inc | Pharr | Texas | 78577 | United States |
| Legacy Heart Center | Plano | Texas | 75024 | United States |
| South Texas Cardiovascular Consultants, PLLC | San Antonio | Texas | 78201 | United States |
| Sun Research Institute | San Antonio | Texas | 78215 | United States |
| Southwest Clinic | San Antonio | Texas | 78221 | United States |
| Victorium Clinical Research | San Antonio | Texas | 78231 | United States |
| Bandera Family Health Care, LLC | San Antonio | Texas | 78249 | United States |
| Northeast Clinical Research of San Antonio, LLC (NECRSA, LLC) | Schertz | Texas | 78154 | United States |
| Acacia Medical Research Institute, LLC | Sugar Land | Texas | 77478 | United States |
| IP + Dry ice deliveries Sugar Lakes Family Practice | Sugar Land | Texas | 77478 | United States |
| Sugar Lakes Family Practice | Sugar Land | Texas | 77479 | United States |
| Northwest Houston Heart Center | Tomball | Texas | 77375-4536 | United States |
| Admin & Storage only:Northwest Heart Center | Tomball | Texas | 77375 | United States |
| Northwest Heart Center | Tomball | Texas | 77375 | United States |
| Northwest Houston Clinical Research, PLLC | Tomball | Texas | 77375 | United States |
| Victoria Heart and Vascular Center, PA | Victoria | Texas | 77901 | United States |
| Utah Cardiology, PC | Bountiful | Utah | 84010 | United States |
| Utah Cardiology, P.C. | Layton | Utah | 84041 | United States |
| Paramount Medical Care | Ogden | Utah | 84405 | United States |
| Aspen Clinical Research LLC | Orem | Utah | 84058 | United States |
| Revere Health | Provo | Utah | 84604 | United States |
| Optimum Clinical Research, Inc. | Salt Lake City | Utah | 84102 | United States |
| Wasatch Clinical Research, LLC | Salt Lake City | Utah | 84107 | United States |
| Holladay Family Practice | Salt Lake City | Utah | 84117 | United States |
| Heart Center at St. Mark's Hospital | Salt Lake City | Utah | 84124 | United States |
| Burke Internal Medicine & Research | Burke | Virginia | 22015 | United States |
| Clinical Research Institute of Northern Virginia | Burke | Virginia | 22015 | United States |
| Virginia Heart | Falls Church | Virginia | 22042 | United States |
| Seven Corners Medical Research Center | Falls Church | Virginia | 22044 | United States |
| Heart Care Associates, P.C. | Hopewell | Virginia | 23860 | United States |
| Virginia Research Center | Midlothian | Virginia | 23114 | United States |
| Chippenham and Johnston Willis Hospitals, Inc. dba CJW Medical Center | Richmond | Virginia | 23225 | United States |
| Retreat Cardiology LLC, dba Cardiology Associates of Richmond | Richmond | Virginia | 23225 | United States |
| Roanoke Heart Institute | Roanoke | Virginia | 24014 | United States |
| Hampton Roads Center for Clinical Research | Suffolk | Virginia | 23435 | United States |
| Office of Daniel W. Gottlieb, MD, PS | Burien | Washington | 98166 | United States |
| Premier Clinical Research | Spokane | Washington | 99202 | United States |
| Universal Research Group, LLC | Tacoma | Washington | 98405 | United States |
| Walla Walla Clinic | Walla Walla | Washington | 99362 | United States |
| Wenatchee Valley Hospital & Clinics | Wenatchee | Washington | 98801 | United States |
| Exemplar Research Inc | Fairmont | West Virginia | 26554 | United States |
| Prevea Clinic, Inc. | Green Bay | Wisconsin | 54303 | United States |
| Clinical Investigation Specialists, Inc. | Kenosha | Wisconsin | 53142 | United States |
| Waukesha Heart Foundation | Waukesha | Wisconsin | 53188 | United States |
| Instituto de Investigaciones Clinicas Bahia Blanca | Bahía Blanca | Buenos Aires | B8000FTD | Argentina |
| Hospital Italiano Regional del Sur | Bahía Blanca | Buenos Aires | B8001HXM | Argentina |
| CIPREC - Centro de Investigacion y Prevencion Cardiovascular S.A. | C.a.b.a. | Buenos Aires | C1119ACN | Argentina |
| Hospital Britanico De Buenos Aires | Ciudad Autonoma de B. Aires | Buenos Aires | C1280AEB | Argentina |
| Investigaciones Medicas IMOBA S.R.L. | Ciudad Autonoma de Buenos Aires | Buenos Aires | C1179AAB | Argentina |
| CEDIC - Consultorios Medicos | Ciudad Autonoma de Buenos Aires | Buenos Aires | C1425DES | Argentina |
| Clinica Coronel Suarez S.A. | Coronel Suárez | Buenos Aires | B7540GHD | Argentina |
| Framingham Centro Medico | La Plata | Buenos Aires | B1902COS | Argentina |
| CIMeL CHAHIN CHAHIN S.A. | Lanús Este | Buenos Aires | B1824KAJ | Argentina |
| Instituto de Investigaciones Clinicas Mar del Plata | Mar del Plata | Buenos Aires | B7600FZN | Argentina |
| DIM Clinica Privada | Ramos Mejía | Buenos Aires | B1704ETD | Argentina |
| Instituto de Investigaciones Clinicas Zarate | Zárate | Buenos Aires | B2800DGH | Argentina |
| STAT Research S.A. | C.a.b.a | Buenos Aires F.D. | C1023AAB | Argentina |
| Consultorios Asociados de Endocrinologia e Investigacion Clinica Aplicada | C.a.b.a | C.a.b.a. | C1425AGC | Argentina |
| Clinica Privada de Especialidades Medicas | Villa María | Córdoba Province | 5901 | Argentina |
| CIPADI Centro Integral de Prevencion y Atencion en Diabetes | Godoy Cruz | Mendoza Province | M5501ARP | Argentina |
| IMEP Instituto Medico Elsa Perez | Ciudadela | PCIA de Buenos Aires | 1702 | Argentina |
| Instituto Medico Aguero | Morón | PCIA de Buenos Aires | B1708CGU | Argentina |
| Cordis - Instituto del Corazon | Resistencia | PCIA de Chaco | H3500CDM | Argentina |
| Hospital de Alta Complejidad "Pte. Juan Domingo Peron" | Formosa | PCIA de Formosa | 3600 | Argentina |
| Hospital Provincial Dr. Jose Maria Cullen | Santa Fe | PCIA de Santa FE | S3000EOZ | Argentina |
| Centro De Investigaciones Clinicas Del Litoral S.R.L. | Santa Fe | PCIA de Santa FE | S3000FWO | Argentina |
| Cedir S.A - Centro De Diagnostico Y Rehabilitacion S.A. | Santa Fe | PCIA de Santa FE | S3004CVS | Argentina |
| Centro Modelo de Cardiologia | San Miguel de Tucumán | PCIA de Tucuman | T4000IFL | Argentina |
| Instituto de Hematologia y Medicina Clinica "Dr. Ruben A. Davoli" | Rosario | Pcia. de Santa FE | S2000CFK | Argentina |
| Instituto Medico Ceniclar - Central De Investigaciones Clinicas Argentina - Sanatorio De La Mujer | Rosario | Santa Fe Province | S2000QID | Argentina |
| Centro Medico CCBR Tucuman | San Miguel de Tucumán | Tucumán Province | T4000IAF | Argentina |
| Universidad Maimonides | Buenos Aires | C1405BCK | Argentina |
| Centro de Investigacion: AXISMED S.R.L. | Buenos Aires | C1430CKE | Argentina |
| Cicemo - Consultorio de Investigaciones Clinicas E.M.O. S.R.L. | Ciudad Autonoma de B. Aires | C1405BUB | Argentina |
| Instituto Cardiovascular De Buenos Aires | Ciudad Autonoma de B. Aires | C1428ART | Argentina |
| Instituto de Cardiologia de Corrientes "Juana Fca. Cabral" | Corrientes | 3400 | Argentina |
| ILAIM Instituto Latinoamericano de Investigaciones Medicas | Córdoba | X5000BNB | Argentina |
| Clinico Chutro SRL | Córdoba | X5000EPU | Argentina |
| Centro de Investigaciones Clinicas "Instituto del Corazon" | Córdoba | X5000EVQ | Argentina |
| Clinica Privada Colombo | Córdoba | x5002AOQ | Argentina |
| Instituto Medico DAMIC S.R.L. | Córdoba | X5003DCE | Argentina |
| Centro Medico Luquez | Córdoba | X5006IKK | Argentina |
| IPAC Caraffa | Córdoba | X5008KKF | Argentina |
| Hospital Central de Mendoza | Mendoza | 5500 | Argentina |
| Cordis S.A. | Salta | 4400 | Argentina |
| Centro Cardiovascular Salta | Salta | A4406BPF | Argentina |
| Instituto Cardiovascular San Luis A.E. | San Luis | D5702JRS | Argentina |
| Boden Institute of Obesity, Nutrition, Exercise and Eating Disorders | Camperdown | New South Wales | 2050 | Australia |
| Royal Prince Alfred Hospital | Camperdown | New South Wales | 2050 | Australia |
| Central Coast Neurosciences Research | Erina | New South Wales | 2250 | Australia |
| Central Coast Local Health District, Gosford Hospital | Gosford | New South Wales | 2250 | Australia |
| Australian Clinical Research Network | Maroubra | New South Wales | 2035 | Australia |
| Holy Spirit Northside Private Hospital Limited | Chermside | Queensland | 4032 | Australia |
| Royal Brisbane and Women's Hospital | Herston | Queensland | 4029 | Australia |
| Core Research Group Pty Ltd | Milton | Queensland | 4064 | Australia |
| Redcliffe Hospital | Redcliffe | Queensland | 4020 | Australia |
| Austrials Pty Ltd | Sherwood | Queensland | 4075 | Australia |
| Gold Coast University Hospital | Southport | Queensland | 4215 | Australia |
| Adelaide Medical Research | Ashford | South Australia | 5035 | Australia |
| SA Heart | Ashford | South Australia | 5035 | Australia |
| Southern Adelaide Diabetes and Endocrine Service | Daws Park | South Australia | 5041 | Australia |
| Department of Cardiology, Lyell McEwin Hospital | Elizabeth Vale | South Australia | 5112 | Australia |
| Heart and Vascular Research | Fullarton | South Australia | 5063 | Australia |
| Launceston General Hospital | Launceston | Tasmania | 7250 | Australia |
| Eastern Health - Box Hill Hospital | Box Hill | Victoria | 3128 | Australia |
| The Northern Hospital | Epping | Victoria | 3076 | Australia |
| Barwon Health-The Geelong Hospital | Geelong | Victoria | 3220 | Australia |
| Austin Health - Heidelberg Repatriation Hospital | Heidelberg West | Victoria | 3081 | Australia |
| Alfred Hospital | Melbourne | Victoria | 3004 | Australia |
| Fremantle Hospital | Fremantle | Western Australia | 6160 | Australia |
| HPS Pharmacies | Joondalup | Western Australia | 6027 | Australia |
| Joondalup Cardiovascular Trials Foundation Inc. | Joondalup | Western Australia | 6027 | Australia |
| VZW Algemeen Ziekenhuis KLINA | Brasschaat | Antwerpen | 2930 | Belgium |
| AZ Sint-Maarten | Mechelen | Antwerp | 2800 | Belgium |
| Algemeen Stedelijk Ziekenhuis | Aalst | Oost-vlaanderen | 9300 | Belgium |
| Az Sint Blasius | Dendermonde | Oost-vlaanderen | 9200 | Belgium |
| AZ Sint Lucas Gent | Ghent | Oost-vlaanderen | 9000 | Belgium |
| Universitair Ziekenhuis Gent | Ghent | Oost-vlaanderen | 9000 | Belgium |
| Az Glorieux | Ronse | Oost-vlaanderen | 9600 | Belgium |
| AZ Nikolaas, Campus Moerland | Sint-Niklaas | Oost-vlaanderen | 9100 | Belgium |
| AZ Groeninge-Campus Loofstraat | Kortrijk | West-vlaanderen | 8500 | Belgium |
| Az Damiaan | Ostend | West-vlaanderen | 8400 | Belgium |
| ZNA Campus Middelheim | Antwerp | 2020 | Belgium |
| Imeldaziekenhuis Bonheiden | Bonheiden | 2820 | Belgium |
| A.Z. St.Jan AV Brugge | Bruges | 8000 | Belgium |
| University Hospital Brussels - Centrum voor hart- en vaatziekten | Brussels | 1090 | Belgium |
| University Hospital Brussels- Diabeteskliniek | Brussels | 1090 | Belgium |
| Private Practice 'Cardiovascular Detection Center' | De Pinte | 9840 | Belgium |
| ZOL Campus Sint-Jan | Genk | 3600 | Belgium |
| AZ Maria Middelares | Ghent | 9000 | Belgium |
| Grand Hopital de Charleroi, Site St-Joseph | Gilly | 6060 | Belgium |
| Hygeia | Hasselt | 3500 | Belgium |
| Jessa Ziekenhuis | Hasselt | 3500 | Belgium |
| Sint-Franciskusziekenhuis | Heusden-Zolder | 3550 | Belgium |
| Centre Hospitalier Regional de Huy | Huy | 4500 | Belgium |
| Jan Yperman Ziekenhuis, Cardiology | Ieper | 8900 | Belgium |
| Centre Hospitalier De Jolimont - Lobbes | La Louviere (Haine-Saint-Paul) | 7100 | Belgium |
| Centre Hospitalier de Jolimont-Lobbes | La Louviere (Haine-Saint-Paul) | 7100 | Belgium |
| University hospitals Leuven - Neurology department | Leuven | 3000 | Belgium |
| University hospitals Leuven | Leuven | 3000 | Belgium |
| Centre Hospitalier Universitaire (CHU) de Liege | Liège | 4000 | Belgium |
| Huisartsenpraktijk Medilink | Linkebeek | 1630 | Belgium |
| Huisartsenpraktijk Luc Capiau | Massemen | 9230 | Belgium |
| C.H.U. Ambroise Pare | Mons | 7000 | Belgium |
| Mariaziekenhuis vzw | Overpelt | 3900 | Belgium |
| Dr. Luc De Wolf - Private Practice | Tienen | 3300 | Belgium |
| Centro de Pesquisas em Diabetes e Doencas Endocrino-Metabolicas Ltda | Fortaleza | Ceará | 60430-140 | Brazil |
| Fundacao Bahiana De Cardiologia | Salvador | Estado de Bahia | 41810-010 | Brazil |
| HBA S/A ASSISTENCIA MEDICA E HOSPITALAR-Hospital da Bahia | Salvador | Estado de Bahia | 41810-011 | Brazil |
| Covance Central Laboratory Services | Indianapolis | Indiana | 46214-2985 | Brazil |
| CARDSEARCH/CARDRESEARCH - Cardiologia Assistencial e de Pesquisa LTDA | Belo Horizonte | Minas Gerais | 30150-240 | Brazil |
| Sociedade Hospitalar Angelina Caron/Hospital e Maternidade Angelina Caron | Campina Grande do Sul | Paraná | 83430-000 | Brazil |
| Hospital Santa Casa de Curitiba | Curitiba | Paraná | 80010-030 | Brazil |
| Quanta Diagnostico e Terapia / Medicina Nuclear Alto da XV | Curitiba | Paraná | 80045-170 | Brazil |
| Nucleo de Pesquisa Clínica | Curitiba | Paraná | 80730-150 | Brazil |
| Universidade Federal do Para - Hospital Universitario Joao de Barros Barreto | Belém | Pará | 66073-000 | Brazil |
| Centro de Pesquisas Medicas Basica e Clinica LTDA | Recife | Pernambuco | 52020-010 | Brazil |
| Hospital Agamenon Magalhaes | Recife | Pernambuco | 52051-380 | Brazil |
| CCBR Brasil - Centro de Pesquisa e Analises Clinicas LTDA | Rio de Janeiro | Rio de Janeiro | 22271-100 | Brazil |
| Hospital Universitario - Associacao Educadora Sao Carlos - AESC | Canoas | Rio Grande do Sul | 92425-055 | Brazil |
| Irmandade Santa Casa de Misericordia de Porto Alegre | Porto Alegre | Rio Grande do Sul | 90020-090 | Brazil |
| Hospital Mae de Deus/Associacao Educadora Sao Carlos AESC / IMV - Instituto de Medicina Vascular | Porto Alegre | Rio Grande do Sul | 90110-270 | Brazil |
| Instituto de Cardiologia do Rio Grande do Sul / Fundacao Universitaria de Cardiologia | Porto Alegre | Rio Grande do Sul | 90620-001 | Brazil |
| Hospital Mae de Deus - Instituto do Cancer | Porto Alegre | Rio Grande do Sul | 90840-440 | Brazil |
| Hospital Mae de Deus-Associacao Educadora de Sao Carlos-AESC/IMV - Instituto de Medicina Vascular | Porto Alegre | Rio Grande do Sul | 90840-440 | Brazil |
| Mae de Deus - Centro de Oncologia Radioterapica (COR) | Porto Alegre | Rio Grande do Sul | 90840-440 | Brazil |
| Hospital Santa Isabel | Blumenau | Santa Catarina | 89010-906 | Brazil |
| Loema Medicina e Bem Estar- Centro Especializado em Cardiologia Ltda. | Campinas | São Paulo | 13010-001 | Brazil |
| CAEP - Centro Avançado de Estudos e Pesquisas Ltda. | Campinas | São Paulo | 13087-567 | Brazil |
| IMC - Instituto de Molestias Cardiovasculares/Equipamentos Cardiovasculares Rio Preto Ltda | São José do Rio Preto | São Paulo | 15015210 | Brazil |
| Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo (HC-FMUSP) | São Paulo | São Paulo | 05403-010 | Brazil |
| CARDSEARCH/CARDRESEARCH - Cardiologia Assistencial e de Pesquisa LTDA | Minas Gerais | 30150-240 | Brazil |
| CPClin- Centro de Pesquisas Clinicas Ltda./Clinica Dr. Freddy Goldberg Eliaschewitz | São Paulo | 01244-030 | Brazil |
| FGM-Clinica Paulista de Doencas Cardiovasculares | São Paulo | 01327-010 | Brazil |
| CEPIC - Centro Paulista de Investigacao Clinica e Servicos Medicos Ltda | São Paulo | 04266-010 | Brazil |
| LMC Diabetes & Endocrinology (Calgary) | Calgary | Alberta | T2H 2G4 | Canada |
| Foothills Hospital/University of Calgary | Calgary | Alberta | T2N 4Z6 | Canada |
| Nanji Professional Corporation | Calgary | Alberta | T2V 4J2 | Canada |
| The Medical Arts Health Research Group | Kelowna | British Columbia | V1Y 1V6 | Canada |
| Kelowna Cardiology Associates | Kelowna | British Columbia | VlY 1V6 | Canada |
| Dr. Raymond Dong Inc. | Surrey | British Columbia | V3V 0C6 | Canada |
| Dr. Richard Bon Inc. & Dr. Adam Yeung Inc. | Surrey | British Columbia | V3V 0C6 | Canada |
| Dr. Stephen S. Cheung Inc. | Surrey | British Columbia | V3V 0C6 | Canada |
| SMH Cardiology Clinical Trials | Surrey | British Columbia | V3V 0C6 | Canada |
| Dr. Dante E. Manyari Inc. | Surrey | British Columbia | V3V 1N1 | Canada |
| Dr. Stephanie Au, Inc. | Surrey | British Columbia | V3V 1N1 | Canada |
| Dr. Stephen Pearce Inc. & Dr. Peter K.H. Tan Inc. | Surrey | British Columbia | V3V 1N1 | Canada |
| SMH Cardiology Clinical Trials Inc | Surrey | British Columbia | V3V 1N1 | Canada |
| Dr. Adam Yeung Inc. | Surrey | British Columbia | V3V OC6 | Canada |
| Dr. Michael Kanakos Inc. | Surrey | British Columbia | V3V OC6 | Canada |
| Dr. Stephen S. Cheung Inc. | Surrey | British Columbia | V3VOC6 | Canada |
| Dr. Kapil M. Bhagirath Medical Services Corporation | Surrey | British Columbia | V3W 3C3 | Canada |
| Victoria Heart Institute Foundation | Victoria | British Columbia | V8R 4R2 | Canada |
| Discovery Clinical Services Ltd. | Victoria | British Columbia | V8T 5G4 | Canada |
| St. Boniface Hospital | Winnipeg | Manitoba | R2H 2A6 | Canada |
| G.A. Research Associates Ltd. | Moncton | New Brunswick | E1G 1A7 | Canada |
| Cardiology Research Associates of New Brunswick | Saint John | New Brunswick | E2L 4L2 | Canada |
| Health Sciences Centre | St. John's | NF | A1B 3V6 | Canada |
| Health Science Centre | St. John's | NF | A1B3V6 | Canada |
| LMC Diabetes & Endocrinology (Brampton) | Brampton | Ontario | L6S 0C9 | Canada |
| Aviva Clinical Trial Group Inc. | Burlington | Ontario | L7M 4Y1 | Canada |
| JBN Medical Diagnostic Services Inc. | Burlington | Ontario | L7M 4Y1 | Canada |
| Philippe R. Beaudry Medicine Professional Corporation | Burlington | Ontario | L7R 4E2 | Canada |
| Cambridge Cardiac Care Centre | Cambridge | Ontario | N1R 6V6 | Canada |
| Vizel Cardiac Research - Saul Vizel Professional Medicine Corporation | Cambridge | Ontario | N1R 7R1 | Canada |
| Moran Medical Centre | Collingwood | Ontario | L9Y 1W3 | Canada |
| C & L Research | Fort Erie | Ontario | L2A 1Z3 | Canada |
| Brian Y.L. Wong Medicine Professional Corporation | Greater Sudbury | Ontario | P3E 2N8 | Canada |
| Parkdale Medical Centre | Hamilton | Ontario | L8K 3P3 | Canada |
| Stroke Prevention & Atherosclerosis Research Centre (SPARC) | London | Ontario | N6G 2V2 | Canada |
| Western University - WCPHFM | London | Ontario | N6G2Ml | Canada |
| LMC Diabetes & Endocrinology (Markham) | Markham | Ontario | L6B 0P9 | Canada |
| Newmarket Cardiology Research Group | Newmarket | Ontario | L3Y 8C3 | Canada |
| LMC Clinical Research Inc. (Oakville) | Oakville | Ontario | L6M 1M1 | Canada |
| The Office of Dr. James Cha | Oshawa | Ontario | L1J 2K1 | Canada |
| Kawartha Cardiology Clinical Trials | Peterborough | Ontario | K9J 0B2 | Canada |
| London Road Diagnostic Clinic and Medical Centre | Sarnia | Ontario | N7T 4X3 | Canada |
| Sarnia Institute of Clinical Research | Sarnia | Ontario | N7T 4X3 | Canada |
| Scarborough Cardiology Research Associates Inc. | Scarborough Village | Ontario | M1E 5E9 | Canada |
| Canadian Centre for Research on Diabetes | Smiths Falls | Ontario | K7A 4W8 | Canada |
| LMC Diabetes & Endocrinology (Thornhill) | Thornhill | Ontario | L4J 8L7 | Canada |
| JJ Dig Research LTD | Toronto | Ontario | M3J 1N2 | Canada |
| Canadian Phase Onward, Inc. | Toronto | Ontario | M3J 2C5 | Canada |
| LMC Diabetes & Endocrinology (Bayview) | Toronto | Ontario | M4G 3E8 | Canada |
| Dr. Anil K. Gupta Medicine Professional Corporation | Toronto | Ontario | M9V 4B4 | Canada |
| Dr. Mohan Babapulle Medicine Professional Cooperation | Waterloo | Ontario | N2T 0C1 | Canada |
| Dr. Louis Yao, MD Office of | Weston | Ontario | M9N 1W4 | Canada |
| Ecogene-21 | Chicoutimi | Quebec | G7H 7K9 | Canada |
| Q & T Research Chicoutimi | Chicoutimi | Quebec | G7H 7Y8 | Canada |
| Q&T Recherche Outaouais Inc. | Gatineau | Quebec | J8Y 6S8 | Canada |
| Omnispec Recherche Clinique Inc. | Mirabel | Quebec | J7J 2K8 | Canada |
| Montreal Heart Institute | Montreal | Quebec | H1T 1C8 | Canada |
| Diex Research Montreal, Inc. | Montreal | Quebec | H2Y 1S1 | Canada |
| Recherche Clinique Sigma inc | Québec | Quebec | G1G 3Y8 | Canada |
| Clinique des maladies lipidiques de Quebec | Québec | Quebec | G1V 4W2 | Canada |
| Centre integre de sante et de services sociaux de Lanaudiere (CISSSL) | Saint-Charles-Borromée | Quebec | J6E 6J2 | Canada |
| CISSS des Laurentides-Point de Service de St-Jerome- Comite d'ethique de la recherche | Saint-Jérôme | Quebec | J7Z 5T3 | Canada |
| St-Jerome Medical Research Inc. | Saint-Jérôme | Quebec | J7Z 5T3 | Canada |
| LMC Clinical Research Inc. (Montreal) | Saint-Laurent | Quebec | H4T 1Z9 | Canada |
| Centre Hospitalier Universitaire de Sherbrooke - Hotel-Dieu | Sherbrooke | Quebec | J1G 2E8 | Canada |
| Centre Integre de Sante et de services sociaux de Chaudiere-Appalaches (CISSA-CA) - | St-Georges, Beauce | Quebec | G5Y 4T8 | Canada |
| C.I.C. Mauricie Inc. | Trois-Rivières | Quebec | G8T 7A1 | Canada |
| Centro de Investigacion Clínica del Sur | Temuco | Araucania | 4781156 | Chile |
| Corporacion de Beneficencia Osorno | Osorno | Los Lagos Region | 5311092 | Chile |
| Biomedica Research Group | Providencia Santiago | Santiago Metropolitan | 7500710 | Chile |
| CICAB | Santiago | Santiago Metropolitan | 7500021 | Chile |
| Servicios Medicos Godoy | Santiago | Santiago Metropolitan | 7500710 | Chile |
| SMOLAM | Santiago | Santiago Metropolitan | 7500739 | Chile |
| Complejo Asitencial Dr. Sotero del Rio | Santiago | Santiago Metropolitan | 8207257 | Chile |
| Quantum Research | Puerto Varas | 5550170 | Chile |
| Hospital y CRS El Pino | Santiago | 8053095 | Chile |
| Hospital Pablo Tobon Uribe | Medellín | Antioquia | 00000 | Colombia |
| Rodrigo Botero S.A.S | Medellín | Antioquia | 50012 | Colombia |
| Centro de Investigacion Clinica Avanzada y Multidisciplinaria CICLAM | Medellín | Antioquia | Colombia |
| Centro de Medicina del Ejercicio y Rehabilitacion Cardiaca S.A. CEMDE S.A. | Medellín | Antioquia | Colombia |
| Clinica de la Costa LTDA | Barranquila | Atlántico | Colombia |
| Centro Cientifico Asistencial Jose Luis Accini S.A.S. | Barranquilla | Atlántico | 80020 | Colombia |
| Corazon Ips S.A.S. | Barranquilla | Atlántico | 80020 | Colombia |
| Corozan Ips Sas | Barranquilla | Atlántico | Colombia |
| Fundacion del Caribe para la Investigacion Biomedica - Fundacion BIOS | Barranquilla | Atlántico | Colombia |
| Asociacion IPS Medicos Internistas de Caldas | Manizales | Caldas Department | Colombia |
| MedPlus Medicina Prepagada S.A. | Bogota D.C. | Cundinamarca | 110911 | Colombia |
| Solano & Terront Servicios Medicos Ltda-Establecimiento Comercial UNIENDO | Bogota D.C. | Cundinamarca | Colombia |
| Dexadiab Servicios Medicos LTDA | Bogota D.C | Cundinamarca | 110221 | Colombia |
| Caja de Compensacion Familiar CAFAM, Sede Centro de Atencion en Salud CAFAM FLORESTA | Bogota D.C | Cundinamarca | 111211 | Colombia |
| Hospital Universitario San Ignacio | Bogota D.C | Cundinamarca | Colombia |
| Instituto de Investigacion Endocrinologia y Prevencion Metabolica - ENDOCARE LTDA. | Bogota D.C | Cundinamarca | Colombia |
| Centro de Diagnostico Cardiologico LTDA. | Cartagena | Departamento de Bolívar | Colombia |
| Instituto del Corazon de Bucaramanga S.A. | Bucaramanga | Santander Department | Colombia |
| Fundación Cardiovacular de Colombia - Instituto del Corazón de Floridablanca | Floridablanca | Santander Department | Colombia |
| Fundacion Reina Isabel | Cali | Valle del Cauca Department | 760001 | Colombia |
| FREMLOVA APHOTECA s.r.o. | Litovel | Czech Republic | 78401 | Czechia |
| BENU Lekarna | Pardubice | Czech Republic | 530 02 | Czechia |
| EDUMED s.r.o. | Broumov | Hradec Králové Region | 55001 | Czechia |
| Edumed S.R.O. | Jaroměř | Hradec Králové Region | 550 01 | Czechia |
| Kardiologicka ambulance | Trutnov | Hradec Králové Region | 54101 | Czechia |
| Lekarna na Poliklinice | Trutnov | Hradec Králové Region | 54101 | Czechia |
| MUDr. Jan Vrkoc s.r.o. | Ostrava | Moravian-Silesian Region | 70200 | Czechia |
| Pv-Kardiologie S.R.O. | Pardubice | Pardubice Region | 53002 | Czechia |
| Kardiologicka Ambulance | Brno | South Moravian | 638 00 | Czechia |
| CCBR Czech Brno, s.r.o. | Brno | 602 00 | Czechia |
| DIKa centrum s.r.o., Kardiologicka a interni ambulance | Havířov | 73601 | Czechia |
| Fakultni nemocnice Hradec Kralove, III. Interni gerontometabolicka klinika | Hradec Králové | 500 05 | Czechia |
| Fakultni nemocnice Hradec Kralove | Hradec Králové | 500 05 | Czechia |
| Kardio interna s.r.o. | Litovel | 784 01 | Czechia |
| Fakultni Nemocnice Olomouc | Olomouc | 775 00 | Czechia |
| Fakultni Nemocnice Olomouc | Olomouc | 77520 | Czechia |
| CCBR Czech a.s. | Pardubice | 530 02 | Czechia |
| Kardiologie Plzen s.r.o. | Pilsen | 326 00 | Czechia |
| Fakultni poliklinika Vseobecne fakultni nemocnice v Praze | Prague | 128 08 | Czechia |
| CCBR Czech Prague, s.r.o | Prague | 130 00 | Czechia |
| Centrum kardiovaskularni prevence 1. LF UK a TN | Prague | 14059 | Czechia |
| Kardiologie a interni lekarstvi | Prague | 158 00 | Czechia |
| NEFROMED, s.r.o. | Prague | 160 00 | Czechia |
| Interna a kardiologie s.r.o. | Rožnov pod Radhoštěm | 756 61 | Czechia |
| Nemocnice Pardubickeho kraje, a.s., Svitavska nemocnice | Svitavy | 568 25 | Czechia |
| Vseobecna kardiologicka ambulance s.r.o. | Tábor | 390 03 | Czechia |
| Lekarna U Nemocnice | Tábor | 39003 | Czechia |
| Lekarna Hradebni s.r.o. | Uherské Hradiště | 686 01 | Czechia |
| MUDr. Antonin Dufka, kardiologicka ambulance | Uherské Hradiště | 686 01 | Czechia |
| MUDr. Nina Zemkova s.r.o. | Uherské Hradiště | 686 01 | Czechia |
| KIGE s.r.o. | Znojmo | 66902 | Czechia |
| Sygehus Sonderjylland Aabenraa | Aabenraa | 6200 | Denmark |
| Aalborg Universitetshospital, Lipidklinikken | Aalborg | 9000 | Denmark |
| CCBR Aalborg | Aalborg | 9000 | Denmark |
| Aarhus Universitetshospital Skejby, Hjertesygdomme ¿ Klinisk Forskning | Aarhus | 8200 | Denmark |
| Aarhus Universitetshospital | Aarhus N | 8250 | Denmark |
| CCBR Ballerup | Ballerup Municipality | 2750 | Denmark |
| Bispebjerg og Frederiksberg Hospital | Copenhagen NV | 2400 | Denmark |
| Rigshospitalet | Copenhagen Oe | 2100 | Denmark |
| Sydvestjysk Sygehus | Esbjerg | 6700 | Denmark |
| Frederiksberg Hospital | Frederiksberg | 2000 | Denmark |
| Glostrup Hospital | Glostrup Municipality | 2600 | Denmark |
| Herlev Universitetshospital, Kardiologisk afdeling S | Herlev | 2730 | Denmark |
| Regionshospitalet Herning | Herning | 7400 | Denmark |
| Hillerod Hospital | Hillerød | 3400 | Denmark |
| Hvidovre Universitetshospital, Hjerte-lungemedicinsk afdeling | Hvidovre | 2650 | Denmark |
| Kolding Sygehus | Kolding | 6000 | Denmark |
| Amager Hospital | København S | 2300 | Denmark |
| Region Sjaelland Sygehus Nord, Koge Sygehus | Køge | 4600 | Denmark |
| Nykobing F. Sygehus-Medicinsk afdeling | Nykøbing Falster | 4800 | Denmark |
| Region Sjaelland Naestved Sygehus | Næstved | 4700 | Denmark |
| Regionshospitalet Randers | Randers | 8930 | Denmark |
| Regionshospitalet Silkeborg, Hjerte Projektkontor | Silkeborg | 8600 | Denmark |
| Slagelse Sygehus | Slagelse | 4200 | Denmark |
| Svendborg Sygehus | Svendborg | 5700 | Denmark |
| CCBR Vejle | Vejle | DK 7100 | Denmark |
| Hospitalsenheden Midt, Regionshospital Viborg | Viborg | 8800 | Denmark |
| Linnan Klinikka Oy | Hämeenlinna | 13100 | Finland |
| Mehilainen Toolo | Helsinki | 00260 | Finland |
| Helsinki University Central Hospital | Helsinki | 00290 | Finland |
| Helsingin yliopistollinen keskussairaala, Sisaetaudit ja kuntoutus, Biomedicum 2U | Helsinki | FI-00290 | Finland |
| Ita-Suomen laakarikeskus Oy | Joensuu | 80100 | Finland |
| Studycor Oy | Jyväskylä | 40620 | Finland |
| Laeaekaerikeskus Aava Kerava | Kerava | 04200 | Finland |
| Menoa oy | Kinkomaa | 40930 | Finland |
| Kokkolan Keskussairaala | Kokkola | 67200 | Finland |
| Mewell liikuntaklinikka | Kotka | 48600 | Finland |
| Itae-Suomen Laeaekaeritalo Oy | Kuopio | 70100 | Finland |
| Terveystalo Kuopio | Kuopio | 70100 | Finland |
| Oulu Mentalcare Oy | Oulu | 90100 | Finland |
| Terveystalo Oulu, Diapolis | Oulu | 90100 | Finland |
| Oulu University Hospital | Oulu | 90220 | Finland |
| Porin Laakaritalo Oy | Pori | 28100 | Finland |
| Terveystalo Siilinjarvi | Siilinjärvi | 71800 | Finland |
| FinnMedi Oy | Tampere | 33520 | Finland |
| Terveystalo Pulssi | Turku | 20100 | Finland |
| Turku University Hospital | Turku | 20520 | Finland |
| Vantaan Tutkimuskeskus | Vantaa | 01600 | Finland |
| CHU Jean Minjoz Cardiologie | Besançon | 25000 | France |
| Centre Hospitalier De Bourg En Bresse - Hopital Fleyriat | Bourg-en-Bresse | 01012 | France |
| CHU de Caen | Caen | 14033 | France |
| Centre Hospitalier de Cannes- Service de Cardiologie | Cannes | 06414 | France |
| Centre Hospitalier Sud-Francilien | Corbeil-Essonnes | 91106 | France |
| Scp Cardiovasculaire De L'Est | Essey-lès-Nancy | 54270 | France |
| Centre Hospitalier Louis Pasteur | Le Coudray | 28630 | France |
| Hopital La Louviere | Lille | 59000 | France |
| Centre Hospitalier Saint Philibert | Lomme | 59462 | France |
| Hopital Cardiovasculaire Et Pneumologique Louis Pradel | Lyon | 69394 | France |
| Hopital Arnaud de Villeneuve | Montpellier | 34295 | France |
| CHU de Nantes - Hopital Nord Laennec | Nantes | 44093 | France |
| Nouvelles Cliniques Nantaises | Nantes | 44200 | France |
| CHU Caremeau | Nîmes | 30000 | France |
| CHU Caremeau | Nîmes | 30029 | France |
| Centre Hospitalier de PAU | Pau | 64046 | France |
| Hopital Cardiologique | Pessac | 33604 | France |
| CHU de Poitiers | Poitiers | 86021 | France |
| CHU de Renes Hopital de Pontchaillou | Rennes | 35033 | France |
| CHU de Toulouse | Toulouse | 31059 | France |
| Hopital Guy Chatiliez | Tourcoing | 59200 | France |
| Hopital Trousseau | Tours | 37044 | France |
| Centre Hospitalier (CH) de Valenciennes | Valenciennes | 59300 | France |
| Polyclinique Vauban | Valenciennes | 59300 | France |
| Universitaets Herzzentrum Freiburg Bad Krozingen | Bad Krozingen | Baden-Wurttemberg | 79189 | Germany |
| Medizinische Universtatsklinik Heidelberg | Heidelberg | Baden-Wurttemberg | 69120 | Germany |
| Ze:ro Arztpraxen | Mannheim | Baden-Wurttemberg | 68165 | Germany |
| Gemeinschaftspraxis im Altstadt Carree | Fulda | Hesse | 36037 | Germany |
| Klinische Forschung Schwerin GmbH | Schwerin | Mecklenburg-Vorpommern | 19055 | Germany |
| Zentrum Klinische Studien Neuwied (ZKSN) | Neuwied | Rhineland-Palatinate | 56564 | Germany |
| Gemeinschaftspraxis Schwabenheim | Schwabenheim | Rhineland-Palatinate | 55270 | Germany |
| Klinikum Altenburger Land Gmbh | Altenburg | 04600 | Germany |
| Zentralklinik Bad Berka GmbH | Bad Berka | 99437 | Germany |
| Forschungszentrum Dr. med Irma Schoell | Bad Homburg | 61348 | Germany |
| Institut fuer Klinische Forschung und Entwicklung(IKFE) Berlin GmbH | Berlin | 10115 | Germany |
| Klinische Forschung Berlin-Mitte GmbH | Berlin | 10117 | Germany |
| POLIKUM Institut GmbH | Berlin | 12157 | Germany |
| DRK Kliniken Kopenick, Zentrum Klinische Forschung | Berlin | 12559 | Germany |
| Berlin Research Centre-Synexus Clinical Research GmbH | Berlin | 12627 | Germany |
| Synexus Clinical Research GmbH | Berlin | 12627 | Germany |
| Deutsches Herzzentrum Berlin | Berlin | 13353 | Germany |
| Medizinisches Versorgungszentrum am Bahnhof Spandau | Berlin | 13597 | Germany |
| Klinikum Bielefeld | Bielefeld | 33604 | Germany |
| Bochum Research Centre-Synexus Clinical Research GmbH | Bochum | 44787 | Germany |
| MediClin Reha-Zentrum Spreewald | Burg | 03096 | Germany |
| Klinikum Coburg | Coburg | 96450 | Germany |
| Zentrum fuer klinische Forschung | Cologne | 51069 | Germany |
| HELIOS Amper-Klinikum Dachau | Dachau | 85221 | Germany |
| Kardiologische Praxisgemeinschaft | Dortmund | 44137 | Germany |
| St. Johannes-Hospital | Dortmund | 44137 | Germany |
| Gemeinschaftspraxis fuer Kardiologie Dres. Med. Willgeroth/Wetzel | Dortmund | 44141 | Germany |
| Klinsche Forschung Dresden GmbH | Dresden | 01069 | Germany |
| Praxis Dr. med. Christoph Axthelm | Dresden | 01277 | Germany |
| GWT-TUD GmbH, Studienzentrum Professor Hanefeld | Dresden | 01307 | Germany |
| Gemeinschaftspraxis Dr. Hagemann/Breiderhoff/Durfeld | Essen | 45355 | Germany |
| Medizentrum Essen Borbeck | Essen | 45355 | Germany |
| Studienzentrum | Essen | 45355 | Germany |
| Gemeinschaftspraxis Dres. Dirk Weber, Ulrich Weber, Heiner Saueressig, Birte Turner und Georg | Essen | 45359 | Germany |
| Schwerpunktpraxis Dr. Luedemann fuer Diabetes Gefaess- und Ernaehrungsmedizin | Falkensee | 14612 | Germany |
| Clinphenomics Gmbh & Co Kg, Studienzentrum | Frankfurt | 60 594 | Germany |
| Synexus Clinical research GmbH | Frankfurt | 60596 | Germany |
| IKF Institut fuer klinische Forschung Frankfurt | Frankfurt am Main | 60596 | Germany |
| Klinik und Poliklinik fuer Innere Medizin B-Kardiologie, Angiologie, Pulmologie, Internistische | Greifswald | 17475 | Germany |
| Cardiologicum Hamburg | Hamburg | 22041 | Germany |
| Praxis Dr. med Cornelia Brauer | Hamburg | 22415 | Germany |
| Klinische Forschung Hannover-Mitte GmbH | Hanover | 30159 | Germany |
| Universitatsklinikum des Saarlandes Klinik fur Innere Medizin III | Homburgsaar | 66421 | Germany |
| Praxis Dr. Heister | Kamp-Lintfort | 47475 | Germany |
| Studienzentrum Dr. Appel | Kassel | 34121 | Germany |
| Gemeinschaftspraxis Dr. Klein / Minnich | Künzing | 94550 | Germany |
| Klinik fur Innere Medizin, Kardiologie und Angiologie MediClin Herzzentrum Lahr/Baden. | Lahr | 77933 | Germany |
| Synexus Clinical research GmbH | Leipzig | 04103 | Germany |
| Synexus Leipzig Clinical Research Centre | Leipzig | 04103 | Germany |
| Polikum Institut Leipzig GmbH | Leipzig | 04109 | Germany |
| Gemeinschaftspraxis Dr. med. Heidrun Taeschner und Dr. med. Susanne Bonigut | Leipzig | 04249 | Germany |
| Maerkische Kliniken GmbH, Klinikum Luedenscheid, Innere III | Lüdenscheid | 58515 | Germany |
| Klinikum Lunen, St. Marienhospital | Lünen | 44534 | Germany |
| SMO.MD GmbH - Zentrum für klinische Studien | Magdeburg | 39120 | Germany |
| SMO.MD GmbH, Zentrum fuer klinische Studien Site Management and Clinical Research Unit | Magdeburg | 39120 | Germany |
| Pfuetzner Science & Health Institute-Gmbh | Mainz | 55116 | Germany |
| Staedtisches Klinikum Muenchen GmbH | Munich | 81737 | Germany |
| Klinikum Der Universitat Munchen | München | 80336 | Germany |
| Klinikum fuer Herz- & Kreislauferkrankungen | München | 80636 | Germany |
| Kardiologische Praxis Northeim | Northeim | 37154 | Germany |
| Gemeinschaftspraxis Drs Haggenmiller/Jeserich, Kardiologie, Angiologie, Innere Medizin | Nuremberg | 90402 | Germany |
| Allgemeinmedizinisch-Internistische Praxisgemeinschaft | Offenbach | 63071 | Germany |
| Praxis Dres. Med Naudts und Nowack | Rodgau | 63110 | Germany |
| Klinik am See Rehabilitationszentrum fur Innere Medizin | Rüdersdorf | 15562 | Germany |
| Kardiologische Gemeinschaftspraxis Dres Med. Gerke/Burger | Soest | 59494 | Germany |
| Praxisgemeinschaft Stuhr-Brinkum | Stuhr-Brinkum | 28816 | Germany |
| Robert-Bosch-Krankenhaus | Stuttgart | 70376 | Germany |
| Josephs-Hospital Warendorf Med. Klinik II, Kardiologie/Angiologie | Warendorf | 48231 | Germany |
| Kardiologische Praxis | Wermsdorf | 04779 | Germany |
| ForschungszentrumRuhr KliFoCenter GmbH | Witten | 58455 | Germany |
| Pecsi Tudomanyegyetem AOK, II. | Pécs | Baranya | 7624 | Hungary |
| Bacs-Kiskun Megyei Korhaz | Kecskemét | Bács-Kiskun county | 6000 | Hungary |
| Szegedi Tudomanyegyetem AOK, I. sz Belgyogyaszati Klinika | Szeged | Csongrád megye | 6720 | Hungary |
| Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz | Székesfehérvár | Fejér | 8000 | Hungary |
| DRC Kft. | Balatonfüred | 8230 | Hungary |
| DRC Kft. | Balatongyörök | 8313 | Hungary |
| Grof Tisza Istvan Korhaz Berettyoujfalu | Berettyóújfalu | 4100 | Hungary |
| Kardiologiai Maganrendelo | Békéscsaba | 5600 | Hungary |
| Budapesti Szent Ferenc Korhaz | Budapest | 1021 | Hungary |
| Synexus Magyarorszag Kft | Budapest | 1036 | Hungary |
| Szent Rokus Korhaz | Budapest | 1085 | Hungary |
| Semmelweis Egyetem | Budapest | 1088 | Hungary |
| Gottsegen Gyorgy Orszagos Kardiologiai Intezet | Budapest | 1096 | Hungary |
| Egyesitett Szent Istvan es Szent Laszlo Korhaz-Rendelointezet | Budapest | 1097 | Hungary |
| Egyesitett Szent Istvan Korhaz es Szent Laszlo Korhaz | Budapest | 1097 | Hungary |
| Semmelweis Egyetem | Budapest | 1125 | Hungary |
| Szent Janos Korhaz es Eszak-budai Egyesitett Korhazak, III. Belgyogyaszat-Kardiologiai Osztaly | Budapest | 1125 | Hungary |
| Debreceni Egyetem | Debrecen | 4032 | Hungary |
| Synexus Magyarorszag Kft. | Gyula | 5700 | Hungary |
| Edes Szivunk Egeszsegkozpont Kft. | Hajdúszoboszló | 4200 | Hungary |
| BKS Research Kft., Albert Schweitzer Korhaz | Hatvan | 3000 | Hungary |
| Somogy Megyei Kaposi Mór Oktató Kórház | Kaposvár | 7400 | Hungary |
| Jutrix Egeszsegugyi Kft | Kecskemét | 6000 | Hungary |
| Megyei Flor Ferenc Korhaz | Kistarcsa | 2143 | Hungary |
| Pest Megyei Flor Ferenc Korhaz | Kistarcsa | 2143 | Hungary |
| Josa Andras Oktatokorhaz | Nyíregyháza | 4400 | Hungary |
| Medifarma-98 Kft. | Nyíregyháza | 4400 | Hungary |
| Pecsi Tudomanyegyetem AOK, I. Belgyogyaszati Klinika | Pécs | 7624 | Hungary |
| Mentahaz Maganorvosi Kozpont | Székesfehérvár | 8000 | Hungary |
| Hetenyi Geza Korhaz | Szolnok | 5000 | Hungary |
| Markusovszky Egyetemi Oktatokarhaz | Szombathely | 9700 | Hungary |
| Dr. Sydo es Tsa Kft. | Veszprém | 8200 | Hungary |
| Zala Megyei Korhaz, Diabetológiai Szakrendelés | Zalaegerszeg | 8900 | Hungary |
| Zala Megyei Korhaz | Zalaegerszeg | 8900 | Hungary |
| Dr. Jivraj Mehta Smarak Health Foundation, Bakeri Medical Research Centre | Ahmedabad | Gujarat | 380007 | India |
| Apex Heart Institute (A Unit of TCVS Pvt. Ltd) | Ahmedabad | Gujarat | 380054 | India |
| SAL Hospital | Ahmedabad | Gujarat | 380054 | India |
| Apple Hospital | Surat | Gujarat | 395 002 | India |
| Unicare Heart Institute & Research Center | Surat | Gujarat | 395002 | India |
| BAPS - Pramukh Swami Hospital | Surat | Gujarat | 395009 | India |
| Rhythm Heart Institute | Vadodara | Gujarat | 390022 | India |
| Jehangir Clinical Development Centre Pvt. Ltd. | Pune | Maharashtra | 411001 | India |
| M.V. Hospital And Research Centre | Lucknow | Uttar Pradesh | 226003 | India |
| Beaumont Hospital | Dublin | Leinster | 9 | Ireland |
| St James's Hospital | Dublin | 8 | Ireland |
| Tel Aviv Sourasky Medical Center | Tel Aviv | Tel Aviv | 64239 | Israel |
| Barzilai Medical Center | Ashkelon | 7830604 | Israel |
| Ben Yair Community Clinic - Clalit Health Services | Beersheba | 84350 | Israel |
| Heart Institute, Hillel Yaffe Medical Center | Hadera | 38100 | Israel |
| Rambam Medical Center | Haifa | 31096 | Israel |
| Cardiovascular Clinical Research Institute | Haifa | 34362 | Israel |
| Edith Wolfson Medical Center | Holon | 58100 | Israel |
| Hadassah Ein Kerem Medical Center | Jerusalem | 91120 | Israel |
| Meir Medical Center | Kfar Saba | 44281 | Israel |
| Galilee Medical Center, Cardiology Department | Nahariya | 22100 | Israel |
| E.M.M.S Nazareth Hospital | Nazareth | 16100 | Israel |
| Rabin Medical Center, Beilinson Hospital | Petah Tikva | 49100 | Israel |
| Rabin Medical Center-Beilinson Hospital | Petah Tikva | 49100 | Israel |
| Rabin Medical Center | Petah Tikva | 49100 | Israel |
| Sha'aria Clinic, Clalit Health Services | Petah Tikva | 4958202 | Israel |
| Shuali Community Clinic, Clalit Health Services | Raanana | 43452 | Israel |
| Department of Neurology & Sagol Neuroscience Center | Ramat Gan | 52621 | Israel |
| Heart Institute, Kaplan Medical Center | Rehovot | 76100 | Israel |
| Kaplan Medical Center Metabolism and Diabetes Clinic, Kaplan Medical Center | Rehovot | 76100 | Israel |
| Internal Medicine A, Ziv Medical Center | Safed | 13100 | Israel |
| Ziv Medical Center | Safed | 13100 | Israel |
| Tel Aviv Sourasky Medical Center | Tel Aviv | 64239 | Israel |
| Assuta Medical Center | Tel Aviv | 6789140 | Israel |
| The Chaim Sheba Medical Center | Tel Litwinsky | 5265601 | Israel |
| A.O. Treviglio e Caravaggio | Treviglio (BG) | Bergamo | 24047 | Italy |
| AOU Policlinico "Mater Domini" UOC di Medicina Interna | Catanzaro | CZ | 88100 | Italy |
| Covance Central Laboratory Services | Meyrin/Geneve | Geneve | 1217 | Italy |
| Ospedale S. L. Mandic di Merate | Merate | Lecco | 23807 | Italy |
| Dipartimento delle Patologie Emergenti, Unita di Medicina Interna e Dislipidemie Genetiche | Palermo | PA | 90127 | Italy |
| Ospedale S. Maria della Misericordia -Dipartimento di Medicina, Medicina Interna, | Perugia | PG | 06132 | Italy |
| Azienda Ospedaliera Della Provincia Di Lecco - Ospedale Manzoni | Lecco | Province OF Lecco | 23900 | Italy |
| Dip Medicina Interna e Specialita Mediche, Policlinico Umberto I | Roma | RM | 00161 | Italy |
| Policlinico Umberto I di Roma | Rome | RM | 00161 | Italy |
| Azienda Ospedaliera S'Andrea di Roma - UOC Cardiologia | Rome | RM | 00189 | Italy |
| Ospedale G. Fracastoro | San Bonifacio | Verona | 37047 | Italy |
| AOUI di Verona - Ospedale Civile Maggiore Borgo Trento | Verona | VR | 37126 | Italy |
| S. C. Cardiologia INRCA | Ancona | 60124 | Italy |
| Ospedale Civile Regionale San Martino, Belluno | Belluno | 32100 | Italy |
| Azienda Ospedaliera G. Brotzu | Cagliari | 09124 | Italy |
| Unità Operativa Solventi e Unità Poliambulatorio | Milan | 20138 | Italy |
| Department of Clinical Medicines and Cardiovascular Sciences, Universita "Federico II" di Napoli | Naples | 80131 | Italy |
| Divisione di Cardiologia con Utic ed Emodinamica - AOU Federico II di Napoli | Naples | 80131 | Italy |
| A.O. di Reggio Emilia Arcispedale "S. Maria Nuova"/IRCCS | Reggio Emilia | 42123 | Italy |
| AUSL Della Romagna-Ospedale Infermi | Rimini | 47923 | Italy |
| Ospedale Santa Maria della Misericordia Azienda ULSS 18 of Rovigo | Rovigo | 45100 | Italy |
| Azienda Ospedaliera Universitaria Santa Maria della Misericordia | Udine | 33100 | Italy |
| Consultorio Dr. Leocadio Gerardo Munoz Beltran | Cd. Juarez | Chihuahua | 32472 | Mexico |
| Centro de Investigacion Clinica del Pacifico, S.A. de C.V. | Acapulco de Juárez | Guerrero | 39670 | Mexico |
| Hospital Del Pacifico,Centro De Investigacion Clinica Del Pacifico Cicpa,Torre Medica Del Pacifico | Acapulco de Juárez | Guerrero | 39670 | Mexico |
| Clinical Trials Mexico, S.A. de C.V. | Pachuca | Hidalgo | 42070 | Mexico |
| Investigacion Biomedica Aplicada de Hidalgo S.A. de C.V. | Pachuca | Hidalgo | 42090 | Mexico |
| Centro de Investigacion Medica Integral S.C. | Guadalajara | Jalisco | 44160 | Mexico |
| Icle S.C. | Guadalajara | Jalisco | 44600 | Mexico |
| Consultorio Privado del Dr. Gabriel Arturo Ramos Lopez | Guadalajara | Jalisco | 44657 | Mexico |
| Unidad de Investigacion Clinica y Atencion Medica Hepa S.C. | Guadalajara | Jalisco | 44760 | Mexico |
| Consultorio de Endocrinologia y Nutriologia | Mexico City | Mexico City | 07760 | Mexico |
| Operadora de Hospitales Angeles S.A. de C.V. (Emergencies) | Mexico City | Mexico City | 07760 | Mexico |
| Centro Especializado en Diabetes Obesidad y Prevencion de Enfermedades Cardiovasculares, SC. | Mexico City | Mexico City | 11650 | Mexico |
| Instituto Nacional de Ciencias Medicas y Nutricion "Salvador Zubiran" | Mexico City | Mexico City | 14000 | Mexico |
| Instituto de Diabetes Obesidad y Nutricion, S.C. | Cuernavaca | Morelos | 62250 | Mexico |
| Hospital Inovamed Cuernavaca (Emergencies) | Cuernavaca | Morelos | 62270 | Mexico |
| Cardiolink Clin Trials, S.C. | Monterrey | Nuevo León | 64060 | Mexico |
| Hospital Universitario "Dr. Jose Eleuterio Gonzalez" | Monterrey | Nuevo León | 64460 | Mexico |
| CRI Centro Regiomontano de Investigacion SC | Monterrey | Nuevo León | 64710 | Mexico |
| Global Trial Research Center S.A. de C.V. | Monterrey | Nuevo León | 64718 | Mexico |
| Centro Integral Medico SJR S.C | San Juan del Río | Querétaro | 76800 | Mexico |
| Centro para el Desarrollo de la Medicina y de Asistencia Médica Especializada S.C. | Culiacán | Sinaloa | 80020 | Mexico |
| Hospital Angeles Culiacan | Culiacán | Sinaloa | 80020 | Mexico |
| Centro de Estudios de Investigacion Metabolicos y Cardiovasculares S.C. | Tampico | Tamaulipas | 89000 | Mexico |
| Centro De Especialidades Medicas Del Estado De Veracruz | Xalapa | Veracruz | 91020 | Mexico |
| Instituto Biomedico De Investigacion A.C. | Aguascalientes | 20127 | Mexico |
| Hospital Cardiologica Aguascalientes | Aguascalientes | 20230 | Mexico |
| Unidad De Investigacion En Salud De Chihuahua S.C. | Chihuahua City | 31203 | Mexico |
| Consultorio Medico de Especialidad Dr. Demetrio Kosturakis Garcia | Chihuahua City | 31217 | Mexico |
| Investigacion en Salud y Metabolismo S.C | Chihuahua City | 31217 | Mexico |
| Instituto Nacional de Ciencia Medicas y Nutricion Salvador Zubiran | Distrito Federal | 14000 | Mexico |
| Lahoja Asociacion para la Investigacion y Farmacovigilancia S.C. | Durango | 34000 | Mexico |
| Centro Especializado en Diabetes, Obesidad y Prevencion de Enfermedades Cardiovasculares, S.C. | México | 11650 | Mexico |
| Pharmacology and Clinical Research S.A. de C.V. | Querétaro | 76000 | Mexico |
| Cardioarritmias e Investigacion S.C. | San Luis Potosí City | 78200 | Mexico |
| Hospital Lomas de San Luis lntemacional (Emergencies) | San Luis Potosí City | 78218 | Mexico |
| Hospital Central "Dr. Ignacio Morones Prieto" | San Luis Potosí City | 78240 | Mexico |
| Centro Especializado En Diabetes Y Metabolismo | Veracruz | 91910 | Mexico |
| Zuyderland MC | Sittard-Geleen | Limburg | 6162 BG | Netherlands |
| Isala | Zwolle | Overijssel | 8025 AB | Netherlands |
| Tjongerschans Ziekenhuis | Heerenveen | Provincie Friesland | 8441 PW | Netherlands |
| St. Franciscus Gasthuis | Rotterdam | South Holland | 3045 PM | Netherlands |
| Het Lange Land Ziekenhuis | Zoetermeer | South Holland | 2725 NA | Netherlands |
| Noordwest Ziekenhuisgroep | Alkmaar | 1815 JD | Netherlands |
| EB Flevoresearch | Almere Stad | 1311 RL | Netherlands |
| Meander Medical Center | Amersfoort | 3813 TZ | Netherlands |
| Meander Medisch Centrum | Amersfoort | 3813 TZ | Netherlands |
| Amstelland Hospital | Amstelveen | 1186 AM | Netherlands |
| Bovenij Ziekenhuis | Amsterdam | 1034 CS | Netherlands |
| OLVG, locatie West | Amsterdam | 1061 AE | Netherlands |
| VU University Medical Center | Amsterdam | 1081 HV | Netherlands |
| Onze Lieve Vrouwe Gasthuis | Amsterdam | 1091 AC | Netherlands |
| Academic Medical Center | Amsterdam | 1105 AZ | Netherlands |
| Gelre Hospitals | Apeldoorn | 7334 DZ | Netherlands |
| Rode Kruis Ziekenhuis | Beverwijk | 1942 LE | Netherlands |
| Tergooi Ziekenhuis | Blaricum | 1261 AN | Netherlands |
| Andro Medical Research B.V. | Breda | 4811 SW | Netherlands |
| Amphia Ziekenhuis | Breda | 4818 CK | Netherlands |
| Reinier de Graaf Ziekenhuis | Delft | 2625 AD | Netherlands |
| Deventer Ziekenhuis | Deventer | 7416SE | Netherlands |
| Van Weel Bethesda Hospital | Dirksland | 3247 BW | Netherlands |
| Slingeland Ziekenhuis | Doetinchem | 7009 BL | Netherlands |
| Albert Schweitzer Ziekenhuis-Albert Schweitzer Hospital | Dordrecht | 3318 AT | Netherlands |
| Ziekenhuis Gelderse Vallei | Ede | 6716 RP | Netherlands |
| Andromed Eindhoven | Eindhoven | 5611 NV | Netherlands |
| Heartcentre Catharina Hospital | Eindhoven | 5623 EJ | Netherlands |
| Medisch Spectrum Twente | Enschede | 7512 KZ | Netherlands |
| Beatrix Hospital | Gorinchem | 4204 AA | Netherlands |
| Beatrix Ziekenhuis | Gorinchem | 4204 AA | Netherlands |
| Groene Hart Ziekenhuis | Gouda | 2803 HH | Netherlands |
| University Medical Center Groningen | Groningen | 9713 GZ | Netherlands |
| Martini Ziekenhuis | Groningen | 9728 NT | Netherlands |
| Spaarne Gasthuis | Haarlem | 2035 RC | Netherlands |
| Ropcke Zweers Hospital | Hardenberg | 7772 SE | Netherlands |
| St. Jansdal Ziekenhuis | Harderwijk | 3844 DG | Netherlands |
| Zuyderland Medisch Centrum | Heerlen | 6419 PC | Netherlands |
| Zuyderland | Heerlen | 6419PC | Netherlands |
| Treant Zorggroep, location Bethesda | Hoogeveen | 7909 AA | Netherlands |
| Vascular Research Centre | Hoorn | 1624 NP | Netherlands |
| Quality Care Research | Kloosterhaar | 7694 AC | Netherlands |
| Medisch Centrum Leeuwarden | Leeuwarden | 8934 AD | Netherlands |
| Leiden University Medical Center | Leiden | 2333 ZA | Netherlands |
| Alrijne Ziekenhuis | Leiden | 2334 CK | Netherlands |
| Alrijne Ziekenhuis | Leiderdorp | 2353 GA | Netherlands |
| GCM Maarssenbroek | Maarssen | 3607 KN | Netherlands |
| Maastricht University Medical Center | Maastricht | 6229 HX | Netherlands |
| Isala Diaconessenhuis | Meppel | 7943 KA | Netherlands |
| St Antonius Hospital | Nieuwegein | 3435 CM | Netherlands |
| Radboud University Nijmegen Medical Centre | Nijmegen | 6525 GA | Netherlands |
| Canisius Wilhelmina Ziekenhuis | Nijmegen | 6532 SZ | Netherlands |
| Waterland Hospital | Purmerend | 1441 RN | Netherlands |
| Andro Medical Research B.V. | Rotterdam | 3021 HC | Netherlands |
| Hedramed | Rotterdam | 3037 AN | Netherlands |
| Rotterdam Research Institute | Rotterdam | 3039 BD | Netherlands |
| Ikazia Ziekenhuis | Rotterdam | 3083AN | Netherlands |
| D&A Research and Genetics | Sneek | 8601 ZR | Netherlands |
| Hedramed | The Hague | 2526 HW | Netherlands |
| Hagaziekenhuis | The Hague | 2545 CH | Netherlands |
| Bronovo Ziekenhuis | The Hague | 2597 AX | Netherlands |
| Ziekenhuis Rivierenland | Tiel | 4002 WP | Netherlands |
| Elisabeth-TweeSteden Ziekenhuis (previously named St. Elisabeth Ziekenhuis) | Tilburg | 5022 GC | Netherlands |
| St. Elisabeth Ziekenhuis | Tilburg | 5022 GC | Netherlands |
| Elisabeth TweeSteden Ziekenhuis (ETZ) | Tilburg | 5042 AD | Netherlands |
| Bernhoven Ziekenhuis | Uden | 5406 PT | Netherlands |
| EB Utrecht | Utrecht | 3511 NH | Netherlands |
| Universitair Medisch Centrum (UMC) Utrecht - Locatie AZU | Utrecht | 3584 CX | Netherlands |
| University Medical Center Utrecht | Utrecht | 3584 CX | Netherlands |
| Maxima Medisch Centrum | Veldhoven | 5504 DB | Netherlands |
| VieCuri Medisch Centrum | Venlo | 5912 BL | Netherlands |
| Twee Steden Ziekenhuis | Waalwijk | 5141 BM | Netherlands |
| Klinisch Onderzoek Praktijk Zoetermeer | Zoetermeer | 2712 AB | Netherlands |
| Albert Schweitzer Hospital | Zwijndrecht | 3331 LZ | Netherlands |
| Henderson Medical Centre | Henderson | Auckland | 0612 | New Zealand |
| North Shore Hospital | Takapuna | Auckland | 0622 | New Zealand |
| Hawke's Bay Hospital | Frimley | Hastings | 4120 | New Zealand |
| North Shore Hospital, Laboratory | Auckland | 0622 | New Zealand |
| North Shore Hospital- Inpatient Pharmacy | Auckland | 0622 | New Zealand |
| Optimal Clinical Trials | Auckland | 1010 | New Zealand |
| Auckland City Hospital | Auckland | 1023 | New Zealand |
| Middlemore Clinical Trials | Auckland | 2025 | New Zealand |
| Lipid and Diabetes Research Group | Christchurch | 8011 | New Zealand |
| Southern Clinical Trials Shirley Ltd Don Beavan Medical Research Centre | Christchurch | 8011 | New Zealand |
| Southern Clinical Trials Riccarton | Christchurch | 8041 | New Zealand |
| Taranaki Base Hospital | New Plymouth | 4310 | New Zealand |
| Papamoa Pines Medical Centre | Papamoa | 3118 | New Zealand |
| Rotorua Hospital | Rotorua | 3010 | New Zealand |
| Clinical Horizons NZ Ltd | Tauranga | 3112 | New Zealand |
| Clinical Trials Unit,Bay of Plenty(BOP) Clinical School | Tauranga | 3112 | New Zealand |
| CCDHB, Wellington Hospital, Clinical Measurement Unit | Wellington | 6021 | New Zealand |
| Wellington Hospital | Wellington | 6021 | New Zealand |
| Wellington Regional Hospital | Wellington | 6242 | New Zealand |
| Synexus Polska Sp. z o.o Oddzial w Poznaniu | Poznan | Greater Poland Voivodeship | 60-702 | Poland |
| Nzoz "Twoja Przychodnia" | Poznan | Greater Poland Voivodeship | 61-006 | Poland |
| SPZOZ Uniwersytecki Szpital Kliniczny im. Wojskowej Akademii Medycznej Uniwersytetu Medycznego | Lodz | Iodzkie | 92-213 | Poland |
| NZOZ Vitamed | Bydgoszcz | Kuyavian-Pomeranian Voivodeship | 85-079 | Poland |
| Nzoz Centrum Medyczne Kermed | Bydgoszcz | Kuyavian-Pomeranian Voivodeship | 85-231 | Poland |
| Specjalistyczna Praktyka Lekarska Piotr Kubalski | Grudziądz | Kuyavian-Pomeranian Voivodeship | 86-300 | Poland |
| Specjalistyczne Gabinety Lekarskie "Medicor Plus" - Jerzy Kopaczewski | Włocławek | Kuyavian-Pomeranian Voivodeship | 87-800 | Poland |
| Landa Specjalistyczne Gabinety Lekarskie | Krakow | Lesser Poland Voivodeship | 30-015 | Poland |
| Szpital Specjalistyczny im. J. Dietla w Krakowie, Oddzial Kardiologii | Krakow | Lesser Poland Voivodeship | 31-121 | Poland |
| Krakowski Szpital Specjalistyczny im. Jana Pawla II, Oddzial Szybkiej Diagnostyki | Krakow | Lesser Poland Voivodeship | 31-202 | Poland |
| Centrum Medyczne Zdrowa J. Trebacz, W. Zajdel Spolka Jawna | Krakow | Lesser Poland Voivodeship | 31-216 | Poland |
| CENTRUM MEDYCZNE A-Z Clinic | Krakow | Lesser Poland Voivodeship | 31-315 | Poland |
| Krakowskie Centrum Medyczne Sp. z o.o. | Krakow | Lesser Poland Voivodeship | 31-501 | Poland |
| Samodzielny Publiczny Zaklad Opieki Zdrowotnej Szpital Uniwersytecki W Krakowie, | Krakow | Lesser Poland Voivodeship | 31-531 | Poland |
| NeuroCor Banaszkiewicz, Kulaga, Ostrowska, Tomaszewski lekarze spolka partnerska | Myślenice | Lesser Poland Voivodeship | 32-400 | Poland |
| INTERCARD Sp. z. o. o. Centrum Kardiologii Inwazyjnej, Elektroterapii i Angiologii w Nowym Targu | Nowy Targ | Lesser Poland Voivodeship | 34-400 | Poland |
| Centrum Szybkiej Diagnostyki Kardiologicznej Kardiomed M. Zabowka E. Zabowka | Tarnów | Lesser Poland Voivodeship | 33-100 | Poland |
| Specjalistyczny Gabinet Lekarski Internistyczno-Kardiologiczny Boguslaw Derlaga | Tarnów | Lesser Poland Voivodeship | 33-100 | Poland |
| Jeleniogorskie Centrum Chorob Serca, Przychodnia Kardiologiczna, Poradnia Kardiologiczna | Jelenia Góra | Lower Silesian Voivodeship | 58-506 | Poland |
| Synexus Polska Sp. z o.o. Oddzial we Wroclawiu | Wroclaw | Lower Silesian Voivodeship | 50-088 | Poland |
| Wojewodzki Szpital Specjalistyczny we Wroclawiu, Osrodek Badawczo-Rozwojowy | Wroclaw | Lower Silesian Voivodeship | 51-124 | Poland |
| Zdrowie s.c. Agnieszka i Donald Drozdz | Wroclaw | Lower Silesian Voivodeship | 51-314 | Poland |
| Halina Serafin NZOZ Centrum Medyczne SERAFIN-MED | Żarów | Lower Silesian Voivodeship | 58-130 | Poland |
| Clinical Best Solutions | Lublin | Lublin Voivodeship | 20-045 | Poland |
| Optimamed Specjalistyczne Gabinety Lekarskie | Lublin | Lublin Voivodeship | 20-091 | Poland |
| KO-MED Centra Kliniczne Lublin II | Lublin | Lublin Voivodeship | 20-362 | Poland |
| KO-MED Centra Kliniczne Pulawy | Puławy | Lublin Voivodeship | 24-100 | Poland |
| KO-MED Centra Kliniczne Zamosc | Zamość | Lublin Voivodeship | 22-400 | Poland |
| Synexus Polska Sp. z o.o. Oddzial w Katowicach | Katowice | Masovian Voivodeship | 40-040 | Poland |
| Niepubliczny Zaklad Opieki Zdrowotnej Specjalistyczna Przychodnia Lekarska "MEDIKARD" | Płock | Masovian Voivodeship | 09-402 | Poland |
| Centrum Medyczne Piaski Filia Nr 9 | Warsaw | Masovian Voivodeship | 01-875 | Poland |
| Centralny Szpital Kliniczny Ministerstwa Spraw Wewnetrznych w Warszawie | Warsaw | Masovian Voivodeship | 02-507 | Poland |
| CSK MSW w Warszawie, Klinika Kardiologii Zachowawczej i Nadcisnienia Tetniczego | Warsaw | Masovian Voivodeship | 02-507 | Poland |
| Wojskowy Instytut Medyczny, Klinika Kardiologii i Chorob Wewnetrznych, Centralny Szpital Kliniczny | Warsaw | Masovian Voivodeship | 04-141 | Poland |
| Instytut Kardiologii im. Prymasa Tysiaclecia Stefana Kardynala Wyszynskiego | Warsaw | Masovian Voivodeship | 04-628 | Poland |
| Specjalistyczny Osrodek Medycyny Wieku Dojrzalego Sp. z o.o. | Warsaw | Masovian Voivodeship | 04-730 | Poland |
| Szpital Specjalistyczny w Brzozowie, Podkarpacki Osrodek Onkologiczny im. Ks. B. Markiewicza Oddzial | Brzozów | Podkarpackie Voivodeship | 36-200 | Poland |
| INTERCARD Sp. z o.o. Centrum Kardiologii Inwazyjnej, Elektroterapii i Angiologii w Krosnie | Krosno | Podkarpackie Voivodeship | 38400 | Poland |
| EMED Centrum Uslug Medycznych Ewa Smialek | Rzeszów | Podkarpackie Voivodeship | 35205 | Poland |
| """OSTEO-MEDIC"" s.c. Artur Racewicz, Jerzy Supronik" | Bialystok | Podlaskie Voivodeship | 15-351 | Poland |
| Podlaski Osrodek Kardiologii Janusz Korecki | Bialystok | Podlaskie Voivodeship | 15-875 | Poland |
| Synexus Polska Sp. z o.o. Oddzial w Gdansku | Gdansk | Pomeranian Voivodeship | 80-382 | Poland |
| Niepubliczny Zaklad Opieki Zdrowotnej Gdanskie Centrum Zdrowia, Poradnia Kardiologiczna | Gdansk | Pomeranian Voivodeship | 80-542 | Poland |
| Centrum Badan Klinicznych Pi-House, Poradnia Diabetologiczna | Gdansk | Pomeranian Voivodeship | 80-546 | Poland |
| Synexus Polska Sp. z o.o. Oddzial w Gdyni | Gdynia | Pomeranian Voivodeship | 81-384 | Poland |
| NZOZ "PRO CORDIS" Sopockie Centrum Badan Kardiologicznych | Gdynia | Pomeranian Voivodeship | 81-423 | Poland |
| Gabinet Kardiologiczno - lnternistyczny | Gdynia | Pomeranian Voivodeship | 81-472 | Poland |
| Centrum Medyczne "SOPMED" Sp. z o.o. | Sopot | Pomeranian Voivodeship | 81-756 | Poland |
| Indywidualna Specjalistyczna Praktyka Lekarska Malgorzata Biedrzycka | Starogard Gdański | Pomeranian Voivodeship | 83-200 | Poland |
| Samodzielny Publiczny Zaklad Opieki Zdrowotnej Wojewodzki Szpital Specjalistyczny Nr 4 w Bytomiu, | Bytom | Silesian Voivodeship | 41-902 | Poland |
| Bogna Gabrylewicz Andrzej Ochala Unimed s.c. | Katowice | Silesian Voivodeship | 40-083 | Poland |
| Pro Familia Altera Poradnia Wielospecjalistyczna | Katowice | Silesian Voivodeship | 40-648 | Poland |
| NZOZ Terapia Optima | Katowice | Silesian Voivodeship | 40-752 | Poland |
| Przychodnia Specjalistyczna Samodzielny Publiczny ZOZ w Rudzie Slaskiej, Poradnie Specjalistyczne, | Ruda Śląska | Silesian Voivodeship | 41-709 | Poland |
| NZOZ "Medyk"Sp. z o. o. | Wola | Silesian Voivodeship | 43-225 | Poland |
| Wojewodzki Szpital Zespolony w Elblagu, Oddzial Kardiologiczny z Pododdzialem Kardiologii Inwazyjnej | Elblag | Warmian-Masurian Voivodeship | 82-300 | Poland |
| "OSTEO-MEDIC" s.c. Artur Racewicz, Jerzy Supronik | Bialystok | 15-351 | Poland |
| NZOZ Vitamed -Ga¿aj I Cichomski sp.j | Bydgoszcz | 85-079 | Poland |
| Medica Pro Familia Sp. z o.o. Spolka Komandytowo Akcyjna, Oddzial w Gdyni | Gdynia | 81-338 | Poland |
| Nzoz Gall-Med | Krakow | 30-053 | Poland |
| Samodzielny Publiczny Zaklad Opieki Zdrowotnej Szpital Uniwersytecki w Krakowie, | Krakow | 31-501 | Poland |
| SP ZOZ Szpital Uniwersytecki w Krakowie | Krakow | 31-501 | Poland |
| NZOZ Centrum Zdrowia i Profilaktyki Dabie Sp. z.o.o. | Krakow | 31-567 | Poland |
| Specjalistyczny Osrodek Medycyny Wieku Dojrzalego | Lodz | 90-368 | Poland |
| "TWOJA PRZYCHODNIA" Sp. Z o.o | Lublin | 20-857 | Poland |
| NeuroCor Banaszkiewicz, Kulaga, Ostrowska, Tomaszewski lekarze spolka partnerska | Myślenice | 32-400 | Poland |
| Medicus w Opolu Sp z o. o. | Opole | 45-706 | Poland |
| Specjalistyczny Osrodek Leczniczo-Badawczy Zbigniew Zegota | Ostróda | 14-100 | Poland |
| Medicome Sp. z o.o. | Oświęcim | 32-600 | Poland |
| Centrum Zdrowia Metabolicznego Pawel Bogdanski | Poznan | 60-592 | Poland |
| NZOZ Przychodnia Specjalistyczna Andrzej wittek Henryk Rudzki S.C. | Ruda Śląska | 41-709 | Poland |
| KO-MED Centra Kliniczne Staszow | Staszów | 28-200 | Poland |
| Synexus Polska Sp. z o.o. Oddzial w Warszawie | Warsaw | 01-192 | Poland |
| Instytut Kardiologii, Ii Klinika Choroby WieCowej | Warsaw | 02-637 | Poland |
| Instytut Kardiologii im. Prymasa Tysiaclecia Stefana Kardynala Wyszynskiego | Warsaw | 04-628 | Poland |
| Instytut Kardiologii im. Prymasa Tysiaclecia Stefana Kardynala | Warsaw | 04-628 | Poland |
| Dobrostan Michal Bogacki | Wroclaw | 53-301 | Poland |
| Gabinet Lekarski Malgorzata Saryusz-Wolska | Lodz | Łódź Voivodeship | 90-132 | Poland |
| Specjalistyczny Osrodek Medycyny Wieku Dojrzalego Sp. z o.o. | Lodz | Łódź Voivodeship | 90-368 | Poland |
| "Prywatny Gabinet Kardiologiczny" Dr N.Med. Maciej Kosmider | Lodz | Łódź Voivodeship | 91-490 | Poland |
| Prywatny Gabinet Lekarski Dr n. med. Michal Ogorek | Piotrkow Trybunalski | Łódź Voivodeship | 97-300 | Poland |
| Centrum Medyczne Ogrodowa Sp. z o.o. | Skierniewice | Łódź Voivodeship | 96-100 | Poland |
| Prywatny Gabinet Lekarski Marianna Janion | Kielce | Świętokrzyskie Voivodeship | 25-315 | Poland |
| Cardiometabolic Research Center, Inc. | Ponce | PR | 00717 | Puerto Rico |
| Endocrine Lipid Diabetes Research Institute | Ponce | PR | 00717 | Puerto Rico |
| Miguel Sosa-Padilla, MD-Private Practice | San Juan | PR | 00926-2832 | Puerto Rico |
| The Office of Roberto J. Ayala-Rios, MD - Research Center and Private Practice (DMRA LLC) | Anasco | 00610 | Puerto Rico |
| Pradnet Inc. | San Juan | 00917 | Puerto Rico |
| Altamira Family Medicine And Research Institute | San Juan | 00920 | Puerto Rico |
| Centro de Diabetes para Puerto Rico | San Juan | 00935 | Puerto Rico |
| Pitesti-Arges County Emergency Hospital | Piteşti | Argeş | 110084 | Romania |
| Medical Practice SRL | Oradea | Bihor County | 410032 | Romania |
| County Clinical Emergency Hospital Oradea | Oradea | Bihor County | 410169 | Romania |
| County Emergency Hospital Deva | Deva | Hunedoara County | 330084 | Romania |
| CMI Pop Calin Florin | Baia Mare | JUD Maramures | 430123 | Romania |
| Centrul Medical Dr. Negrisanu SRL, Diabet Zaharat Nutritie si Boli Metabolice | Timișoara | Judet Timis | 300456 | Romania |
| Dr. Pop Calin Florin - Cabinet Cardiologie | Baia Mare | Maramureş | 430130 | Romania |
| Podoleanu G. Cristian-Gheorghe-Calin - Cardiology Medical Practice | Târgu Mureş | Mureș County | 540143 | Romania |
| Diabmed Dr. Popescu Alexandrina SRL, Diabet, Nutritie, Boli Metabolice | Ploieşti | Prahova | 100163 | Romania |
| Dr. Busegeanu Mihaela Private Practice | Ploieşti | Prahova | 100342 | Romania |
| Clinica Medicala Synexus Ltd. | Bucharest | Sectorul 2 | 021611 | Romania |
| Institute of Cardiovascular Diseases Timisoara | Timișoara | Timiș County | 300310 | Romania |
| Euromedica Hospital | Baia Mare | 430032 | Romania |
| S.C. Polimed Dacia S.R.L. | Brasov | 500209 | Romania |
| Centrul Medical de Diagnostic si Tratament Ambulator Neomed SRL, Medicina Interna | Brasov | 500283 | Romania |
| Spitalul Clinic Judetean De Urgenta Braila(Braila County Clincal Emergency Hospital) | Brăila | 810249 | Romania |
| Data Plus Medical Clinic | Bucharest | 010192 | Romania |
| Spitalul Universitar De Urgenta Militar Central, Dr. Carol Davila | Bucharest | 010825 | Romania |
| "Prof. Dr. N.C. Paulescu" National Institute of Diabetes, Nutrition and Metabolic Diseases, | Bucharest | 020045 | Romania |
| Spitalul Clinic Colentina, Departament Cardiologie | Bucharest | 020125 | Romania |
| SC Centrul Medical Policlinico Di Monza SRL, Cardiologie | Bucharest | 021967 | Romania |
| SC Policlinica CCBR SRL | Bucharest | 030463 | Romania |
| Med Plus SRL (Med Plus Ltd.) | Bucharest | 061118 | Romania |
| S.C. Centrul Medical "Sanatatea Ta" S.R.L. | Bucharest | 20614 | Romania |
| Med Plus Srl | Bucharest | 61118 | Romania |
| Spitalul Clinic Judetean De Urgenta Cluj-Napoca, Diabet Zabarat | Cluj-Napoca | 400006 | Romania |
| Spitalul Clinic Judetean de Urgenta Cluj-Napoca, Diabet Zaharat, Nutritie si Boli Metabolice | Cluj-Napoca | 400006 | Romania |
| Dr. Mistodie Cristina Victoria MD, Office of | Galati | 800098 | Romania |
| S.C. Diamed Obesity S.R.L. | Galati | 800291 | Romania |
| County Emergency Hospital Satu Mare Diabetes, Nutrition And Metabolic Diseases Department | Satu Mare | 440055 | Romania |
| County Clinical Emergency Hospital Sibiu | Sibiu | 550245 | Romania |
| Cardio Med SRL, Cardiologie | Tg. Mures | 540124 | Romania |
| Centrul Medical Sf. Stefan | Timișoara | 300125 | Romania |
| Institution Centrul Medical Sf. Stefan SRL, Diabet Nutritie si Boli Metabolice | Timișoara | 300125 | Romania |
| State Budgetary Healthcare Institution "Research Institution - Regional Clinical Hospital #1 | Krasnodar | Krasnodarskiy Kray | 350086 | Russia |
| State Budgetary Healthcare Institution of Moscow Region "Lubertsy Regional Hospital #2" | Lubertsy | Moscow Oblast | 140006 | Russia |
| Federal State Budgetary Institution of Healthcare Hospital of Russian Academy of Sciences | Troitsk | Moscow Oblast | 142190 | Russia |
| 1st Pavlov State Medical University of St. Petersburg | Saint Petersburg | Sankt-Peterburg | 197022 | Russia |
| Saint Petersburg State Budgetary Institution of Healthcare | Saint Petersburg | Sestroretsk | 197706 | Russia |
| FSBEI of HE Kazan State Medical University on the base of SBHI Clinical Hospital No.2 | Kazan' | Tatarstan Republic | 420033 | Russia |
| Municipal Budgetary State Healthcare Institution "City Clinical Hospital #6" | Chelyabinsk | 454047 | Russia |
| Non-State Institution of Healthcare | Chelyabinsk | 454092 | Russia |
| State Budgetary Healthcare Institution ¿Region Clinical Hospital #3¿ | Chelyabinsk | 454136 | Russia |
| Regional Budgetary Healthcare Institution "Cardiology Dispensary" | Ivanovo | 153012 | Russia |
| State Budgetary Institution of Healthcare of Kaluga Region "Kaluga Regional Hospital" | Kaluga | 428007 | Russia |
| Federal State Budgetary Educational Institution of Higher Education "Kazan State Medical University" | Kazan' | 420012 | Russia |
| State Autonomous Healthcare Institution "Republic Clinical Hospital" | Kazan' | 420064 | Russia |
| "SAHI of Kemerovo ""Regional Clinical Hospital of Emergency Medical Care n.a. M.A Podgorbunsky """ | Kemerovo | 650000 | Russia |
| Municipal Budgetary Institution of Healthcare Municipal Clinical Hospital #3 n.a. M.A. Podgorbunsky | Kemerovo | 650000 | Russia |
| FSBI "Research institute of complex problems of cardio-vascular diseases" of | Kemerovo | 650002 | Russia |
| FSHI "Medical and Sanitary Unit of the Ministry of Internal Affairs of Russia across | Kemerovo | 650099 | Russia |
| Kirov Regional State Budgetary Healthcare Institution "Kirov City Clinical Hospital #1" | Kirov | 610014 | Russia |
| Regional Budgetary Healthcare Institution "Kursk City Clinical Emergency Hospital" | Kursk | 305035 | Russia |
| Non-State Institution of Healthcare "Central Clinical Hospital #6 OAO "RZhD" | Moscow | 109388 | Russia |
| SBHI Moscow city "City Clinical Hospital #15 n.a. O.M. Filatova" of Moscow Healthcare Department | Moscow | 111539 | Russia |
| Federal State Budgetary Institution "Central Clinical Hospital with Polyclinic" | Moscow | 121359 | Russia |
| "Federal State Budgetary Institution "Russian Cardiology Research And Production Complex" Of | Moscow | 121552 | Russia |
| Moscow State Healthcare Institution "City clinical hospital n.a. S.P.Botkin" | Moscow | 125284 | Russia |
| State Budget Institution of Healthcare (SBIH) of Moscow "City Clinical Hospital #81 | Moscow | 127644 | Russia |
| Federal State Budget Institution "Out-patient Clinic #3" of Russian Federation, President's | Moscow | 129090 | Russia |
| State Regional Budgetary Healthcare Institution | Murmansk | 183047 | Russia |
| State Budgetary Healthcare Institution of Nizhegorodskaya Region | Nizhny Novgorod | 603076 | Russia |
| Federal State Budgetary Institution "Research Institute of Therapy and Preventive Medicine" | Novosibirsk | 630089 | Russia |
| "Reafan" LLC | Novosibirsk | 630099 | Russia |
| Municipal Budgetary Institution of Healthcare of Novosibirsk | Novosibirsk | 630102 | Russia |
| State Budgetary Institution of Healthcare of Novosibirsk region City Clinical Hospital of Emergency | Novosibirsk | 630102 | Russia |
| State Budgetary Healthcare Institution (SBHI) N.N. Burdenko Regional Clinical Hospital of Penza | Penza | 440026 | Russia |
| SBHI of Saint-Petersburg "City Hospital # 38 n.a. N.A. Semashko" | Pushkin | 196601 | Russia |
| State Budgetary Educational Institution Of Higher Professional Education | Rostov-on-Don | 344022 | Russia |
| State Budgetary Educational Institution of Higher Professional Education | Rostov-on-Don | 344068 | Russia |
| State Budgetary Institution "Ryazan Regional Clinical Hospital" | Ryazan | 390039 | Russia |
| Saint-Petersburg State Budgetary Institution of Healthcare "City Hospital #23" | Saint Petersburg | 192148 | Russia |
| Saint-Petersburg State Budgetary Healthcare Institution "City Alexandrovskaya Hospital" | Saint Petersburg | 193312 | Russia |
| Limited Liability Company "Reavita" | Saint Petersburg | 194354 | Russia |
| LLC "Institution of medical studies" | Saint Petersburg | 196084 | Russia |
| Saint-Petersburg State Budgetary Institution of Healthcare "City Hospital #26" | Saint Petersburg | 196247 | Russia |
| Federal State Budgetary Educational Institution of Higher Education "Academician I.P. Pavlov First | Saint Petersburg | 197022 | Russia |
| SBEI of HPE "First Pavlov State Medical University of St. Petersburg" of the MoH of the RF | Saint Petersburg | 197022 | Russia |
| Federal State Budgetary Institution "Advisory Diagnostic Center and Polyclinic" | Saint Petersburg | 197110 | Russia |
| Federal State Budgetary Institution "Federal Almazov Medical Research Centre" of | Saint Petersburg | 197341 | Russia |
| Saint-Petersburg State Budgetary Healthcare Institution "City Hospital #15" | Saint Petersburg | 198205 | Russia |
| Limited Liability Company International Medical Centre SOGAZ | Saint-Petersberg | 191186 | Russia |
| State Budgetary Healthcare Institution "Samara Regional Clinical Cardiology Dispensary" | Samara | 443070 | Russia |
| MHI "City Clinical Hospital 12"of the Healthcare Committee of | Saratov | 410039 | Russia |
| State Institution of Healthcare "Regional Clinical Hospital" | Saratov | 410053 | Russia |
| Tyumen Cardiology Research Center-branch of the Tomsk NRMC | Tomsk | 634009 | Russia |
| State Budgetary Educational Institution of Highest Professional Education | Tomsk | 634050 | Russia |
| State Autonomous Healthcare Institution of Tyumen region "Scientific-Practical Medical Center" | Tyumen | 625000 | Russia |
| "Tyumen Cardiology Center" Affiliate of the FSBSI "Scientific and Research Institution of Cardiology | Tyumen | 625026 | Russia |
| State Autonomous Healthcare Institution of Yaroslavl region Clinical Emergency Hospital n.a..N.V.So | Yaroslavl | 150003 | Russia |
| State Autonomous Healthcare Institution of Yaroslavl Region | Yaroslavl | 150003 | Russia |
| FSBEI of HE "Yaroslavl State Medical University" MH of the Russian Federation based on Clinical | Yaroslavl | 150010 | Russia |
| State Budgetary Healthcare Institution of Yaroslavl Region "Clinical Hospital No. 10" | Yaroslavl | 150023 | Russia |
| State Healthcare Institution of Yaroslavl Region "Clinical Hospital #8" | Yaroslavl | 150030 | Russia |
| Municipal Autonomous Institution "City Clinical Hospital #14" | Yekaterinburg | 620039 | Russia |
| Nemocnica Ruzinov-Univerzitna Nemocnica Bratislava (UNB) | Bratislava | Bratislava Region | 826 06 | Slovakia |
| Stredoslovensky ustav srdcovych a cievnych chorob a.s. | Banská Bystrica | 974 01 | Slovakia |
| Fakultna nemocnica F. D. Roosevelta | Banská Bystrica | 97517 | Slovakia |
| Alian s.r.o., kardiologicka ambulancia | Bardejov | 08501 | Slovakia |
| Metabol KLINIK s.r.o., Ambulancia pre diabetologiu, poruchy latkovej premeny a vyzivy | Bratislava | 811 08 | Slovakia |
| Univerzitna nemocnica Bmtislava, Nemocnica Stare Mesto | Bratislava | 81369 | Slovakia |
| Univerzitna nemocnica Bratislava, Nemocnica Stare Mesto, l.interna klinika | Bratislava | 81369 | Slovakia |
| Univerzitna nemocnica Bratislava, Nemocnica Stare Mesto | Bratislava | 81369 | Slovakia |
| UN Bratislava, Nemocnica Ruzinov, V. interna klinika LFUK a UN Bratislava | Bratislava | 826 06 | Slovakia |
| Kardiovaskularne Centrum S.R.O. | Bratislava | 83101 | Slovakia |
| Metabolicke Centrum MUDr. Katariny Raslovej, S.R.O. | Bratislava | 83101 | Slovakia |
| Narodny ustav srdcovych a cievnych chorob, a.s. | Bratislava | 833 48 | Slovakia |
| Univerzitna Nemocnica Bratislava | Bratislava | 83305 | Slovakia |
| Narodny ustav srdcovych a cievnych chorob, a.s. | Bratislava | 83348 | Slovakia |
| KARDIO-SANUS spol.,s.r.o.,Kardiologicka, interna a sonograficka ambulancia | Bratislava | 841 08 | Slovakia |
| KARDIO-SANUS spol. s.r.o. | Bratislava | 84107 | Slovakia |
| VERIA, s.r.o. -Kardiologicka ambulancia | Bratislava | 85101 | Slovakia |
| UN Bratislava Nemocnica Sv.Cyrila a Metoda, kardiologicka ambulancia 1 | Bratislava | 85107 | Slovakia |
| Endiamed s.r.o. Nestatna diabetologicka a endokrinologicka ambulancia | Dolný Kubín | 02601 | Slovakia |
| JM-Interna s.r.o., interna ambulancia | Dolný Kubín | 02601 | Slovakia |
| CARDIO D&R s.r.o., Kardiologicka ambulancia | Košice | 040 01 | Slovakia |
| AGTO., spol. s r. o. | Košice | 04011 | Slovakia |
| Cardio D&R spol.s.r.o., kardiologicka ambulancia | Košice | 04022 | Slovakia |
| Medicentrum Heart, Spol. S.R.O | Kráľovský Chlmec | 077 01 | Slovakia |
| CELL-B s.r.o. interna ambulancia | Levice | 93405 | Slovakia |
| Liptovska nemocnica s poliklinikou MUDr.Ivana Stodolu Liptovsky Mikulas | Liptovský Mikuláš | 031 23 | Slovakia |
| KARDIO 1 s.r.o. | Lučenec | 984 39 | Slovakia |
| Narodny Endokrinologicky A Diabetologicky Ustav N.O. | Ľubochňa | 034 91 | Slovakia |
| Klinika hematologie a transfuziologie, Univerzitna nemocnica Martin | Martin | 036 59 | Slovakia |
| MEDI M&M s.r.o., Ambulancia vnutorneho lekarstva | Moldava nad Bodvou | 045 01 | Slovakia |
| MUDr. Kanderkova s.r.o., Diabetologicka ambulancia | Námestovo | 02901 | Slovakia |
| Kardiocentrum Nitra s.r.o., kardiologicka ambulancia | Nitra | 94901 | Slovakia |
| Fakultna nemocnica s poliklinikou Nove Zamky, I. interna klinika | Nové Zámky | 940 34 | Slovakia |
| Mediab s.r.o. Diabetologicka ambulancia | Pezinok | 90201 | Slovakia |
| BENIMED s.r.o. | Piešťany | 921 01 | Slovakia |
| Medispol S.R.O. | Prešov | 08001 | Slovakia |
| Medilex s.r.o. Interna ambulancia | Rimavská Sobota | 979 01 | Slovakia |
| Kardioamb S.R.O. | Rimavská Sobota | 97901 | Slovakia |
| DIAMEL, s.r.o., Diabetologicka ambulancia | Trenčín | 911 01 | Slovakia |
| BV Medical, s.r.o. Diabetologicka ambulancia, | Trnava | 917 01 | Slovakia |
| Kardiologicka ambulancia | Trnava | 917 01 | Slovakia |
| Medivasa S.R.O., Diabetologicka Ambulancia | Žilina | 01001 | Slovakia |
| IATROS International | Bloemfontein | Free State | 9301 | South Africa |
| JOSHA Research | Bloemfontein | Free State | 9301 | South Africa |
| Welkom Clinical Trial Centre | Welkom | Free State | 9460 | South Africa |
| Midrand Medical Centre | Halfway House | Gauteng | 1685 | South Africa |
| Centre for Diabetes and Endocrinology | Houghton Estate | Gauteng | 2198 | South Africa |
| Sunninghill Hospital | Johannesburg | Gauteng | 2157 | South Africa |
| I Engelbrecht Research (Pty) Ltd | Lyttelton | Gauteng | 0157 | South Africa |
| Charlotte Maxeke Johannesburg Academic Hospital | Parktown | Gauteng | 2193 | South Africa |
| Medipark Centre for Clinical Research | Pretoria | Gauteng | 0158 | South Africa |
| Synexus Watermeyer Clinical Research Centre | Pretoria | Gauteng | 0184 | South Africa |
| Jongaie Research | Pretoria West | Gauteng | 0183 | South Africa |
| Roodepoort Medicross Clinical Research Centre | Roodepoort | Gauteng | 1724 | South Africa |
| Wits Clinical Research-Chris Hani Baragwanath Hospital | Soweto | Gauteng | 2013 | South Africa |
| Medi-Clinic Heart Hospital | Sunnyside | Gauteng | 0083 | South Africa |
| Suite 502 | Durban | KwaZulu-Natal | 4001 | South Africa |
| Dr Ganesh c/o Dr NB Maharaj | Durban | KwaZulu-Natal | 4091 | South Africa |
| Nash Ranjith Research Centre | Merebank, Durban | KwaZulu-Natal | 4052 | South Africa |
| Limpopo Clinical Research Initiative | Thabazimbi | Limpopo | 0380 | South Africa |
| Zinakekele Medical Centre | Moloto South | Mpumalanga | 1022 | South Africa |
| Drs Joynt Venter & Associates | Witbank (eMalahleni) | Mpumalanga | 1035 | South Africa |
| Dr JM Engelbrecht Trial Site-Vergelegen Mediclinic | Cape Town | Western Cape | 7130 | South Africa |
| Tiervlei Trial Centre | Cape Town | Western Cape | 7530 | South Africa |
| Synopsis Research cc | Cape Town | Western Cape | 7700 | South Africa |
| Helderberg Research Institute | Somerset West | Western Cape | 7130 | South Africa |
| Synexus Helderberg Clinical Research Centre | Somerset West | Western Cape | 7130 | South Africa |
| Vergelegen Mediclinic-Helderberg Research Institute | Somerset West | Western Cape | 7130 | South Africa |
| Unitas Hospital. | Centurion | 0157 | South Africa |
| Clinresco Centres (Pty) Ltd-Central Professional Suits | Gauteng | 1619 | South Africa |
| Paarl Research Centre | Paarl | 7646 | South Africa |
| TREAD Research cc | Parow | 7500 | South Africa |
| Clinical Projects Research SA (Pty) Ltd | Worcester | 6850 | South Africa |
| Chungbuk National University Hospital | Cheongju-si | Chungcheonbuk-do | 362-711 | South Korea |
| Kangwon National University Hospital | Chuncheon | Gangwon-do | 24289 | South Korea |
| Yonsei University Wonju College of Medicine, Wonju Severance Christian Hospital | Wŏnju | Gangwon-do | 26426 | South Korea |
| Yonsei University Wonju Severance Christian Hospital | Wŏnju | Gangwon-do | 26426 | South Korea |
| Dongguk University Ilsan Hospital | Goyang-si | Gyeonggi-do | 10326 | South Korea |
| Inje University Ilsan Paik Hospital | Goyang-si | Gyeonggi-do | 10380 | South Korea |
| Myongji Hospital | Goyang-si | Gyeonggi-do | 10475 | South Korea |
| Seoul National University Bundang Hospital | Seongnam-si | Gyeonggi-do | 13620 | South Korea |
| Ajou University Hospital | Suwon | Gyeonggi-do | 443-380 | South Korea |
| Uijeongbu St. Mary's Hospital-The Catholic University of Korea | Uijeongbu-si | Gyeonggi-do | 11765 | South Korea |
| Donguk University Gyeongju Hospital | Gyeongju | Gyeongsangbuk-do | 780-350 | South Korea |
| Inje University Busan Paik Hospital | Busan | 47392 | South Korea |
| Dong-A University Hospital | Busan | 49201 | South Korea |
| Daegu Catholic University Medical Center | Daegu | 42472 | South Korea |
| Gachon University Gil Medical Center | Incheon | 21565 | South Korea |
| Asan Medical Center | Seoul | 05505 | South Korea |
| Seoul Medical Center | Seoul | 131-795 | South Korea |
| Hallym University Kangdong Sacred Heart Hospital | Seoul | 134-701 | South Korea |
| Gangnam Severance Hospital, Yonsei University Health System | Seoul | 135-720 | South Korea |
| The Catholic University Of Korea Seoul St.Marys Hospital | Seoul | 137-701 | South Korea |
| Seoul Metropolitan Government - Seoul National University Boramae Medical Center | Seoul | 156-707 | South Korea |
| Hospital Clinico Universitario de Santiago de Compostela | Santiago de Compostela | A Coruna | 15706 | Spain |
| Hospital Virgen De Los Lirios | Alcoy | Alicante | 03804 | Spain |
| Hospital Regional Universitario de Malaga | Málaga | Andalusia | 29010 | Spain |
| Hospital Universitario Virgen del Rocio | Seville | Andalusia | 41013 | Spain |
| Hospital Comarcal d'Inca | Inca | Balearic Islands | 07300 | Spain |
| Cap Florida | L'Hospitalet de Llobregat | Barcelona-cataluna | 08905 | Spain |
| CAP Disset De Setembre (Sant Cosme I Sant Damia) | el Prat de Llobregat | Barcelona/cataluna | 08820 | Spain |
| Hospital Universitari de Bellvitge | L'Hospitalet de Llobregat | Barcelona | 08907 | Spain |
| CAP La Mina | Sant Adrià de Besòs | Barcelona | 08930 | Spain |
| EAP Vic | Vic | Barcelona | 08500 | Spain |
| Hospital Universitario de Cruces | Barakaldo | Basque Country | 48903 | Spain |
| Hospital Universitario Marques De Valdecilla | Santander | Cantabria | 39008 | Spain |
| Hospital Universitari de Tarragona Joan XXIII | Tarragona | Catalonia | 43007 | Spain |
| Albera Salut | Peralada | Gerona | 17491 | Spain |
| Hospital De Figueres | Figueres | Girona-catalonia | 17600 | Spain |
| Hospital Santa Caterina | Salt, Girona | Girona | 17190 | Spain |
| Hospital Arquitecto Marcide | Ferrol | LA Coruna | 15405 | Spain |
| Hospital Hospital Universitario Puerta de Hierro - Majadahonda | Majadahonda | Madrid | 28222 | Spain |
| Hospital Universitario Quiron Madrid | Pozuelo de Alarcón | Madrid | 28223 | Spain |
| Centro de Salud El Cristo | Oviedo | Principality of Asturias | 33006 | Spain |
| Centro Salud Paulino Prieto | Oviedo | Principality of Asturias | 33009 | Spain |
| Hospital Universitario Sant Joan de Reus | Reus | Tarragona | 43204 | Spain |
| Hospital Universitario San Juan de Alicante | Alicante | Valencia | 03550 | Spain |
| Hospital General De Requena | Requena | Valencia | 46340 | Spain |
| Gerencia de Gestion integrada de A Coruna | A Coruña | 15006 | Spain |
| Complejo Hospitalario Universitario de Albacete | Albacete | 02006 | Spain |
| Hospital General Universitario de Alicante; Servicio Cardiologia | Alicante | 03010 | Spain |
| Hospital Virgen del Mar | Almería | 04120 | Spain |
| Parc de Salut mar ¿ Hospital del Mar | Barcelona | 08003 | Spain |
| Parc de Salut Mar- Hospital del Mar | Barcelona | 08003 | Spain |
| Centre Teknon | Barcelona | 08022 | Spain |
| EAP Sardenya | Barcelona | 08025 | Spain |
| Hospital de la Santa Creu i Sant Pau | Barcelona | 08025 | Spain |
| Hospital Universitari Vall d'Hebron | Barcelona | 08035 | Spain |
| CAP Centelles | Barcelona | 08540 | Spain |
| CAP Amadeu Torner | Barcelona | 08902 | Spain |
| Hospital Universitario de Bellvitge | Barcelona | 08907 | Spain |
| Fundacio Hospital de I'Esperit Sant | Barcelona | 08923 | Spain |
| Hospital Universitario Reina Sofia | Córdoba | 14004 | Spain |
| Complexo Hospitalario Universitario Arquitecto Marcide-Profesor Novoa Santos De Ferrol | Ferrol | 15401 | Spain |
| Hospital Universitario San Cecilio | Granada | 18012 | Spain |
| Hospital Universitario Virgen de las Nieves (HUVN) | Granada | 18014 | Spain |
| Hospital Universitari Arnau de Vilanova (HUAV) | Lleida | 25198 | Spain |
| Hospital Universitari Arnau de Vilanova | Lleida | 25198 | Spain |
| Pharmacy - Hospital Universitari Arnau de Vilanova (HUAV) | Lleida | 25198 | Spain |
| Hospital Universitario Lucus Augusti | Lugo | 27003 | Spain |
| Hospital Universitario de La Princesa | Madrid | 28006 | Spain |
| Hospital General Universitario Gregorio Maranon | Madrid | 28007 | Spain |
| Hospital Carlos III | Madrid | 28029 | Spain |
| Hospital Universitario Ramon y Cajal | Madrid | 28034 | Spain |
| Fundacion Jimenez Diaz | Madrid | 28040 | Spain |
| Hospital Universitario Fundacion Jimenez Diaz | Madrid | 28040 | Spain |
| Hospital Universitario La Paz; Unidad Metabolico-Vascular | Madrid | 28046 | Spain |
| Hospital Universitario Infanta Sofía | Madrid | 28702 | Spain |
| Carretera Alcala-Meco s/n | Madrid | 28805 | Spain |
| H. U. Principe de Asturias | Madrid | 28805 | Spain |
| Hospital Universitario Virgen de la Victoria. CE San Jose Obrero | Málaga | 29006 | Spain |
| Hospital Regional Universitario de Malaga | Málaga | 29009 | Spain |
| Hospital Universitario Virgen De La Victoria | Málaga | 29010 | Spain |
| Hospital General Universitario Morales Meseguer | Murcia | 30008 | Spain |
| Hospital Universitario Sant Joan de Reus | Reus (Tarragona) | 43204 | Spain |
| Clinica Nuevas Tecnologias En Diabetes Y Endocrinologia | Seville | 41003 | Spain |
| Hospital Universitario Virgen Macarena | Seville | 41009 | Spain |
| Hospital Universitario Virgen de Valme | Seville | 41014 | Spain |
| CAP Muralles | Tarragona | 43002 | Spain |
| Hospital General Universitario de Valencia | Valencia | 46014 | Spain |
| Hospital Clinico Universitario Miguel Servet; Medicina Interna | Zaragoza | 50009 | Spain |
| Karolinska universitetssjukhuset Huddinge | Stockholm | Huddinge | 141 86 | Sweden |
| Kasernens Läkarservice AB | Eksjö | 57535 | Sweden |
| Sahlgrenska Universitetssjukhuset | Gothenburg | 41345 | Sweden |
| Pharmasite AB | Helsingborg | 252 20 | Sweden |
| Medicinklinikens forskningsenhet | Kristianstad | 291 85 | Sweden |
| Hjartmottagningen, Capio Citykliniken | Lund | 222 21 | Sweden |
| Probar E Lund AB | Lund | 222 22 | Sweden |
| Karlkliniken, Skanes Universitetssjukhus i Malmo | Malmö | 205 02 | Sweden |
| Pharmasite AB | Malmö | 211 52 | Sweden |
| Forskningsenheten, Medicinmottagningen Sahlgrenska Universitetssjukhuset/Molndal, Hus J | Mölndal | 431 80 | Sweden |
| Ostersunds Sjukhus | Östersund | 83183 | Sweden |
| Dalecarlia Clinical Research Center | Rättvik | 79530 | Sweden |
| Skelleftea Lasarett | Skellefteå | 93186 | Sweden |
| A+Science City site | Stockholm | 111 57 | Sweden |
| Karolinska Universitetssjukhuset | Stockholm | 17176 | Sweden |
| Hjartkliniken | Stockholm | 182 82 | Sweden |
| Akademiska Sjukhuset | Uppsala | 75185 | Sweden |
| Vastmanlands Sjukhus Vasteras | Västerås | 721 89 | Sweden |
| Diagene Laboratories Inc. | Reinach | Basel | 4153 | Switzerland |
| Universitatsspital | Basel | Canton of Basel-City | 4031 | Switzerland |
| Hospitaux Universitaires de Geneve (HUG) | Geneva | Canton of Geneva | 1211 | Switzerland |
| Policlinique Medicale Universitaire | Lausanne | Canton of Vaud | 1011 | Switzerland |
| Kantonsspital Winterthur | Winterthur | Canton of Zurich | 8401 | Switzerland |
| Centre Hospitalier Universitaire Vaudois | Lausanne | 1011 | Switzerland |
| Luzerner Kantonsspital Luzern | Lucerne | CH-6000 | Switzerland |
| Cardiocentro Ticino | Lugano | CH-6900 | Switzerland |
| Fondazione Diabete Lugano | Lugano | CH-6900 | Switzerland |
| Kantonsspital St. Gallen | Sankt Gallen | CH-9007 | Switzerland |
| China Medical University Hospital | Taichung | Taiwan R O C | 40447 | Taiwan |
| National Taiwan University Hospital | Taipei | Taiwan R O C | 10002 | Taiwan |
| Kaohsiung Medical University Chung-Ho Memorial Hospital - New | Kaohsiung City | 807 | Taiwan |
| Cardinal Tien Hospital | New Taipei City | 23148 | Taiwan |
| Chung Shan Medical University Hospital | Taichung | 402 | Taiwan |
| National Cheng Kung University (NCKU) Hospital | Tainan | 70428 | Taiwan |
| National Taiwan University Hospital | Taipei | 10041 | Taiwan |
| MacKay Memorial Hospital | Taipei | 10449 | Taiwan |
| Taipei Veterans General Hospital | Taipei | 11217 | Taiwan |
| Division of Cardiology, Department of Medicine, Faculty of Medicine, Siriraj Hospital, | Bangkoknoi | Bangkok | 10700 | Thailand |
| Faculty of Medicine, Srinagarind Hospital, Khon Kaen University | Muang | Changwat Khon Kaen | 40002 | Thailand |
| Heart Center, Songklanagarind Prince of Songkla University | Hat Yai | Changwat Songkhla | 90110 | Thailand |
| Cardiology Unit,Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, | Bangkok | 10400 | Thailand |
| Division Of cardiology,Department of Medicine,Faculty Of Medicine,Chulalongkorn University | Bangkok | 10400 | Thailand |
| Baskent University, Adana Yuregir Training & Research Hospital | Adana | 01250 | Turkey (Türkiye) |
| A.karahisar Kocatepe Universitesi Hastanesi Ahmet Needet Sezer Uygulama ve | Afyonkarahisar | 03200 | Turkey (Türkiye) |
| Diskapi Yildirim Beyazit Egitim ve Arastirma Hastanesi | Ankara | 06110 | Turkey (Türkiye) |
| Ufuk University School of Medicine, Dr. Ridvan Ege Training & Research Hospital | Ankara | 06520 | Turkey (Türkiye) |
| Akdeniz Universitesi Tip Fakultesi | Antalya | 07059 | Turkey (Türkiye) |
| Antalya Training & Research Hospital | Antalya | 07100 | Turkey (Türkiye) |
| Adnan Menderes Universitesi Uygulama ve Arastirma Hastanesi | Aydin | 09100 | Turkey (Türkiye) |
| Bursa Yuksek Ihtisas Egitim ve Arastirma Hastanesi | Bursa | 16320 | Turkey (Türkiye) |
| Firat Universitesi | Elâzığ | 23119 | Turkey (Türkiye) |
| Gaziantep Universitesi Tip Fakultesi Sahinbey Egitim ve Arastirma Hastanesi | Gaziantep | 27310 | Turkey (Türkiye) |
| Bezmialem Vakif Universitesi Tip Fakultesi Kardiyoloji Bolurnu | Istanbul | 34093 | Turkey (Türkiye) |
| Istanbul Universitesi Istanbul Tip Fakultesi | Istanbul | 34093 | Turkey (Türkiye) |
| Istanbul Universitesi Kardiyoloji Enstitusu | Istanbul | 34096 | Turkey (Türkiye) |
| Ege University, School of Medicine | Izmir | 35100 | Turkey (Türkiye) |
| Izmir Tepecik Egitim ve Arastirma Hastanesi | Izmir | 35170 | Turkey (Türkiye) |
| Dokuz Eylul Universitesi Tip Fakultesi Hastanesi | Izmir | 35340 | Turkey (Türkiye) |
| Dokuz Eylul Universitesi Tip Fakultesi | Izmir | 35340 | Turkey (Türkiye) |
| Kocaeli University School Of Medicine-Kocaeli Universitesi Tip Fakultesi | Kocaeli | 41380 | Turkey (Türkiye) |
| Mersin University, School of Medicine | Mersin | 33343 | Turkey (Türkiye) |
| Recep Tayyip Erdogan University School of Medicine, Training & Research Hospital | Rize | 53020 | Turkey (Türkiye) |
| Synexus Thames Valley Clinical Research Centre | Reading | Berkshire | RG2 0TG | United Kingdom |
| Peterborough and Stamford Hospitals NHS Foundation Trust | Peterborough | Cambridgeshire | PE3 9GZ | United Kingdom |
| Brannel Surgery | St Austell | Cornwall | PL26 7RL | United Kingdom |
| Queens Hospital | Romford | Essex | RM7 0AG | United Kingdom |
| Synexus Manchester Clinical Research Centre-Manchester Science Park | Manchester | Greater Manchester | M15 6SX | United Kingdom |
| Royal Oldham Hospital | Oldham | Greater Manchester | OL1 2JH | United Kingdom |
| Salford Royal NHS Foundation Trust | Salford | Greater Manchester | M6 8HD | United Kingdom |
| Lister Hospital | Stevenage | Hertfordshire | SG1 4AB | United Kingdom |
| Queen Elizabeth II Hospital, East and North Hertfordshire NHS Trust | Welwyn Garden City | Hertfordshire | AL7 4HQ | United Kingdom |
| Medway Maritime Hospital | Gillingham | KENT | ME7 5NY | United Kingdom |
| Synexus Scotland Clinical Research Centre | Glasgow | Lanarkshire | G20 0SP | United Kingdom |
| Bolton NHS Foundation Trust | Bolton | Lancashire | BL4 0JR | United Kingdom |
| Synexus Lancashire Clinical Research Centre | Chorley | Lancashire | PR7 7NA | United Kingdom |
| Layton Medical Centre | Layton, Blackpool | Lancashire | FY3 7EN | United Kingdom |
| Synexus Merseyside Clinical Research Centre | Liverpool | Merseyside | L22 0LG | United Kingdom |
| Whitby Group Practice | Whitby | North Yorkshire | YO21 1SD | United Kingdom |
| Albany House Medical Centre | Wellingborough | Northants | NN84RW | United Kingdom |
| Southern Health & Social Care Trust, Craigavon Area Hospital | Portadown | Northern Ireland | BT63 5QQ | United Kingdom |
| Synexus North East Clinical Research Centre - Hexham General Hospital | Hexham | Northumberland | NE46 1QJ | United Kingdom |
| South Axholme Practice | Doncaster | South Yorkshire | DN9 2HY | United Kingdom |
| Central Manchester University Hospitals NHS Foundation Trust | Manchester | South Yorkshire | M13 9WL | United Kingdom |
| The Crouch Oak Family Practice | Addlestone | Surrey | KT15 2BH | United Kingdom |
| Ely Bridge Surgery | Cardiff | Wales | CF5 4AD | United Kingdom |
| Synexus Midlands Clinical Research Centre | Birmingham | WEST Midlands | B15 2SQ | United Kingdom |
| City Hospital | Birmingham | WEST Midlands | B18 7QH | United Kingdom |
| Prince Philip Hospital | Llanelli | WEST Wales | SF14 8QF | United Kingdom |
| Royal Free London NHS Foundation Trust | Barnet | EN5 3DJ | United Kingdom |
| Laurie Pike Health Centre | Birmingham | B6 6BB | United Kingdom |
| Heart of England NHS Foundation Trust, Dept. of Clinical Biochemistry & Immunology | Birmingham | B9 5SS | United Kingdom |
| Synexus Wales Clinical Research Centre | Cardiff | CF14 5GJ | United Kingdom |
| Ashgate Medical Practice | Chesterfield | S404AA | United Kingdom |
| Little Common Surgery | East Sussex | TN39 4SP | United Kingdom |
| Sea Road Surgery | East Sussex | TN40 1JJ | United Kingdom |
| Staploe Medical Centre | Ely | CB7 5JD | United Kingdom |
| McGlone Practice - Ballieston Health Centre | Glasgow | G69 7AD | United Kingdom |
| The Queen Elizabeth University Hospital- NHS Greater Glasgow and Clyde | Glosgow | G51 4TF | United Kingdom |
| Burbage Surgery | Hinckley | LE10 2SE | United Kingdom |
| The Royal Liverpool and Broadgreen -University Hospitals NHS | Liverpool | L7 8XP | United Kingdom |
| Barts Health NHS Trust | London | EC1M 6BQ | United Kingdom |
| Royal Free Hospital | London | NW3 2QG | United Kingdom |
| Peart-Rose Research Unit, Hammersmith Hospital, Imperial College NHS Trust | London | W12 OHS | United Kingdom |
| The Red Porto cabin, The James Cook University Hospital | Middlesbrough | TS4 3BW | United Kingdom |
| St Mary's Hospital | Newport | PO30 5TG | United Kingdom |
| Wansford And Kings Cliffe Practice | Peterborough | PE8 6PL | United Kingdom |
| Rothwell and Desborough Healthcare Group | Rothwell, Northants | NN14 6JQ | United Kingdom |
| Abertawe Bro Morgannwg University Local Health Board Joint | Swansea | SA2 8PP | United Kingdom |
| Western Sussex Hosptials NHS Trust | Worthing | BN11 2DH | United Kingdom |
| York Medical Group | York | YO30 6AE | United Kingdom |
| Strensall Healthcare Centre | York | YO32 5UA | United Kingdom |
| 29685591 | Derived | Ridker PM, Rose LM, Kastelein JJP, Santos RD, Wei C, Revkin J, Yunis C, Tardif JC, Shear CL; Studies of PCSK9 Inhibition and the Reduction of vascular Events (SPIRE) Investigators. Cardiovascular event reduction with PCSK9 inhibition among 1578 patients with familial hypercholesterolemia: Results from the SPIRE randomized trials of bococizumab. J Clin Lipidol. 2018 Jul-Aug;12(4):958-965. doi: 10.1016/j.jacl.2018.03.088. Epub 2018 Apr 3. |
| 28304242 | Derived | Ridker PM, Revkin J, Amarenco P, Brunell R, Curto M, Civeira F, Flather M, Glynn RJ, Gregoire J, Jukema JW, Karpov Y, Kastelein JJP, Koenig W, Lorenzatti A, Manga P, Masiukiewicz U, Miller M, Mosterd A, Murin J, Nicolau JC, Nissen S, Ponikowski P, Santos RD, Schwartz PF, Soran H, White H, Wright RS, Vrablik M, Yunis C, Shear CL, Tardif JC; SPIRE Cardiovascular Outcome Investigators. Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients. N Engl J Med. 2017 Apr 20;376(16):1527-1539. doi: 10.1056/NEJMoa1701488. Epub 2017 Mar 17. |
Participants received single dose of PF-04950615, 150 milligrams, subcutaneous injection once in every 2 weeks over a period of 3 years. Participants were followed up to 40 days after the last dose. |
| Treated |
|
| COMPLETED |
|
| NOT COMPLETED |
|
|
Full analysis set (FAS): all participants who were randomized, excluding who attempted to be randomized more than once into a bococizumab cardiovascular (CV) outcomes trial (B1481022/B1481038) or attempted to be randomized in more than 1 CV outcomes trial and all participants enrolled at study Site 3027 where a quality-related event was identified.
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Placebo | Participants received single dose of placebo matched to PF-04950615 subcutaneous injection once in every 2 weeks over a period of 3 years. Participants were followed up to 40 days after the last dose. |
| BG001 | Bococizumab (PF-04950615) | Participants received single dose of PF-04950615, 150 milligrams, subcutaneous injection once in every 2 weeks over a period of 3 years. Participants were followed up to 40 days after the last dose. |
| BG002 | Total | Total of all reporting groups |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Mean | Standard Deviation | Years |
| |||||||||||||||
| Sex: Female, Male | Count of Participants | Participants |
| ||||||||||||||||
| Ethnicity (NIH/OMB) | Full analysis set (FAS): all participants who were randomized, excluding who attempted to be randomized more than once into a bococizumab cardiovascular (CV) outcomes trial (B1481022/B1481038) or attempted to be randomized in more than 1 CV outcomes trial and all participants enrolled at study Site 3027 where a quality-related event was identified. | Count of Participants | Participants |
| |||||||||||||||
| Race (NIH/OMB) | FAS: all participants who were randomized, excluding who attempted to be randomized more than once into a bococizumab cardiovascular (CV) outcomes trial (B1481022/B1481038) or attempted to be randomized in more than 1 CV outcomes trial and all participants enrolled at study Site 3027 where a quality-related event was identified. | Count of Participants | Participants |
|
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Event Rate Per 100 Participant-years for First Occurrence of Major Cardiovascular (CV) Event | Event rate per 100 participant-years for first occurrence of major CV event (adjudicated by Adjudication Committee) was reported. Major CV event was defined as any of the following: CV death [defined as sudden cardiac death, fatal myocardial infarction (MI), death due to heart failure, death due to stroke (fatal ischemic stroke or fatal stroke of undetermined etiology), or death due to other CV causes] non-fatal MI, non-fatal stroke, and hospitalization for unstable angina needing urgent revascularization. Event rate was calculated as the number of events per 100 participant-years at risk. | FAS: all participants who were randomized, excluding who attempted to be randomized more than once into a bococizumab CV outcomes trial (B1481022/B1481038) or attempted to be randomized in more than 1 CV outcomes trial and all participants enrolled at study Site 3027 where a quality-related event was identified. | Posted | Number | 95% Confidence Interval | Events per 100 participant-years | From baseline until the date of first adjudicated and confirmed occurrence of major CV event (maximum duration: up to 3.4 years) |
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Secondary | Event Rate Per 100 Participant-years for First Occurrence of Composite Endpoint of Cardiovascular (CV) Death, Non-fatal Myocardial Infraction (MI) or Non-fatal Stroke | Event rate per 100 participant-years for first occurrence of composite endpoint of CV Death, non-fatal MI or non-fatal stroke (adjudicated by Adjudication Committee) was reported. CV death was defined as sudden cardiac death, fatal MI, death due to heart failure, death due to stroke (fatal ischemic stroke or fatal stroke of undetermined etiology), or death due to other CV causes. Event rate was calculated as the number of events per 100 participant-years at risk. | FAS: all participants who were randomized, excluding who attempted to be randomized more than once into a bococizumab CV outcomes trial (B1481022/B1481038) or attempted to be randomized in more than 1 CV outcomes trial and all participants enrolled at study Site 3027 where a quality-related event was identified. | Posted | Number | 95% Confidence Interval | Events per 100 participant-years | From baseline until the date of first adjudicated and confirmed occurrence of CV death, non-fatal MI or non-fatal stroke (maximum duration: up to 3.4 years) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Secondary | Event Rate Per 100 Participant-years for First Occurrence of Composite Endpoint of All-cause Death, Non-fatal Myocardial Infraction (MI), Non-fatal Stroke or Hospitalization for Unstable Angina Needing Urgent Revascularization | Event rate per 100 participant-years for first occurrence of composite endpoint of all-cause death, non-fatal MI, non-fatal stroke or hospitalization for unstable angina needing urgent revascularization (adjudicated by Adjudication Committee) was reported. All-cause death was defined as the death due to any cause during the course of study. Event rate was calculated as the number of events per 100 participant-years at risk. | FAS: all participants who were randomized, excluding who attempted to be randomized more than once into a bococizumab CV outcomes trial (B1481022/B1481038) or attempted to be randomized in more than 1 CV outcomes trial and all participants enrolled at study Site 3027 where a quality-related event was identified. | Posted | Number | 95% Confidence Interval | Events per 100 participant-years | From baseline until the date of first adjudicated and confirmed occurrence of all-cause death, non-fatal MI, non-fatal stroke or hospitalization for unstable angina needing urgent revascularization (maximum duration: up to 3.4 years) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Secondary | Event Rate Per 100 Participant-years for First Occurrence of Composite Endpoint of All-cause Death, Non-fatal Myocardial Infarction (MI) or Non-fatal Stroke | Event rate per 100 participant-years for first occurrence of composite endpoint of all-cause death, non-fatal MI or non-fatal stroke (adjudicated by Adjudication Committee) was reported. All-cause death was defined as the death due to any cause during the course of study. Event rate was calculated as the number of events per 100 participant-years at risk. | FAS: all participants who were randomized, excluding who attempted to be randomized more than once into a bococizumab CV outcomes trial (B1481022/B1481038) or attempted to be randomized in more than 1 CV outcomes trial and all participants enrolled at study Site 3027 where a quality-related event was identified. | Posted | Number | 95% Confidence Interval | Events per 100 participant-years | From baseline until the date of first adjudicated and confirmed occurrence of all-cause death, non-fatal MI or non-fatal stroke (maximum duration: up to 3.4 years) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Secondary | Event Rate Per 100 Participant-years for First Occurrence of Hospitalization for Unstable Angina Needing Urgent Revascularization | Event rate per 100 participant-years for first occurrence of hospitalization for unstable angina needing urgent revascularization (adjudicated by Adjudication Committee) was reported. Event rate was calculated as the number of events per 100 participant-years at risk. | FAS: all participants who were randomized, excluding who attempted to be randomized more than once into a bococizumab CV outcomes trial (B1481022/B1481038) or attempted to be randomized in more than 1 CV outcomes trial and all participants enrolled at study Site 3027 where a quality-related event was identified. | Posted | Number | 95% Confidence Interval | Events per 100 participant-years | From baseline until the date of first adjudicated and confirmed occurrence of hospitalization for unstable angina needing urgent revascularization (maximum duration: up to 3.4 years) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Secondary | Event Rate Per 100 Participant-years for First Occurrence of Composite Endpoint of Cardiovascular (CV) Death, Non-fatal Myocardial Infarction (MI), Non-fatal Stroke or Hospitalization for Unstable Angina | Event rate per 100 participant-years for first occurrence of composite endpoint of CV death, non-fatal MI, non-fatal stroke or hospitalization for unstable angina (adjudicated by Adjudication Committee) was reported. CV death was defined as sudden cardiac death, fatal MI, death due to heart failure, death due to stroke (fatal ischemic stroke or fatal stroke of undetermined etiology), or death due to other CV causes. Event rate was calculated as the number of events per 100 participant-years at risk. | FAS: all participants who were randomized, excluding who attempted to be randomized more than once into a bococizumab CV outcomes trial (B1481022/B1481038) or attempted to be randomized in more than 1 CV outcomes trial and all participants enrolled at study Site 3027 where a quality-related event was identified. | Posted | Number | 95% Confidence Interval | Events per 100 participant-years | From baseline until the date of first adjudicated and confirmed occurrence of CV death, non-fatal MI, non-fatal stroke or hospitalization for unstable angina (maximum duration: up to 3.4 years) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Secondary | Event Rate Per 100 Participant-years for Cardiovascular (CV) Death | Event rate per 100 participant-years for occurrence of CV death (adjudicated by Adjudication Committee) was reported. CV death was defined as sudden cardiac death, fatal MI, death due to heart failure, death due to stroke (fatal ischemic stroke or fatal stroke of undetermined etiology), or death due to other CV causes. Event rate was calculated as the number of events per 100 participant-years at risk. | FAS: all participants who were randomized, excluding who attempted to be randomized more than once into a bococizumab CV outcomes trial (B1481022/B1481038) or attempted to be randomized in more than 1 CV outcomes trial and all participants enrolled at study Site 3027 where a quality-related event was identified. | Posted | Number | 95% Confidence Interval | Events per 100 participant-years | From baseline until the date of adjudicated and confirmed occurrence of CV death (maximum duration: up to 3.4 years) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Secondary | Event Rate Per 100 Participant-years for First Occurrence of Any Myocardial Infarction (Fatal or Non-fatal) | Event rate per 100 participant-years for first occurrence of any myocardial infarction (fatal or non-fatal) (adjudicated by Adjudication Committee) was reported. Event rate was calculated as the number of events per 100 participant-years at risk. | FAS: all participants who were randomized, excluding who attempted to be randomized more than once into a bococizumab CV outcomes trial (B1481022/B1481038) or attempted to be randomized in more than 1 CV outcomes trial and all participants enrolled at study Site 3027 where a quality-related event was identified. | Posted | Number | 95% Confidence Interval | Events per 100 participant-years | From baseline until the date of first adjudicated and confirmed occurrence of any myocardial infarction (fatal or non-fatal) (maximum duration: up to 3.4 years) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Secondary | Event Rate Per 100 Participant-years for Fatal Myocardial Infarction (MI) | Event rate per 100 participant-years for occurrence of fatal MI (adjudicated by Adjudication Committee) was reported. Event rate was calculated as the number of events per 100 participant-years at risk. | FAS: all participants who were randomized, excluding who attempted to be randomized more than once into a bococizumab CV outcomes trial (B1481022/B1481038) or attempted to be randomized in more than 1 CV outcomes trial and all participants enrolled at study Site 3027 where a quality-related event was identified. | Posted | Number | 95% Confidence Interval | Events per 100 participant-years | From baseline until the date of adjudicated and confirmed occurrence of fatal MI (maximum duration: up to 3.4 years) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Secondary | Event Rate Per 100 Participant-years for First Occurrence of Non-fatal Myocardial Infarction (MI) | Event rate per 100 participant-years for first occurrence of non-fatal MI (adjudicated by Adjudication Committee) was reported. Event rate was calculated as the number of events per 100 participant-years at risk. | FAS: all participants who were randomized, excluding who attempted to be randomized more than once into a bococizumab CV outcomes trial (B1481022/B1481038) or attempted to be randomized in more than 1 CV outcomes trial and all participants enrolled at study Site 3027 where a quality-related event was identified. | Posted | Number | 95% Confidence Interval | Events per 100 participant-years | From baseline until the date of first adjudicated and confirmed occurrence of non-fatal MI (maximum duration: up to 3.4 years) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Secondary | Event Rate Per 100 Participant-years for First Occurrence of Any Stroke (Fatal or Non-fatal) | Event rate per 100 participant-years for first occurrence of any stroke (fatal or non-fatal) (adjudicated by Adjudication Committee) was reported. Event rate was calculated as the number of events per 100 participant-years at risk. | FAS: all participants who were randomized, excluding who attempted to be randomized more than once into a bococizumab CV outcomes trial (B1481022/B1481038) or attempted to be randomized in more than 1 CV outcomes trial and all participants enrolled at study Site 3027 where a quality-related event was identified. | Posted | Number | 95% Confidence Interval | Events per 100 participant-years | From baseline until the date of first adjudicated and confirmed occurrence of any stroke (fatal or non-fatal) (maximum duration: up to 3.4 years) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Secondary | Event Rate Per 100 Participant-years for First Occurrence of Any Stroke (Fatal or Non-fatal), of Any Etiology | Event rate per 100 participant-years for first occurrence of any stroke (fatal or non-fatal) of any etiology (adjudicated by Adjudication Committee) was reported. Event rate was calculated as the number of events per 100 participant-years at risk. | FAS: all participants who were randomized, excluding who attempted to be randomized more than once into a bococizumab CV outcomes trial (B1481022/B1481038) or attempted to be randomized in more than 1 CV outcomes trial and all participants enrolled at study Site 3027 where a quality-related event was identified. | Posted | Number | 95% Confidence Interval | Events per 100 participant-years | From baseline until the date of first adjudicated and confirmed occurrence of any stroke (fatal or non-fatal) of any etiology (maximum duration: up to 3.4 years) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Secondary | Event Rate Per 100 Participant-years for Fatal Stroke | Event rate per 100 participant-years for occurrence of fatal stroke (adjudicated by Adjudication Committee) was reported. Event rate was calculated as the number of events per 100 participant-years at risk. | FAS: all participants who were randomized, excluding who attempted to be randomized more than once into a bococizumab CV outcomes trial (B1481022/B1481038) or attempted to be randomized in more than 1 CV outcomes trial and all participants enrolled at study Site 3027 where a quality-related event was identified. | Posted | Number | 95% Confidence Interval | Events per 100 participant-years | From baseline until the date of adjudicated and confirmed occurrence of fatal stroke (maximum duration: up to 3.4 years) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Secondary | Event Rate Per 100 Participant-years for First Occurrence of Non-fatal Stroke | Event rate per 100 participant-years for first occurrence of non-fatal stroke (adjudicated by Adjudication Committee) was reported. Event rate was calculated as the number of events per 100 participant-years at risk. | FAS: all participants who were randomized, excluding who attempted to be randomized more than once into a bococizumab CV outcomes trial (B1481022/B1481038) or attempted to be randomized in more than 1 CV outcomes trial and all participants enrolled at study Site 3027 where a quality-related event was identified. | Posted | Number | 95% Confidence Interval | Events per 100 participant-years | From baseline until the date of first adjudicated and confirmed occurrence of non-fatal stroke (maximum duration: up to 3.4 years) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Secondary | Event Rate Per 100 Participant-years for First Occurrence of Hospitalization for Unstable Angina | Event rate per 100 participant-years for first occurrence of hospitalization for unstable angina (adjudicated by Adjudication Committee) was reported. Event rate was calculated as the number of events per 100 participant-years at risk. | FAS: all participants who were randomized, excluding who attempted to be randomized more than once into a bococizumab CV outcomes trial (B1481022/B1481038) or attempted to be randomized in more than 1 CV outcomes trial and all participants enrolled at study Site 3027 where a quality-related event was identified. | Posted | Number | 95% Confidence Interval | Events per 100 participant-years | From baseline until the date of first adjudicated and confirmed occurrence of hospitalization for unstable angina (maximum duration: up to 3.4 years) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Secondary | Event Rate Per 100 Participant-years for First Occurrence of Hospitalization for Congestive Heart Failure (CHF) | Event rate per 100 participant-years for first occurrence of hospitalization for CHF (adjudicated by Adjudication Committee) was reported. Event rate was calculated as the number of events per 100 participant-years at risk. | FAS: all participants who were randomized, excluding who attempted to be randomized more than once into a bococizumab CV outcomes trial (B1481022/B1481038) or attempted to be randomized in more than 1 CV outcomes trial and all participants enrolled at study Site 3027 where a quality-related event was identified. | Posted | Number | 95% Confidence Interval | Events per 100 participant-years | From baseline until the date of first adjudicated and confirmed occurrence of hospitalization for CHF (maximum duration: up to 3.4 years) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Secondary | Event Rate Per 100 Participant-years for First Occurrence of Coronary Revascularization | Event rate per 100 participant-years for first occurrence of coronary revascularization (adjudicated by Adjudication Committee) was reported. Event rate was calculated as the number of events per 100 participant-years at risk. | FAS: all participants who were randomized, excluding who attempted to be randomized more than once into a bococizumab CV outcomes trial (B1481022/B1481038) or attempted to be randomized in more than 1 CV outcomes trial and all participants enrolled at study Site 3027 where a quality-related event was identified. | Posted | Number | 95% Confidence Interval | Events per 100 participant-years | From baseline until the date of first adjudicated and confirmed occurrence of coronary revascularization (maximum duration: up to 3.4 years) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Secondary | Event Rate Per 100 Participant-years for First Occurrence of Coronary Artery Bypass Graft Surgery (CABG) | Event rate per 100 participant-years for first occurrence of CABG (adjudicated by Adjudication Committee) was reported. Event rate was calculated as the number of events per 100 participant-years at risk. | FAS: all participants who were randomized, excluding who attempted to be randomized more than once into a bococizumab CV outcomes trial (B1481022/B1481038) or attempted to be randomized in more than 1 CV outcomes trial and all participants enrolled at study Site 3027 where a quality-related event was identified. | Posted | Number | 95% Confidence Interval | Events per 100 participant-years | From baseline until the date of first adjudicated and confirmed occurrence of CABG (maximum duration: up to 3.4 years) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Secondary | Event Rate Per 100 Participant-years for First Occurrence of Percutaneous Coronary Intervention (PCI) | Event rate per 100 participant-years for first occurrence of PCI (adjudicated by Adjudication Committee) was reported. Event rate was calculated as the number of events per 100 participant-years at risk. | FAS: all participants who were randomized, excluding who attempted to be randomized more than once into a bococizumab CV outcomes trial (B1481022/B1481038) or attempted to be randomized in more than 1 CV outcomes trial and all participants enrolled at study Site 3027 where a quality-related event was identified. | Posted | Number | 95% Confidence Interval | Events per 100 participant-years | From baseline until the date of first adjudicated and confirmed occurrence of PCI (maximum duration: up to 3.4 years) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Secondary | Event Rate Per 100 Participant-years for First Occurrence of Any Arterial Revascularizations | Event rate per 100 participant-years for first occurrence of any arterial revascularizations (adjudicated by Adjudication Committee) was reported. Event rate was calculated as the number of events per 100 participant-years at risk. | FAS: all participants who were randomized, excluding who attempted to be randomized more than once into a bococizumab CV outcomes trial (B1481022/B1481038) or attempted to be randomized in more than 1 CV outcomes trial and all participants enrolled at study Site 3027 where a quality-related event was identified. | Posted | Number | 95% Confidence Interval | Events per 100 participant-years | From baseline until the date of first adjudicated and confirmed occurrence of any arterial revascularizations (maximum duration: up to 3.4 years) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Secondary | Event Rate Per 100 Participant-years for All-cause Death | Event rate per 100 participant-years for occurrence of all-cause death (adjudicated by Adjudication Committee) was reported. All-cause death was defined as the death due to any cause during the course of study. Event rate was calculated as the number of events per 100 participant-years at risk. | FAS: all participants who were randomized, excluding who attempted to be randomized more than once into a bococizumab CV outcomes trial (B1481022/B1481038) or attempted to be randomized in more than 1 CV outcomes trial and all participants enrolled at study Site 3027 where a quality-related event was identified. | Posted | Number | 95% Confidence Interval | Events per 100 participant-years | From baseline until the date of adjudicated and confirmed occurrence of all-cause death (maximum duration: up to 3.4 years) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Secondary | Percent Change From Baseline in Low Density Lipoprotein Cholesterol (LDL-C) at Week 14 | Analysis was performed on FAS. Here, "Number of participants analyzed" (N) signifies those participants who were evaluable for this outcome measure. | Posted | Least Squares Mean | Standard Error | Percent change | Baseline, Week 14 |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Secondary | Nominal Change From Baseline in Low Density Lipoprotein Cholesterol (LDL-C) at Week 14 | Analysis was performed on FAS. Here, "N" signifies those participants who were evaluable for this outcome measure. | Posted | Least Squares Mean | Standard Error | mg/dL | Baseline, Week 14 |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Secondary | Percent Change From Baseline in Low Density Lipoprotein Cholesterol (LDL-C) at Last Post-baseline Measurement | Analysis was performed on FAS. Here, "N" signifies those participants who were evaluable for this outcome measure. | Posted | Least Squares Mean | Standard Error | Percent change | Baseline, last post-baseline measurement (any time up to Week 140) |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Secondary | Percent Change From Baseline in Lipid Levels at Week 14 | Lipids included non-high density lipoprotein cholesterol (non-HDL-C), very low density lipoprotein cholesterol (VLDL-C), remnant lipoprotein cholesterol (RLP-C), apolipoprotein B (Apo B), HDL-C, apolipoprotein A-I (Apo A-I) and total cholesterol. | FAS population. Here, number analyzed "n" signifies number of participants who were evaluable for the specified categories. | Posted | Least Squares Mean | Standard Error | Percent change | Baseline, Week 14 |
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Secondary | Percent Change From Baseline in Log-transformed Triglycerides and Lipoprotein (a) (Lp[a]) at Week 14 | FAS population. Here, number analyzed "n" signifies number of participants who were evaluable for the specified categories. | Posted | Mean | Standard Deviation | Percent change | Baseline, Week 14 |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Secondary | Percent Change From Baseline in Log-transformed High Sensitivity C-Reactive Protein (Hs-CRP) at Week 14 | Analysis was performed on FAS. Here, "N" signifies those participants who were evaluable for this outcome measure. | Posted | Mean | Standard Deviation | Percent change | Baseline, Week 14 |
|
|
Baseline up to 3.4 years
Safety analysis set: all participants who randomized, had atleast 1 dose of study drug, excluding those attempted to randomize more than once in a bococizumab CV outcomes trial (B1481022/B1481038) or attempted to randomize in more than 1 CV outcomes trial, and all participants enrolled at study Site 3027 where a quality-related event was identified
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Placebo | Participants received single dose of placebo matched to PF-04950615 subcutaneous injection once in every 2 weeks over a period of 3 years. Participants were followed up to 40 days after the last dose. | 61 | 5,279 | 994 | 5,279 | 2,128 | 5,279 |
| EG001 | Bococizumab (PF-04950615) | Participants received single dose of PF-04950615, 150 milligrams, subcutaneous injection once in every 2 weeks over a period of 3 years. Participants were followed up to 40 days after the last dose. | 54 | 5,276 | 934 | 5,276 | 2,453 | 5,276 |
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Anaemia | Blood and lymphatic system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Autoimmune haemolytic anaemia | Blood and lymphatic system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Haemorrhagic anaemia | Blood and lymphatic system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Hypochromic anaemia | Blood and lymphatic system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Iron deficiency anaemia | Blood and lymphatic system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Leukocytosis | Blood and lymphatic system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Pancytopenia | Blood and lymphatic system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Acute coronary syndrome | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Acute left ventricular failure | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Acute myocardial infarction | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Angina pectoris | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Angina unstable | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Anginal equivalent | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Aortic valve incompetence | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Aortic valve stenosis | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Arrhythmia | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Arrhythmia supraventricular | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Arteriosclerosis coronary artery | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Arteriospasm coronary | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Atrial fibrillation | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Atrial flutter | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Atrial thrombosis | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Atrioventricular block | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Atrioventricular block complete | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Atrioventricular block second degree | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Bradycardia | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Cardiac arrest | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Cardiac failure | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Cardiac failure acute | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Cardiac failure chronic | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Cardiac failure congestive | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Cardiac valve disease | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Cardio-respiratory arrest | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Cardiogenic shock | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Cardiomyopathy | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Cardiopulmonary failure | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Cardiorenal syndrome | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Conduction disorder | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Congestive cardiomyopathy | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Coronary artery disease | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Coronary artery insufficiency | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Coronary artery occlusion | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Coronary artery stenosis | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Coronary artery thrombosis | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Diastolic dysfunction | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Dressler's syndrome | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Ischaemic cardiomyopathy | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Left ventricular dysfunction | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Left ventricular failure | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Left ventricular hypertrophy | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Mitral valve incompetence | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Myocardial infarction | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Myocardial ischaemia | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Palpitations | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Pericarditis | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Sinus arrhythmia | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Sinus node dysfunction | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Sinus tachycardia | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Supraventricular tachycardia | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Systolic dysfunction | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Tachycardia | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Tachycardia paroxysmal | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Torsade de pointes | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Trifascicular block | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Ventricular arrhythmia | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Ventricular extrasystoles | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Ventricular fibrillation | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Ventricular tachycardia | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Hydrocele | Congenital, familial and genetic disorders | MedDRA 19.1 | Non-systematic Assessment | This event was gender specific. |
|
| Phimosis | Congenital, familial and genetic disorders | MedDRA 19.1 | Non-systematic Assessment | This event was gender specific. |
|
| Sudden hearing loss | Ear and labyrinth disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Tinnitus | Ear and labyrinth disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Vertigo | Ear and labyrinth disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Vertigo positional | Ear and labyrinth disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Vestibular disorder | Ear and labyrinth disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Addison's disease | Endocrine disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Goitre | Endocrine disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Hyperparathyroidism | Endocrine disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Hyperthyroidism | Endocrine disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Hypothyroidism | Endocrine disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Thyroid mass | Endocrine disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Amaurosis fugax | Eye disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Cataract | Eye disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Diabetic retinopathy | Eye disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Diplopia | Eye disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Macular fibrosis | Eye disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Retinal detachment | Eye disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Retinal haemorrhage | Eye disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Retinal infarction | Eye disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Vitreous haemorrhage | Eye disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Abdominal adhesions | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Abdominal hernia | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Abdominal pain | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Abdominal pain upper | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Acute abdomen | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Anal fistula | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Anal incontinence | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Coeliac artery stenosis | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Colitis | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Colitis ischaemic | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Constipation | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Crohn's disease | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Diarrhoea | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Diverticular perforation | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Diverticulum | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Diverticulum intestinal | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Diverticulum oesophageal | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Duodenal ulcer | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Dyspepsia | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Dysphagia | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Enteritis | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Erosive oesophagitis | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Faecaloma | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Gastric disorder | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Gastric haemorrhage | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Gastric ulcer | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Gastric ulcer haemorrhage | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Gastritis | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Gastritis haemorrhagic | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Gastrointestinal haemorrhage | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Gastrooesophageal reflux disease | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Haematochezia | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Haemorrhagic erosive gastritis | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Ileus | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Ileus paralytic | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Impaired gastric emptying | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Incarcerated umbilical hernia | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment | This event was gender specific. |
|
| Inguinal hernia | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Intestinal haemorrhage | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Intestinal ischaemia | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Intestinal obstruction | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Intestinal perforation | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Irritable bowel syndrome | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Large intestinal obstruction | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Large intestine polyp | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Lip disorder | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Lower gastrointestinal haemorrhage | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Mallory-Weiss syndrome | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Nausea | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Oesophageal food impaction | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Oesophageal spasm | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Pancreatitis | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Pancreatitis acute | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Pancreatitis chronic | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Reactive gastropathy | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Rectal haemorrhage | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Rectal polyp | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Retroperitoneal haematoma | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Small intestinal obstruction | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Strangulated umbilical hernia | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment | This event was gender specific. |
|
| Ulcerative gastritis | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Umbilical hernia | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment | This event was gender specific. |
|
| Umbilical hernia, obstructive | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment | This event was gender specific. |
|
| Upper gastrointestinal haemorrhage | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Vomiting | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Adverse drug reaction | General disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Asthenia | General disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Cardiac death | General disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Chest discomfort | General disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Chest pain | General disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Complication associated with device | General disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Death | General disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Drug withdrawal syndrome | General disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Fatigue | General disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Hernia | General disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Ill-defined disorder | General disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Impaired healing | General disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Inflammation | General disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Multi-organ disorder | General disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Multiple organ dysfunction syndrome | General disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Non-cardiac chest pain | General disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Oedema peripheral | General disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Pain | General disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Peripheral swelling | General disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Polyp | General disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Pyrexia | General disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Stenosis | General disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Sudden cardiac death | General disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Sudden death | General disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Systemic inflammatory response syndrome | General disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Vascular stent restenosis | General disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Vascular stent stenosis | General disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Vascular stent thrombosis | General disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Alcoholic liver disease | Hepatobiliary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Bile duct obstruction | Hepatobiliary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Bile duct stone | Hepatobiliary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Biliary colic | Hepatobiliary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Biliary fistula | Hepatobiliary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Cholangitis | Hepatobiliary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Cholecystitis | Hepatobiliary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Cholecystitis acute | Hepatobiliary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Cholecystitis chronic | Hepatobiliary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Cholelithiasis | Hepatobiliary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Drug-induced liver injury | Hepatobiliary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Gallbladder perforation | Hepatobiliary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Gallbladder polyp | Hepatobiliary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Jaundice | Hepatobiliary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Liver injury | Hepatobiliary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Anaphylactic reaction | Immune system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Drug hypersensitivity | Immune system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Food allergy | Immune system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Hypersensitivity | Immune system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Immunosuppression | Immune system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Abdominal wall abscess | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Abscess | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Abscess intestinal | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Abscess limb | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Anal abscess | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Appendicitis | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Arteriovenous graft site infection | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Arthritis infective | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Bacteraemia | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Bacterial diarrhoea | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Biliary sepsis | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Bronchitis | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Campylobacter gastroenteritis | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Cardiac valve vegetation | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Cellulitis | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Cholecystitis infective | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Chronic sinusitis | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Clostridium difficile colitis | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Clostridium difficile infection | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Cystitis | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Device related infection | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Diabetic foot infection | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Diabetic gangrene | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Diverticulitis | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Endocarditis | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Epididymitis | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Epstein-Barr virus infection | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Erysipelas | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Escherichia bacteraemia | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Gangrene | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Gastritis viral | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Gastroenteritis | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Gastroenteritis clostridial | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Gastroenteritis viral | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Groin abscess | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Groin infection | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Haematoma infection | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Hepatic cyst infection | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Hepatitis A | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Hepatitis C | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Herpes zoster | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Incision site infection | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Infected skin ulcer | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Infection | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Infectious colitis | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Infectious pleural effusion | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Influenza | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Kidney infection | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Laryngitis | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Localised infection | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Lower respiratory tract infection | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Lung abscess | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Medical device site abscess | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Muscle abscess | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Necrotising fasciitis | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Osteomyelitis | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Otitis externa | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Pelvic abscess | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Peritonitis | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Pneumonia | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Pneumonia bacterial | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Pneumonia influenzal | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Pneumonia legionella | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Post procedural pneumonia | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Postoperative wound infection | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Pulmonary sepsis | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Pyelocystitis | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Pyelonephritis | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Pyelonephritis acute | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Rectal abscess | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Respiratory tract infection | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Scrotal abscess | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Sebaceous gland infection | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Sepsis | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Septic shock | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Sinusitis | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Sinusitis bacterial | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Staphylococcal bacteraemia | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Staphylococcal infection | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Staphylococcal sepsis | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Subcutaneous abscess | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Tick-borne viral encephalitis | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Tooth abscess | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Tracheobronchitis | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Upper respiratory tract infection | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Urinary tract infection | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Urosepsis | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Viral infection | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Viral sepsis | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Wound infection | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Acoustic shock | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Ankle fracture | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Arterial bypass thrombosis | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Arterial restenosis | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Arthropod sting | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Cardiac procedure complication | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Clavicle fracture | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Concussion | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Contusion | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Craniocerebral injury | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Dural tear | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Fall | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Femoral neck fracture | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Femur fracture | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Fibula fracture | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Foot fracture | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Fractured sacrum | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Gallbladder injury | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Gastrointestinal stoma complication | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Hand fracture | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Hip fracture | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Humerus fracture | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Incarcerated incisional hernia | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Incisional hernia | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Injury | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Intentional overdose | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Joint dislocation | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Kidney rupture | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Ligament injury | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Ligament rupture | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Limb injury | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Lower limb fracture | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Lumbar vertebral fracture | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Meniscus injury | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Muscle rupture | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Neck injury | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Overdose | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Patella fracture | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Pelvic fracture | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Peripheral artery restenosis | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Post procedural complication | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Post procedural haemorrhage | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Postoperative fever | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Postoperative ileus | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Postoperative respiratory failure | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Postoperative wound complication | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Procedural haemorrhage | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Procedural pain | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Radius fracture | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Rib fracture | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Road traffic accident | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Skull fracture | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Spinal compression fracture | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Subarachnoid haemorrhage | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Subdural haematoma | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Subdural haemorrhage | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Suture related complication | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Tendon rupture | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Tibia fracture | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Traumatic liver injury | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Traumatic renal injury | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Upper limb fracture | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Urinary tract stoma complication | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Vascular graft occlusion | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Vascular procedure complication | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Vascular pseudoaneurysm | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Wound | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Wound dehiscence | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Wound necrosis | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Alanine aminotransferase increased | Investigations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Anticoagulation drug level above therapeutic | Investigations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Aspartate aminotransferase increased | Investigations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Blood creatine phosphokinase increased | Investigations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Blood glucose increased | Investigations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Blood ketone body increased | Investigations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Blood magnesium decreased | Investigations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Blood pressure increased | Investigations | MedDRA 19.1 | Non-systematic Assessment |
| |
| ECG signs of myocardial ischaemia | Investigations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Ejection fraction abnormal | Investigations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Electrocardiogram ST segment elevation | Investigations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Electrocardiogram T wave inversion | Investigations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Exercise test abnormal | Investigations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Gamma-glutamyltransferase increased | Investigations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Hepatic enzyme increased | Investigations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Liver function test abnormal | Investigations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Liver function test increased | Investigations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Myocardial necrosis marker increased | Investigations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Neurological examination | Investigations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Prostatic specific antigen increased | Investigations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Renal function test abnormal | Investigations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Staphylococcus test positive | Investigations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Stress echocardiogram abnormal | Investigations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Transaminases increased | Investigations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Troponin increased | Investigations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Dehydration | Metabolism and nutrition disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Diabetes mellitus | Metabolism and nutrition disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Diabetes mellitus inadequate control | Metabolism and nutrition disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Diabetic ketoacidosis | Metabolism and nutrition disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Electrolyte imbalance | Metabolism and nutrition disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Failure to thrive | Metabolism and nutrition disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Fluid overload | Metabolism and nutrition disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Hyperglycaemia | Metabolism and nutrition disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Hyperkalaemia | Metabolism and nutrition disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Hyperosmolar hyperglycaemic state | Metabolism and nutrition disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Hypertriglyceridaemia | Metabolism and nutrition disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Hypoglycaemia | Metabolism and nutrition disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Hypokalaemia | Metabolism and nutrition disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Hyponatraemia | Metabolism and nutrition disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Hypovolaemia | Metabolism and nutrition disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Metabolic acidosis | Metabolism and nutrition disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Metabolic disorder | Metabolism and nutrition disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Obesity | Metabolism and nutrition disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Type 2 diabetes mellitus | Metabolism and nutrition disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Ankylosing spondylitis | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Arthralgia | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Arthritis | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Back disorder | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Back pain | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Bone pain | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Bursitis | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Cervical spinal stenosis | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Compartment syndrome | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Costochondritis | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Fibromyalgia | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Flank pain | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Haemarthrosis | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Intervertebral disc degeneration | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Intervertebral disc disorder | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Intervertebral disc protrusion | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Jaw cyst | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Lumbar spinal stenosis | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Meniscal degeneration | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Muscle disorder | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Muscle spasms | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Muscular weakness | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Musculoskeletal chest pain | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Musculoskeletal pain | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Myalgia | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Myopathy | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Neck pain | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Osteoarthritis | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Osteochondrosis | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Osteonecrosis | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Osteonecrosis of jaw | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Osteoporosis | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Pain in extremity | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Periarthritis | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Peripheral arthritis | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Polyarthritis | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Polymyalgia rheumatica | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Psoriatic arthropathy | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Rhabdomyolysis | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Rotator cuff syndrome | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Soft tissue mass | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Spinal column stenosis | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Spinal disorder | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Spinal osteoarthritis | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Synovial cyst | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Tenosynovitis | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Tenosynovitis stenosans | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Acute myeloid leukaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Adenocarcinoma gastric | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Adenocarcinoma of colon | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Anal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Basal cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Benign breast neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Benign lymph node neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Bladder neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Bladder papilloma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Bladder transitional cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Bone cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Bowen's disease | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Brain cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Brain neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Breast cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Breast cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Breast neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Cardiac myxoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Cervix carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment | This event was gender specific. |
|
| Clear cell renal cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Colon adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Colon cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Colon cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Colorectal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Duodenal neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Endometrial adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment | This event was gender specific. |
|
| Follicular thyroid cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Gastric adenoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Gastric cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Gastric cancer stage IV | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Gastric neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Glioblastoma multiforme | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Hypopharyngeal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Invasive ductal breast carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Invasive lobular breast carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Laryngeal squamous cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Lentigo maligna | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Leukaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Lipoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Lung adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Lung adenocarcinoma stage I | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Lung cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Lung carcinoma cell type unspecified stage IV | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Lung neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Lung neoplasm malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Malignant ascites | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Malignant haemangiopericytoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Malignant melanoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Meningioma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Meningioma benign | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Metastases to bone | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Metastases to central nervous system | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Metastases to liver | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Metastases to lung | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Metastases to spine | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Metastasis | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Metastatic bronchial carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Metastatic neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Metastatic renal cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Neoplasm malignant | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Neoplasm skin | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Neuroendocrine carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Non-Hodgkin's lymphoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Non-small cell lung cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Oesophageal carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Pancreatic carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Pancreatic neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Papillary thyroid cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Parathyroid tumour benign | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Penile squamous cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment | This event was gender specific. |
|
| Prostate cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment | This event was gender specific. |
|
| Rectal adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Renal cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Renal cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Renal cell carcinoma recurrent | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Renal neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Respiratory tract neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Salivary gland neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Small cell lung cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Small cell lung cancer metastatic | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Squamous cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Thyroid cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Transitional cell carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment |
| |
| Uterine leiomyoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 19.1 | Non-systematic Assessment | This event was gender specific. |
|
| Amputation stump pain | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Ataxia | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Balance disorder | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Basal ganglia stroke | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Brain stem haemorrhage | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Brain stem infarction | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Carotid artery disease | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Carotid artery stenosis | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Carpal tunnel syndrome | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Cerebellar infarction | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Cerebral haemorrhage | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Cerebral infarction | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Cerebral ischaemia | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Cerebrovascular accident | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Cervical radiculopathy | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Cervicobrachial syndrome | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Cognitive disorder | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Diabetic neuropathy | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Dizziness | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Embolic cerebral infarction | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Embolic stroke | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Encephalopathy | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Epilepsy | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Facial paralysis | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Fahr's disease | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Haemorrhage intracranial | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Haemorrhagic stroke | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Headache | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Hemiparesis | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Hemiplegic migraine | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Hypoaesthesia | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Hypoglycaemic coma | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Hypoxic-ischaemic encephalopathy | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Intracranial aneurysm | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Ischaemic cerebral infarction | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Ischaemic neuropathy | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Ischaemic stroke | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Lacunar infarction | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Lethargy | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Lumbar radiculopathy | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Lumbosacral radiculopathy | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Memory impairment | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Migraine | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Monoplegia | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Nerve root compression | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Nervous system disorder | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Neuralgia | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Neuritis | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Paraesthesia | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Paralysis recurrent laryngeal nerve | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Parkinson's disease | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Partial seizures | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Peripheral motor neuropathy | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Polyneuropathy | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Presyncope | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Radicular syndrome | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Radiculopathy | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Sciatica | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Seizure | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Sensory disturbance | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Serotonin syndrome | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Speech disorder | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Spinal cord compression | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Spondylitic myelopathy | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Subarachnoid haematoma | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Syncope | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Thrombotic stroke | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Transient global amnesia | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Transient ischaemic attack | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Vertebral artery stenosis | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Visual field defect | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Abortion missed | Pregnancy, puerperium and perinatal conditions | MedDRA 19.1 | Non-systematic Assessment | This event was gender specific. |
|
| Device dislocation | Product Issues | MedDRA 19.1 | Non-systematic Assessment |
| |
| Device malfunction | Product Issues | MedDRA 19.1 | Non-systematic Assessment |
| |
| Device material issue | Product Issues | MedDRA 19.1 | Non-systematic Assessment |
| |
| Manufacturing issue | Product Issues | MedDRA 19.1 | Non-systematic Assessment |
| |
| Thrombosis in device | Product Issues | MedDRA 19.1 | Non-systematic Assessment |
| |
| Alcohol abuse | Psychiatric disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Alcohol withdrawal syndrome | Psychiatric disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Alcoholism | Psychiatric disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Anxiety | Psychiatric disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Confusional state | Psychiatric disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Delirium | Psychiatric disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Delirium tremens | Psychiatric disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Delusional disorder, unspecified type | Psychiatric disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Depression | Psychiatric disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Drug abuse | Psychiatric disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Major depression | Psychiatric disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Mental disorder | Psychiatric disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Mental status changes | Psychiatric disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Neurologic somatic symptom disorder | Psychiatric disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Psychotic disorder | Psychiatric disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Suicidal ideation | Psychiatric disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Suicide attempt | Psychiatric disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Acute kidney injury | Renal and urinary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Acute prerenal failure | Renal and urinary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Anuria | Renal and urinary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Bladder diverticulum | Renal and urinary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Bladder outlet obstruction | Renal and urinary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Bladder spasm | Renal and urinary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Calculus urinary | Renal and urinary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Chronic kidney disease | Renal and urinary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Diabetic nephropathy | Renal and urinary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Dysuria | Renal and urinary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Haematuria | Renal and urinary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Hydronephrosis | Renal and urinary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Nephrolithiasis | Renal and urinary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Nephropathy | Renal and urinary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Nephropathy toxic | Renal and urinary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Obstructive uropathy | Renal and urinary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Proteinuria | Renal and urinary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Renal artery stenosis | Renal and urinary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Renal artery thrombosis | Renal and urinary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Renal colic | Renal and urinary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Renal failure | Renal and urinary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Renal impairment | Renal and urinary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Stress urinary incontinence | Renal and urinary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Ureterolithiasis | Renal and urinary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Urethral disorder | Renal and urinary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Urethral stenosis | Renal and urinary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Urinary incontinence | Renal and urinary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Urinary retention | Renal and urinary disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Benign prostatic hyperplasia | Reproductive system and breast disorders | MedDRA 19.1 | Non-systematic Assessment | This event was gender specific. |
|
| Breast hyperplasia | Reproductive system and breast disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Cervical dysplasia | Reproductive system and breast disorders | MedDRA 19.1 | Non-systematic Assessment | This event was gender specific. |
|
| Cystocele | Reproductive system and breast disorders | MedDRA 19.1 | Non-systematic Assessment | This event was gender specific. |
|
| Dysfunctional uterine bleeding | Reproductive system and breast disorders | MedDRA 19.1 | Non-systematic Assessment | This event was gender specific. |
|
| Endometrial hyperplasia | Reproductive system and breast disorders | MedDRA 19.1 | Non-systematic Assessment | This event was gender specific. |
|
| Genital haemorrhage | Reproductive system and breast disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Ovarian cyst | Reproductive system and breast disorders | MedDRA 19.1 | Non-systematic Assessment | This event was gender specific. |
|
| Prostatitis | Reproductive system and breast disorders | MedDRA 19.1 | Non-systematic Assessment | This event was gender specific. |
|
| Rectocele | Reproductive system and breast disorders | MedDRA 19.1 | Non-systematic Assessment | This event was gender specific. |
|
| Uterine haemorrhage | Reproductive system and breast disorders | MedDRA 19.1 | Non-systematic Assessment | This event was gender specific. |
|
| Uterine prolapse | Reproductive system and breast disorders | MedDRA 19.1 | Non-systematic Assessment | This event was gender specific. |
|
| Acute pulmonary oedema | Respiratory, thoracic and mediastinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Acute respiratory failure | Respiratory, thoracic and mediastinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Asthma | Respiratory, thoracic and mediastinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Asthma-chronic obstructive pulmonary disease overlap syndrome | Respiratory, thoracic and mediastinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Bronchitis chronic | Respiratory, thoracic and mediastinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Chronic obstructive pulmonary disease | Respiratory, thoracic and mediastinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Dyspnoea | Respiratory, thoracic and mediastinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Dyspnoea exertional | Respiratory, thoracic and mediastinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Epistaxis | Respiratory, thoracic and mediastinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Haemoptysis | Respiratory, thoracic and mediastinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Haemothorax | Respiratory, thoracic and mediastinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Hyperventilation | Respiratory, thoracic and mediastinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Hypoxia | Respiratory, thoracic and mediastinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Idiopathic pulmonary fibrosis | Respiratory, thoracic and mediastinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Interstitial lung disease | Respiratory, thoracic and mediastinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Laryngeal dysplasia | Respiratory, thoracic and mediastinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Lung disorder | Respiratory, thoracic and mediastinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Nasal septum deviation | Respiratory, thoracic and mediastinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Obstructive airways disorder | Respiratory, thoracic and mediastinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Pleural effusion | Respiratory, thoracic and mediastinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Pleurisy | Respiratory, thoracic and mediastinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Pneumonia aspiration | Respiratory, thoracic and mediastinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Pneumothorax | Respiratory, thoracic and mediastinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Pulmonary embolism | Respiratory, thoracic and mediastinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Pulmonary haemorrhage | Respiratory, thoracic and mediastinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Pulmonary hypertension | Respiratory, thoracic and mediastinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Pulmonary mass | Respiratory, thoracic and mediastinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Pulmonary oedema | Respiratory, thoracic and mediastinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Pulmonary thrombosis | Respiratory, thoracic and mediastinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Respiratory acidosis | Respiratory, thoracic and mediastinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Respiratory distress | Respiratory, thoracic and mediastinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Respiratory failure | Respiratory, thoracic and mediastinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Sleep apnoea syndrome | Respiratory, thoracic and mediastinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Stridor | Respiratory, thoracic and mediastinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Vocal cord leukoplakia | Respiratory, thoracic and mediastinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Angioedema | Skin and subcutaneous tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Diabetic foot | Skin and subcutaneous tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Idiopathic angioedema | Skin and subcutaneous tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Neuropathic ulcer | Skin and subcutaneous tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Peau d'orange | Skin and subcutaneous tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Rash | Skin and subcutaneous tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Rash generalised | Skin and subcutaneous tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Skin ulcer | Skin and subcutaneous tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Immobile | Social circumstances | MedDRA 19.1 | Non-systematic Assessment |
| |
| Accelerated hypertension | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Aortic aneurysm | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Aortic occlusion | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Aortic stenosis | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Aortic thrombosis | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Arterial disorder | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Arterial rupture | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Arterial stenosis | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Arteriosclerosis | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Axillary vein thrombosis | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Circulatory collapse | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Deep vein thrombosis | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Diabetic vascular disorder | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Dry gangrene | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Embolism | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Embolism venous | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Femoral artery embolism | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Granulomatosis with polyangiitis | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Haematoma | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Hypertension | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Hypertensive crisis | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Hypertensive emergency | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Hypotension | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Iliac artery occlusion | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Infarction | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Intermittent claudication | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Internal haemorrhage | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Labile hypertension | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Microangiopathy | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Orthostatic hypotension | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Peripheral arterial occlusive disease | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Peripheral artery occlusion | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Peripheral artery stenosis | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Peripheral embolism | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Peripheral ischaemia | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Peripheral vascular disorder | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Shock | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Temporal arteritis | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Thrombosis | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Varicose vein | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Vascular pain | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Vasculitis | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
|
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Injection site reaction | General disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Angina pectoris | Cardiac disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Diarrhoea | Gastrointestinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Fatigue | General disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Injection site erythema | General disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Non-cardiac chest pain | General disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Bronchitis | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Influenza | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Nasopharyngitis | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Upper respiratory tract infection | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Urinary tract infection | Infections and infestations | MedDRA 19.1 | Non-systematic Assessment |
| |
| Fall | Injury, poisoning and procedural complications | MedDRA 19.1 | Non-systematic Assessment |
| |
| Diabetes mellitus | Metabolism and nutrition disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Type 2 diabetes mellitus | Metabolism and nutrition disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Arthralgia | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Back pain | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Muscle spasms | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Myalgia | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Pain in extremity | Musculoskeletal and connective tissue disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Dizziness | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Headache | Nervous system disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Cough | Respiratory, thoracic and mediastinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Dyspnoea | Respiratory, thoracic and mediastinal disorders | MedDRA 19.1 | Non-systematic Assessment |
| |
| Hypertension | Vascular disorders | MedDRA 19.1 | Non-systematic Assessment |
|
As specified in statistical analysis plan, due to discontinuation of the bococizumab clinical development program, health care resource utilization endpoints were not evaluated.
Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Pfizer ClinicalTrials.gov Call Center | Pfizer, Inc. | 1-800-718-1021 | ClinicalTrials.gov_Inquiries@pfizer.com |
| Prot_000.pdf |
| SAP | No | Yes | No | Statistical Analysis Plan | Dec 20, 2016 | Mar 21, 2018 | SAP_001.pdf |
| ID | Term |
|---|---|
| D002318 | Cardiovascular Diseases |
| D009203 | Myocardial Infarction |
| D020521 | Stroke |
| D006949 | Hyperlipidemias |
| ID | Term |
|---|---|
| D017202 | Myocardial Ischemia |
| D006331 | Heart Diseases |
| D014652 | Vascular Diseases |
| D007238 | Infarction |
| D007511 | Ischemia |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D009336 | Necrosis |
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
| D050171 | Dyslipidemias |
| D052439 | Lipid Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| C000598888 | bococizumab |
Not provided
Not provided
Not provided
| Male |
|
| Not Hispanic or Latino |
|
| Unknown or Not Reported |
|
| Asian |
|
| Native Hawaiian or Other Pacific Islander |
|
| Black or African American |
|
| White |
|
| More than one race |
|
| Unknown or Not Reported |
|
|
|
|
Participants received single dose of PF-04950615, 150 milligrams, subcutaneous injection once in every 2 weeks over a period of 3 years. Participants were followed up to 40 days after the last dose. |
|
|
|
|
|
|
|
|
|
Participants received single dose of PF-04950615, 150 milligrams, subcutaneous injection once in every 2 weeks over a period of 3 years. Participants were followed up to 40 days after the last dose. |
|
|
|
|
|
|
| Units | Counts |
|---|---|
| Participants |
|
|
|
| Units | Counts |
|---|
| Participants |
|
|
|
| Units | Counts |
|---|---|
| Participants |
|
|
|
| Units | Counts |
|---|---|
| Participants |
|
|
|
| Units | Counts |
|---|---|
| Participants |
|
|
|
| Units | Counts |
|---|
| Participants |
|
|
| Units | Counts |
|---|---|
| Participants |
|
|
|
| Units | Counts |
|---|---|
| Participants |
|
|
|
| Units | Counts |
|---|---|
| Participants |
|
|
|
| Units | Counts |
|---|---|
| Participants |
|
|
|
| Units | Counts |
|---|---|
| Participants |
|
|
|
| Units | Counts |
|---|---|
| Participants |
|
|
|
| Units | Counts |
|---|---|
| Participants |
|
|
|
| Units | Counts |
|---|---|
| Participants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|